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Schizotypal traits, when considered as an attenuated form of schizophrenia, hold 
promise in research as they grant a unique opportunity to investigate neurodevelopmental 
and psychological factors underlying schizophrenia. Theories deriving from both 
psychiatric and dimensional approaches have been employed to conceptualize and 
understand it as early as 1950s. While there are many self-report instruments measuring 
schizotypal traits, the Schizotypal Personality Questionnaire (SPQ) and Schizotypal 
Personality Questionnaire-Brief (SPQ-B) have been particularly popular as they have 
been applied widely in clinical and non-clinical settings, and validated across different 
cultures. However, while they have been widely used, there have also been questions 
raised in relation to scales’ cross-cultural validity. Such as, can test scores obtained in 
different cultural populations be interpreted in the same way across these populations? 
Can one instrument that has been reliable and valid in one particular culture be applied in 
another after translation?  Different factorial structure of both SPQ and SPQ-B have been 
found in cultural contexts, suggesting that perhaps there is cultural bias in construction 
and translation issues, implicating a need for evaluating the cross-cultural validity of SPQ 
and its related measure for further research.  
This thesis will review the theoretical viewpoints underpinning the concept of 
schizotypy, the association between schizotypy and clinical disorders, the assessment 
instruments for schizotypy – SPQ and its brief versions, their cultural application, as well 
as the future directions researchers may consider to take in light of the existing cultural 
differences. Four studies are proposed and carried out in light of the gaps identified in the 
literature by employing cross-cultural samples in this thesis. Firstly, in Study One 
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participants from Australia, Chile, China and India were recruited to examine whether the 
SPQ-B can be used cross-culturally; followed by Study two, exploring the validity of 
SPQ and its brief versions (i.e. SPQ-B and Schizotypal Personality Questionnaire-Brief 
Revise (SPQ-BR)) in Chinese Mainland population with university student sample; 
subsequently, in Study Three the items of SPQ-B and SPQ-BR were revised with a new 
translation, with the aim of developing a culturally appropriate assessment tool for 
Chinese population. Lastly, the thesis concludes with Study Four, validating the new 
scale (i.e. Chinese SPQ-BR Updated) in the Chinese clinical population.      
Key findings of the series of studies are: (i) the schizotypal measures examined in 
this thesis, including SPQ, SPQ-B, SPQ-BR, and Chinese SPQ-BR Updated did not 
appear to be adequate measures for assessing schizotypal measures in Chinese population 
regardless of whether the sample was drawn from the community/university or from a 
clinical sample; (ii) there is a possibility that the SPQ and its related brief measures 
cannot tap into ‘schizophrenia-like’ features (especially positive symptomatology) among 
Chinese participants, but certain personality traits only; (iii) the Chinese SPQ-BR 
Updated does not exclusively tap into schizotypal traits and is not recommended for 
predicting diagnoses of schizophrenia in Chinese clinical population, as it was effective 
in capturing more depression and anxiety related traits rather than the crucial component 
of schizotypy, the positive dimensions. Finally, findings and limitations of the thesis are 
discussed generally, and recommendations for future research in cross-cultural 
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This chapter will introduce readers to three major approaches that are used to 
conceptualize schizotypy and provide a selective framework for the readers to understand 
the development of theories related to schizotypy, from how it was thought as a 
phenotype representation pertaining to psychosis till it became a position placed in the 
middle on a continuum of psychosis, followed by briefly exploring the positive and 





The term ‘schizotypy’ was first coined by Rado (1953), an American 
psychoanalyst, as an abbreviation for ‘schizophrenic genotype’, which was meant to 
signify the hereditary disposition to schizophrenia (Rado, 1953; Claridge, 1997). 
However, due to conceptualizations based on different approaches (e.g personality and 
psychiatry), schizotypy has become a rather broad term, alternative terms of ‘schizotypy’ 
include ‘schizoidness’, ‘psychosis-pronesness’, and ‘psychoticism’ depending on the 
context of usage (Claridge, 1997). Nowadays, it generally refers to an enduring 
personality condition that is conceptually, clinically, etymologically related to psychosis, 
and in particular, schizophrenia (Claridge, 1997).    
Similar to schizophrenia, schizotypal traits can also be categorised into positive, 
negative and disorganised dimensions. Positive symptoms relate to traits, behaviours or 
beliefs that are present, but should not be.  They are often used interchangeably with the 
term ‘cognitive-perceptual’ elements (e.g ideas of reference, magical thinking, unusual 
perceptual ideations, and suspiciousness). In contrast, negative symptoms relate to 
attributes that are lacking, but should be present. For example, it relates to difficulties 
with interpersonal relations (e.g. social anxiety, anhedonia, and constricted affect). The 
final group of attributes is disorganised traits, such as odd speech and behaviours (Raine, 
1991; Raine et al., 1994; Raine & Benishay, 1995). Considerable effort was spent in 
understanding the range of expressions and construct of schizotypy as it represents a 
liability in developing schizophrenia (Lenzenweger, 2018). Perhaps the most influential 
early evidence that established the link between schizotypal phenomenology and clinical 
schizophrenia could be traced to the Danish Adoption Study of Schizophrenia (Kety, 
Rosenthal, Wender, & Schulsinger, 1968). Kety et al.’s finding of a significantly higher 
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incidence of schizophrenia in the close relative of patients with schizophrenia and an 
increasing incidence in such relatives implicated hereditary factors in the etiology of 
schizophrenia. However, they also acknowledged that such evidence is inconclusive as it 
fails to remove the influence of certain environmental factors. Similarly, despite there  
being evidence to suggest some unusual expressions of schizotypy (i.e. delusions, 
hallucinations and paranoid ideations) that can be found among the general population, at 
subclinical levels, without necessarily being associated with a mental health condition 
(Fonseca-Pedrero & Debbane, 2017; Linscott & Van Os, 2013; Van Os et al., 2009), few 
individuals with expression of schizotypal traits will develop schizophrenia, or even have 
psychotic episodes (i.e. they can be transitory and disappear over time, Fonseca-Pedrero 
& Debbane, 2017). It therefore asks the ultimate question, “What is the nature of 
schizotypy?”   
The intention of this chapter is to introduce the readers to three major approaches 
that are used to conceptualize schizotypy and provide a selective framework for the 
reader to understand the development of theories related to schizotypy, from how it was 
thought as a phenotype representation related to psychosis until it became a position 
placed in the middle on a continuum of psychosis, followed by briefly exploring the 
positive and negative outcomes associated with schizotypy.  
Quasi-dimensional approach 
 
In the field of conceptualizing and classifying schizotypy, three major theoretical 
viewpoints have emerged from literature. They are the quasi-dimensional (psychiatric) 
approach, the dimensional (personality) approach and the full-dimensional approach 
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(composite model) (Claridge, 1994; 1997). The quasi-dimensional viewpoint could be 
traced back to Bleuler, who coined the term ‘schizophrenia’ (Claridge, 1997), and 
investigated the pre-morbid and post-morbid personality changes after the onset of overt 
psychosis in individuals with schizophrenia and their relatives. Bleuler and Kraepelin 
made note of what they termed ‘latent schizophrenia’, a personality aberration regarded 
as a less severe expression of schizophrenia, which described schizophrenic-like traits in 
patients prior to their illness, and in the relatives of patients (Lenzenweger, 2018; Kwapil 
& Chun, 2015). Their findings considerably influenced the formation of the notion that 
there are direct signs of an underlying neurological disease process in schizophrenia 
(Claridge, 1997). The idea was embraced and further developed by Rado (1953) and 
Meehl (1990), exemplified through Rado’s creation of the term ‘schizotypy’.  Rado 
believed that schizotypy lay firmly in the domain of disease, that it is an individual’s 
genetic make-up that predisposed him/her to a lifelong schizophrenia. This particular take 
was also favoured by Crow (1991), who proposed the idea of “psychosis gene”. He 
strongly argued that there is a ‘continuum of psychosis’, running from normal, through 
affective disorder, to schizophrenia, biologically mediated by a single or a few genes for 
some unique neurodevelopmental features in brain asymmetry (Claridge, 1994; 1997). 
Meehl (1990) substantially updated his original model and later added that approximately 
10 per cent of the population was schizotypic and that about 10 per cent of schizotypes 
progress into schizophrenia (corresponding with the 1 per cent lifetime prevalence rate of 
schizophrenia, Kwapil & Chun, 2015). In general, this school of thought expressed that 
the continuity in psychosis definitely exists but it might be limited to a biological 
component in an underlying disease process. Pertinent to etiological concerns, it stressed 
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the nature and cause of neurological and psychiatric malfunctioning aspects of the disease, 
neglecting other social possibilities (Claridge, 1997). 
Dimensional approach 
 
In contrast, the dimensional approach is couched in personality theory. It 
interpreted schizotypy as a moderate expression that is located along the continuum of 
the ‘psychoticism’ personality construct, which presents in general population without 
any necessary references to abnormal psychology (Claridge, 1997; Eysenck, 1992). This 
model is most closely associated with the work of Eysenck. His theory of personality 
indicates that, like all continuous personality constructs (e.g. introversion-extraversion), 
psychosis is not categorical, that someone either has it or not, rather, it is merely an 
extreme expression along the spectrum of ‘psychoticism’ that has liability to progressing 
into personality disorders (e.g. schizoid personality, schizotypal personality disorder) 
(Claridge, 1994; Claridge, 1997; Eysenck, 1992). The personality disorders Eysenck 
proposed were eventually introduced in the DSM-III diagnostic category (Claridge, 1994). 
However, criticisms of this model are that this approach of understanding schizotypy was 
solely grounded on personality theory and omitted the intrinsic neurological processes 
involved (Claridge, 1997).   
Fully dimensional approach 
The latest fully dimensional approach, is construed as a composite model that 
incorporated elements of both the quasi-dimensional model and the dimensional model. 
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This model derives mainly from Claridge’s work, that assumes psychotic symptoms exist 
along the continuum of psychosis across the full population (DeRosse & Karlsgodt, 
2015). It concerns not only the genetic disposition but also the cognitive, social 
influences, and personality liability, as they are all implicated in the genesis of psychotic 
illness (Claridge, 1997). In Claridge’s view, symptoms of psychosis may be adaptive or 
maladaptive depending on other characteristics (i.e. intelligence). For example, some 
highly creative healthy individuals may be genetically predisposed to schizophrenia, but 
they do not necessarily become clinically psychotic due to “protective factors” such as 
high general intelligence that confers immunity in the form of intellectual reserves 
(DeRosse & Karlsgodt, 2015).  
On the continuum of psychosis, schizotypy is regarded as a dimension of 
personality, normally distributed throughout the population, sitting at the mild non-
psychotic end of the spectrum. Schizotypal Personality Disorder (SPD) falls in the 
intermediate range, while schizophrenia is on the extremely psychotic end of the 
continuum as the most severe form of psychosis (Claridge, 1994; 1997). The implication 
of the continuum is that the same types of symptoms that presented in patients with 
psychotic disorder can be found and measured in non-clinical populations (Claridge, 
1994; van Os et al., 2009), albeit in an attenuated way. 
Consequences and outcomes associated with schizotypy 
 
Individuals who are relatively high in schizotypal traits have been shown to share 
various psychophysiological, neuropsychological, cognitive characteristics with people 
25 
 
diagnosed with psychosis (Claridge, 1997). However, while high levels of schizotypal 
traits are conceived as an increased risk of psychotic illness, they are not deemed as 
essentially pathological. Schizotypal traits are found to be related to both benign and 
abnormal mental health issues (Claridge, 1997). Taking an analogy of a spectrum, on the 
benign and positive end, schizotypal traits have been found to be associated with 
creativity (Burch, Pavelis, Hamsley, & Corr, 2006; Fisher et al., 2004; Nettle, 2006) and 
spiritual experience (Jackson, 1997), while on the pathological and negative end of the 
spectrum, schizotypal traits have been found to be linked with a variety of mental health 
conditions such as lower overall life satisfaction (Abbott, Do & Byrne, 2012), diminished 
subjective well-being (Abbott & Byrne, 2012; Fumero, Marrero, & Fonseca-Pedrero, 
2018),  and other forms of pathology (Hodgekins, 2015). 
Schizotypy and Creativity  
 
The notion of “mad and creative genius” is a well-established one, with both a 
rich classical and contemporary context, from world-renowned painters such as Vincent 
Van Gogh and Pablo Picasso to Hollywood movie stars like Marilyn Monroe and Robin 
Williams (Kottler, 2006), implicating a strong link between creativity and 
psychopathology. However, the question is, does madness inspire creativity? Or does 
creativity breed madness? 
Creativity is commonly known in terms of ‘adaptive novelty’ (Eysenck, 1993), 
meaning simple idiosyncrasy or bizarreness is not sufficient, but originality, when 
appropriately applied in contexts such as solving trivial problems in daily life or 
producing aesthetically artistic performance can be regarded as creativity (Holt, 2015). 
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Past studies suggested that the links between creativity and mental illnesses are most 
obvious in schizotypy: and the peak creativity was observed among those who exhibit 
certain schizotypy characteristics (e.g. positive-impulsive and unspecified schizotypy) 
(Acer & Sen, 2013). Focusing on the spectrum of schizophrenia, creativity was lower 
among those who did not indicate any sign of schizotypy and was lowest among people 
with schizophrenia (Acar & Sen, 2013). Such findings may seem surprising as 
schizophrenia are found positively correlated with creativity (Eysenck, 1993), however, 
recent findings of patients with schizophrenia score poorly on creative cognition tests 
compared with controls, stressed the fact that schizophrenia is too debilitating to enable 
creative functioning (Holt, 2015). Thereby “schizophrenia-like” symptoms may only 
facilitate creativity up to a certain point, but inhibit it when symptoms are too severe 
(Holt, 2015).  
In contrast, schizotypy, as a mild form of schizophrenia, is related not only to 
higher scores on measures of creativity but also increased right-hemisphere brain activity 
which indicates a higher level of creative thinking (Fink, Graif & Neubauer, 2009; Fisher 
et al., 2004). In a meta-analysis, Acar and Sen (2013) reported that positive schizotypy 
(e.g. impulsive schizotypy) dimensions were significant positive predictors of creativity, 
while negative schizotypy (e.g. introvertive anhedonia) was a negative correlate of 
creativity. Similarly, a series of studies investigating the behavioural, neuropsychological, 
and neuroimaging correlates of positive and negative schizotypy, reported that positive 
schizotypy was associated with better performance on measures of creativity, enhanced 
responsivity to threatening emotional stimuli, and more right prefrontal cortical activity 
(Fisher et al., 2004). These results back the notion that positive schizotypy is related to 
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patterns of cognitive and emotional function (e.g. divergent thinking, heightened emotion) 
that are common to both creativity and psychopathology (Fisher et al., 2004).  
However, the research into creativity and schizotypy is not without any 
limitations. In a broad review, Silvia and Kaufman (2010) pointed out that there is 
enormous variability in the definition and assessment of creativity. When creativity is the 
independent variable, it was quantified based on creative eminence or scores on creativity 
tests, whereas when it was regarded as the outcome, creativity was quantified as the 
quality of creative products, lifetime creative achievements and so on.  
In summary, there appears to be a relationship between the positive features of 
schizotypy and creativity, instead of the more widely held belief of “mad and creative 
genius” which suggests a strong link between creativity and psychopathology. However, 
conclusions drawn from past studies may have been depended on how creativity was 
operationalized. Still, as a benign outcome of schizotypy, considering the value of 
creativity and how widely it is applied in everyday life, perhaps there may be a certain 
biological advantage in high schizotypy (Jackson, 1997). Lastly, a quote from Kottler 
may best describe the function of schizotypy, “Madness can afford the individual certain 
resources and abilities that are not available to others. The fantasy life, free flight of ideas, 
distortions of reality, and heightened sense that are associated with mood disorders offer 
a unique perspective on the world” (Kottler, 2006, pp:3).  
Schizotypy and Spiritual Experience   
 
The nature of the relationship between religious and psychotic experiences is 
intriguing, yet the distinction between these two is often not a clear cut. The mystical 
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states, in this case ‘Spiritual Experience’, often overlaps with delusional psychosis 
(Joseph, Smith, & Diduca, 2002). There is clinical evidence suggests that people 
experience psychosis often present with religious delusions (Maltby, Garner, Lewis, & 
Day, 2000; Joseph et al., 2002). Further, reports that members of New Religious 
Movements (i.e. religious cult groups) showing higher levels of positive schizotypal traits 
than control groups (non-religious and Christians) suggest there is a positive relationship 
between spiritual experience and schizotypy (Day & Peters, 1999).  
Spiritual Experience describes behaviours that researchers have variously termed 
religious, self-actualizing, transcendental, mystical, visionary, psychedelic, transpersonal, 
psychic experiences (Jackson, 1997). The most widely reported characteristics of such 
experiences include the sense of external presence, feeling the presence of a deceased 
person, a spiritual entity, or sentient being in nature, feelings of profound insight, being 
guided externally, or simply a loss of ego boundaries, that allowing individuals to enter 
‘another dimension’, conveying the sense of being in an ‘altered state of consciousness’ 
(Jackson, 1997).  
Experiences such as “another dimension” and “altered state of consciousness” 
could be interpreted as ‘magical thinking’ that relates to both positive facets of 
schizotypy well as positive symptomatology of schizophrenia. Interesting, one study 
reported that dimensions of religious/spiritual well-being (e.g. general religiosity, hope 
and forgiveness) based on magical thinking was not only understood as neurotic 
symptoms but also positively correlated with subjective well-being (Unterrainer, Huber, 
Sorgo, & Fink, 2011). This underlines the hypothesis that schizotypy can be both 
pathogenetic as well as salutogenetic.  
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One explanation was that there is certain ‘overlap’ between psychotic experiences 
accounted in schizotypal individuals and spiritual experience. For example, central 
themes in schizotypy research discuss anomalous patterns of attentional inhibition and 
instability of Central Nervous System homeostasis in individuals with high levels of 
schizotypal traits (Beech & Williams, 1997). These present strong parallels to early 
theories of spiritual experience, that individuals deep in the spiritual life are distinguished 
by relatively ready access to ‘unconscious’ contents, for them, ‘the door to this region 
seems unusually wide open’ (Jackson, 1997). Such experiences lead to profoundly 
positive outcomes for the experiencer, such as increased empathy, ecological awareness, 
acceptance of bereavement, altruistic feelings (Jackson, 1997) and positive subjective 
well-being (Unterrainer et al., 2011). One investigation by Powers and colleagues 
highlighted such potential ‘protective factors’ in voice-hearing experiences among 
psychics (Powers, Kelly & Corlett, 2016). Through conducting phenomenological 
interviews with clairaudient psychics who receive auditory messages, patients diagnosed 
with a psychotic disorder who hear voices and patients with a psychotic disorder without 
auditory hallucination and matched controls, it revealed that the hallucinatory 
experiences of psychics to be very similar to those of patients who were diagnosed with 
psychotic disorder (Powers, Kelly & Corlett, 2016). However, the psychics were able to 
control the onset and offset of their voices, that they were less distressed by their voice-
hearing experiences, as they were more spiritual and willing to engage with their voices 
than those in the treatment-seeking groups (patients who hear voices). These observations 
have led to implications that the capacity to have religiosity and spirituality can be seen 
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as an adaptive feature of human nature (Jackon, 1997), perhaps even a source of help and 
acceptance (Powers, Kelly & Corlett, 2016).  
In summary, the definition of ‘Spiritual Experience’ can range from religious and 
self-actualizing to psychotic and mystic, in fact, research has found schizotypal traits to 
be significantly associated with spiritual experience, by either serving the function of 
overcoming bereavement or leading the experiencer to the dark side of delusional 
psychosis. Such results underline the hypothesis that perhaps schizotypy can be both 
pathogenetic and salutogenetic.  
Schizotypy and psychopathology 
 
Since schizotypy has long historical roots in the medical model (quasi-
dimensional theory), that it was once considered as ‘latent schizophrenia’, a personality 
aberration regarded as a less severe expression of schizophrenia (Lenzenweger, 2018), it 
is therefore not surprising that a myriad of research was done on its relationship with 
different forms of psychopathology. For example, a variety of mental health conditions 
has been found to be associated with schizotypy in literature: from the diminished life 
satisfaction (higher schizotypal traits corresponds to lower overall life satisfaction) 
(Abbott, Do & Byrne, 2012); to greater risk of progressing to psychosis and related 
disorders, (adolescents and young adults who reported schizotypal experiences are at 
greater risk of developing psychosis and related disorders in future than those who do not) 
(Poulton et al., 2000; Zammit et al., 2013); to a stronger disposition to developing 
schizophrenia, (the first degrees of biological relatives of individuals with schizophrenia 
have higher-level schizotypal traits compared to the general population) (Lewis, 2012). 
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As such, schizotypy may be considered as a generalized vulnerability to common mental 
health conditions.  
The relationship between schizotypy and different forms of psychopathology will 
be outlined and discussed in depth in the following chapter (chapter III) with a particular 
focus on the underlying mechanism behind the association between schizotypy and 
clinical disorders.  
Conclusion 
 
Overall, this section has introduced and provided a selective framework for the 
reader to understand the conceptualization behind different approaches to schizotypy. 
Firstly, schizotypy in the quasi-dimensional model was thought as ‘latent schizophrenia’ 
that is genetically related to psychosis and schizophrenia. Later in the dimensional model, 
it was seen as a personality trait, an extreme expression that is located along the 
continuum of the ‘psychoticism’ personality construct. Finally, the fully dimensional 
model recognized the flaws of the preceding models and combined these two models. It 
stressed the significance that schizotypy cannot be explained or caused by one single 
factor, it is most like the interplay of genetic disposition, cognitive and social influences, 
as well as personality liability. The last approach seems to be most popular in current 
literature, as reported by a recent review that, schizotypal traits can be transient and 
vanish with time, but can progress into psychotic-spectrum disorder if coupled with 
external factors (e.g. cannabis use, stress, genetic disposition) (Fonseca-Pedrero & 
Debanne, 2017). This will be the approach we choose to take in the following chapters. 
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In addition, the present chapter also selectively briefly reviewed several outcomes 
associated schizotypy, such as creativity, spiritual experience and psychopathology. It is 
not within the scope of this thesis to discuss the limitations associated with research on 
creativity and spiritual experience in great depth, still it is interesting to note that despite 
having a lineage from medical model (quasi-dimensional), schizotypy can be thought of 
as being associated with some positive outcomes for the individual, a silver lining in a 
dark cloud rather than solely embedded in psychopathology. Furthermore, the evidence 
presented from creativity (i.e. positive schizotypy best predicts creativity) and spiritual 
experience (i.e. overcoming bereavement) represents important implications. For 
example, these studies here could suggest a need for clinicians to recognize and to work 
with the more benign, positive component of schizotypy, therefore an attitude of 
openness towards its therapeutic potential is necessary (Jackson, 1997). Many individuals 
diagnosed with psychosis feel that their intense and sometimes bizarre spiritual 
experience is pathologized by mental health professionals (Jackson, 1997), yet this aspect 
of their psyche may be precisely what holds considerable promise for healing and 
potentially transformative experiencing leading to personal and spiritual growth if given 
proper support (Hagen & Nixon, 2010). Perhaps future research may consider tapping 
into the positive psychology of schizotypy, which presents the opportunity for 
discovering human resilience and innovation, and more importantly, a new possibility of 
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Chapter II  
Schizotypy and Clinical Disorders 
Overview 
 
This chapter reviews the literature examining links between schizotypy and 
clinical disorders. It will begin by discussing current literature on schizotypal traits and 
schizophrenia, anxiety, depression as well as other forms of psychopathology. Following 
this, implications for the assessment of schizotypal traits will be discussed. The intention 
of this chapter is to introduce the readers to schizophrenia and other forms of 
psychopathology, as well as key characteristics of schizotypy, and to identify several 
central theoretical and empirical research that span across the overlap between schizotypy 












Schizotypy has been traditionally linked to psychosis and schizophrenia, however 
elevated levels of schizotypy have been highlighted in other mental health difficulties, 
including mood disorders such as anxiety, depression (Hanssen et al., 2003; 
Lewandowski et al., 2006; Lin et al., 2013); bipolar disorder (Schurhoff, Laguerre, Szoke, 
Meary, & Leboyer, 2005); proneness to develop post-traumatic stress disorder (PTSD) 
(Hardy, 2017); correlation with schizotypy and autism-spectrum disorders (ASD) 
particularly in relationship to negative symptoms (e.g. withdrawal) (Hodgekins, 2015; 
Shi et al., 2017); physical and social anhedonia (Chan et al., 2012; Wang et al., 2014), 
elevated schizotypal scores in Alzheimer’s disease with psychosis (Eror, Lopez, Dekosky, 
& Sweet, 2005); childhood trauma (Green et al., 2018; Quide et al., 2018); schizotypal 
traits that are insufficient in severity to meet a clinical diagnosis, are associated with 
increased risk of psychiatric morbidity (e.g. adolescent suicidal ideation and behaviour, 
mental health issues) (Kelleher, Cederlof, & Lichtenstein, 2014; Schimanski et al., 2017) 
and genetic susceptibility for progressing into schizophrenia (Ma et al., 2007) and so on.  
Although not all individuals identified as being at risk for psychosis in the early 
stages will eventually cross the threshold for psychotic illness, sub-clinical symptoms 
may not only indicate a specific risk but also implicate a more general underlying 
psychopathology that predisposes such individuals to various common mental disorders 
(Rössler et al., 2011). In a Rössler and colleagues’ 30-year longitudinal study, individuals 
reporting schizotypal signs at age 20 were more likely to develop common mental health 
problems (including dysthymia, bipolar disorder, social phobia, and obsessive-
compulsive disorder at age 50 (Rössler et al., 2011). Considering the range of evidence 
presented above, schizotypy can be seen as a generalized vulnerability to common mental 
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health conditions. Therefore, understanding schizotypal traits may not only assist to 
clarify aetiological mechanism, but also provide an opportunity to examine the putative 
risk associated with schizotypy (Barrantes-Vidal et al., 2015; Fonseca-Pedrero et al., 
2018). For this reason, it is important to have accurate an assessment of schizotypy. This 
chapter will focus on the links between schizotypy and schizophrenia, depression, anxiety.  
Schizophrenia 
 
Schizophrenia, a severe psychiatric disorder affecting 0.5-1% of the general 
population (Saha, Chant, Walham & McGrath, 2005). It is well known for its defining 
characteristics, i.e. positive symptoms that include hallucinations, delusions, thought 
disorders; negative symptoms that encompasses avolition, affective flattening, asociality, 
alogia, and premorbid social dysfunction (Lenzenweger, 2018; Gross, Kwapil, Raulin, 
Silvia, & Barrantes-Vidal, 2018; van Os, Kenis, & Rutten, 2010). Research evidence has 
shown that the aetiology of schizophrenia is heavily influenced by genes.  There is 
evidence of abnormalities in dopaminergic, serotonergic, and glutamatergic 
neurotransmitters systems, and profound dysfunction in a variety of neurocognitive 
processes and associated neural systems (Lensenweger, 2018; Walter, Fernandez, 
Snelling, & Barkus, 2016). Further, gene-environment interactions (e.g. level of familiar 
clustering of psychotic disorder is higher when measured in risk environments such as 
urbanicity) can increase the heritability estimation of schizophrenia (van Os et al., 2010).  
While schizotypy, represents a set of personality traits, it may reflect the 
subclinical expression of the signs and symptoms of schizophrenia (Ettinger et al., 2015), 
suggesting schizotypal can be intrinsically similar but less severe than symptoms 
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presented by individuals with the schizophrenia-spectrum disorder. Indeed, past studies 
found that positive schizotypy (e.g. unusual experiences, magic ideation) was associated 
with positive psychotic symptoms; while negative schizotypy (e.g. introvertive anhedonia) 
was associated with both positive and negative psychotic symptoms (Lin et al., 2013). 
Individuals with schizotypal traits were reported exhibiting similar social anhedonia 
comparing with patients with schizophrenia, which significantly differed from the non-
schizotypal group (Wang et al., 2014). Such evidence in the literature suggest schizotypy 
may have the ability to predict progression to schizophrenia-spectrum disorders (e.g. Lin 
et al, 2011; 2013; Lensenweger, 2018; Fonseca-Pedrero & Debbane, 2017).  
Besides symptom expressions, a myriad of recent research indicates that there is a 
significant overlap between schizotypy and schizophrenia at different levels. The 
impairments observed in schizophrenia are also reported in schizotypy, covering areas 
such as genetic proximity (e.g. similar chromosomal region in both schizophrenia and 
schizotypy) (Walter et al., 2016), brain structure and functional deficits (Ettinger, 
Meyhofer, Steffens, Wagner & Koutsouleris, 2014; Ettinger et al., 2015), cognition, eye 
movements (Ettinger et al., 2015), and environmental risk factors (e.g. winter birth, 
urbanity, migrant status, childhood trauma, cannabis use) (Ettinger et al., 2014; 
Mimarakis, Roumeliotaki, Roussos, Giakoumaki, & Bitsios, 2018).  
These above findings reveal an important overlap in schizotypal traits and 
schizophrenia, supporting the idea that the schizotypy traits indicate a unifying construct 
that links a broad continuum of clinical and subclinical psychosis manifestations together 
with normal personality variation (Kwapil & Barrantes-Vidal, 2015). Furthermore, 
understanding schizotypal traits may not only assist to clarify aetiological mechanisms of 
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schizophrenia, but also presents an opportunity to examine the putative risks and 
protective factors in order to enable early detection and preventive intervention strategies 
for those who are at risk for schizophrenia (Barrantes-Vidal et al., 2015; Fonseca-Pedrero 
et al., 2018).  
Anxiety 
 
Symptoms of anxiety are frequently present in patients with schizophrenia and 
related conditions (e.g. schizotypy) (Hanssen et al., 2003; Lewandowski et al., 2006; 
Seghers, McCleery, & Docherty, 2011; Rössler et al., 2011). In a longitudinal study 
investigating co-occurrence of personality disorders, McGlashan and colleague reported 
that the co-occurrence of schizotypal personality disorder with Axis I disorder in DSM-
IV is as high as 66.3% for major depression, 20.9% for dysthymia, 40.7% for panic 
disorder, and 31.4% for social phobia (McGlashan et al., 2000). Indeed, many of the 
symptom expressions of schizophrenia overlap with symptoms features of anxiety (e.g. 
worry, concentration difficulties) and depression (e.g. social withdrawal, anhedonia), 
suggesting there may be a common underlying mechanism (Lewandowski et al., 2006). 
In particular, findings from Freeman and colleagues’ investigation suggested a close 
association between anxiety and persecutory ideation (a feature in both schizotypy and 
schizophrenia). Through assessing the state of paranoia and social anxiety in a non-
clinical general population in the United Kingdom by using virtual reality environment, 
Freeman and colleagues found that social anxiety and persecutory ideation share many of 
the same predictive factor (Freeman et al., 2008). When an individual is feeling anxious, 
“having odd internal feelings in social situations may lead to delusional ideas through a 
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sense of things not seeming right”, it confirms the idea that anxiety can very much 
contribute to paranoid experience (Freeman et al., 2008). 
However, despite seemingly sharing a number of similarities with the negative 
dimension of schizophrenia, research on anxiety and depression revealed otherwise 
(Lewandowski et al., 2006). Past findings show that anxiety appears to be more strongly 
associated with the positive factor of schizophrenia and schizotypy rather than the 
negative factor (Lewandowski et al., 2006; Lin et al., 2013). To be precise, correlations 
between anxiety and unusual experience, cognitive disorganisation, as well as impulsive 
nonconformity have been reported (Day & Peters, 1999; Lin et al., 2013). An explanation 
offered by Debbané and colleagues pointed out that there is a bidirectional, reciprocal 
relationship between anxiety and positive schizotypy. Anxiety influences the expression 
of schizotypy, while positive schizotypal cognitions (e.g. hallucination and delusion-like 
expressions) encourage symptoms of anxiety or anxiety-provoking events, including 
schizotypal thought content, that could be associated with the persistence positive 
schizotypy and ongoing psychological distress in adolescents (Debbané et al., 2012). To 
back up this explanation further, Najolia, Buckner and Cohen (2012) found that social 
anxiety moderated the relationship between schizotypy and frequent cannabis use and 
more cannabis-related problems among cannabis users, even after controlling for the 
impact of depression and trait anxiety. Such a finding potentially leads to speculation that, 
as some clinical evidence has suggested that cannabis is effective in reducing anxiety 
symptoms (Walsh et al., 2013), so perhaps some people use cannabis for reducing 
feelings of anxiety associated with schizotypy.  
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However, one limitation that has emerged in the literature can provide an 
alternative explanation for the link between anxiety and schizotypy. Several studies (e.g. 
Day & Peters, 1999; Lin et al., 2013) mentioned above employed O-LIFE (Oxford-
Liverpool Inventory of Feelings and Experiences) to assess schizotypal traits. A 
particular item on the unusual experiences subscale of O-LIFE is “do you ever have a 
sense of vague danger or sudden dread for reasons that you do not understand”. This is 
likely to be endorsed by individuals experiencing high levels of anxiety, especially 
considering O-LIFE only gives respondents dichotomous answering format of selecting 
“true” or “false” (Hodgekins, 2015). Such design of a schizotypal measure may plausibly 
inflate the scores of anxiety-related items, and therefore explain the established strong 
association between anxiety and schizotypal traits. It also underpins the importance of 
having a valid measuring instrument for assessing schizotypy. The issues surround 
schizotypal measures will be outlined and discussed in-depth in the following chapter.   
Depression 
 
Similar to anxiety, many studies investigating the relationship between mood 
disorder and poor emotional affect included both anxiety and depression as their variables. 
The impact of depression on schizotypy appears to be the same as anxiety (see studies 
reviewed above), for example, there is an established pattern among individuals 
manifesting schizotypal personality traits, that they exhibit increased levels of depression, 
anxiety, social impairment, while they appear to be less able to identify and verbalize the 
emotions they are experiencing (Seghers et al., 2011). However, the findings on the 
association between depression and schizotypy are inconsistent.  
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Several studies mentioned in the previous section established the fact that 
depression is more strongly associated with positive schizotypy instead of negative 
schizotypy (Lewandowski et al., 2006; Lin et al., 2013). However, others found that 
depression was more closely related to the disorganized and negative schizotypy (i.e. 
interpersonal factors) (Fonseca-Pedrero, Paino, Giraldez, & Muniz, 2011; Najolia et al., 
2012), or all aspects of schizotypy (i.e. cognitive disorganisation, unusual experience, 
introvertive anhedonia) (Day & Peters, 1999). Such variability in findings could be 
attributed to the use of different measures of schizotypy. For example, some researchers 
utilized Schizotypal Personality Questionnaires-Brief (SPQ-B) (e.g. Fonseca-Pedrero et 
al., 2011), while others preferred O-LIFE (e.g. Day & Peters, 1999; Lin et al., 2013). 
Refer to Chapter III for a detailed description of instruments assessing schizotypy.    
However, more importantly, the divergent results suggest that schizotypal traits 
may fluctuate due to the influence of biological and environmental factors. Some of the 
dimensions of schizotypal traits could be more likely to be underpinned by stable genetic 
factors, while others are triggered by an environmental factor (Walter et al., 2016). For 
instance, disorganization and interpersonal schizotypal traits are enduringly stable 
because there is a biological underpinning to them (Walter et al., 2016). Whilst 
expressions of unusual perceptual experiences may be more susceptible to an interaction 
of genetic and environmental influences, given that they are likely triggered by factors 
such as stress or substance use (Walter et al., 2016). In this sense, it can be inferred that 
the association between depression and schizotypy could be moderated or affected by 
environmental factors such as stress or substance use. Certainly, more studies are 
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required in order to confirm how biological and/or environmental factors alter 
schizotypal traits.    
Conclusion and Implications 
 
This chapter has reviewed and discussed the links between schizotypy and 
psychopathology with a particular focus on schizophrenia, anxiety and depression. When 
occurring in conjunction with psychopathology, schizotypy may complicate the disorder 
presentation and produce a negative impact on recovery and long-term outcomes, it might 
also lead to the development of a range of mental health issues including mood disorders 
and anxiety (Hodgekins, 2015; Rössler et al., 2011). In summary, schizotypy, as a set of 
personality traits that reflects the subclinical expression of the signs and symptoms of 
schizophrenia, shares a number of common characteristics with schizophrenia. The 
impairments observed in schizophrenia are often reported in schizotypy, covering 
different aspects, from genetic heritability to environmental risk factors. Furthermore, 
current research reveals that anxiety and depression symptoms are frequently present in 
patients with schizophrenia and schizotypy. Anxiety, in particular, was thought to have a 
bidirectional and reciprocal relationship with positive schizotypy, this relationship might 
be related to the moderation of cannabis use as well as the design of schizotypy 
instrument. In relation to depression, on the other hand, despite having an established 
association with schizotypy (Seghers et al., 2011), findings on this link appear to be 
inconsistent.  
These gaps in the literature suggest that the presence of schizotypal traits would 
not only increase an individual’s risk of making a transition to schizophrenia but also 
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represents a risk indicator for generalized mental health conditions. Therefore, it is 
important to have psychometrically sound instruments for measuring schizotypy, to 
enable early detection and intervention for mental health conditions. Critically reviewing 
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One of the most popular instruments for measuring schizotypy is the Schizotypal 
Personality Questionnaire (SPQ), since its introduction by Adrian Raine in 1991 (Raine, 
1991), it has been modified, revised and shortened into different versions, including the 
Schizotypal Personality Questionnaire-Brief (SPQ-B; Raine & Benishay, 1995), the 
Schizotypal Personality Questionnaire-Brief Revised (SPQ-BR; Callaway, Cohen, 
Matthews & Dinzeo, 2014) as well as the Schizotypal Personality Questionnaire-Brief 
Revised Updated (SPQ-BR U; Davidson, Hoffman, & Spaulding, 2016). These have been 
widely replicated and validated in various countries. However, the cross-cultural 
construct validity of SPQ and SPQ-B has remained a pending question. This is mostly 
due to the findings of the controversial factorial structure of the instrument, bias in the 
construction, mixed psychometric property as well as cultural differences. This chapter 
introduces the different measures of schizotypy, critically reviews the assessment tools of 
schizotypy (the SPQ and its associated versions), and then discusses the various 
limitations that have emerged in current literature. This chapter concludes with the 
directions of future research, which informs the reader of the rationale for the empirical 




There are three major methods for identifying schizotypy. First, the familial 
approach entails assessing at-risk participants (i.e. the first-degree relative of patients 
with schizophrenia), this is most well-known due to the considerable amount of studies 
involving family member and relatives of schizophrenia patients. Second, the clinical 
approach, it identifies high-risk individuals based on schizophrenia or prodromal 
diagnoses. The last approach is psychometric instruments, which involves using sound 
psychometric research instruments that are designed to identify symptoms, trait, 
neurocognitive and biobehavioural vulnerability to schizotypy (Kwapil & Chun, 2015). 
The psychometric questionnaires present a number of notable advantages, such as they 
are by their nature non-invasive and inexpensive. This allows ease of administration and 
scoring. Thus it is feasible to screen a large number of individuals from the general 
population at one time (Kwapil & Chun, 2015). 
There are many existing psychometric measuring instruments for schizotypy. 
These include; The Wisconsin Schizotypy Scales (i.e. also known as Chapman Scales of 
Psychosis Proneness) (Chapman, Chapman, & Raulin, 1976; Chapman, Edell, & 
Chapman, 1980; Eckblad & Chapman, 1983; Eckblad, Chapman, Chapman, & Mishlove, 
1982), The Psychoticism Scale (Chapman, Chapman & Kwapil, 1994); Oxford 
Schizotypal Personality Scale (STA; Claridge & Broks, 1984); The Schizotypal 
Personality Questionnaire (SPQ; Raine, 1991), its brief version (SPQ-B; Raine & 
Benishay, 1995), its brief revised version (SPQ-BR; Callaway, Cohen, Matthews, & 
Dinzeo, 2014). Details of current schizotypy measures outlining the name of the test, its 
authors, the year of development, the purpose of development, content, subscales, 
number of items, internal consistency and other findings are presented in Table 1.  
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This chapter aims to critically review the assessment tools of schizotypy by 
focusing on the SPQ and its associated versions, identifying the gaps in the literature with 
discussions around underlying factorial solutions, psychometric properties as well as 
limitations in terms of cultural differences, and finally concluding this chapter with 
suggestions for future research.  
The SPQ and SPQ-B 
 
Among all the psychometric scale summarized in Table 1, one of the most 
popular measuring instruments for schizotypy is the Schizotypal Personality 
Questionnaire (SPQ). Since its introduction by Adrian Raine in 1991 (Raine, 1991), it has 
been modified, revised and shortened into versions as the Schizotypal Personality 
Questionnaire-Brief (SPQ-B; Raine & Benishay, 1995) and the Schizotypal Personality 
Questionnaire-Brief Revised (SPQ-BR; Callaway et al., 2014). Although it is widely used 
due to its popularity, the series of revisions suggest that perhaps the underlying structure 
of SPQ is not yet clearly established.   
The SPQ is a 74-item dichotomous (yes/no) format self-report questionnaire 
developed based on the nine features of Schizotypal Personality Disorder (SPD) as 
defined in the Diagnostic and Statistical Manual of Mental Disorders (DSM). Each “Yes” 
response on the SPQ item scores one point, with the total scores ranging from 0 to 74. 
The subscales scores can be calculated by the addition of the items endorsed in the 
individual subscales. The SPQ is constructed in a way that, the 74 items group together to 
be nine subscales, which directly reflects the diagnostic criteria of all nine symptoms of 
SPD in DSM-III: social anxiety, no close friends, constricted affect, paranoia, ideas of 
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reference, magical thinking, unusual perceptual experiences, odd speech, and odd 
behavior (Raine, 1991). The subscales of the SPQ originally found to be classified into 
three factors, which relate in part to the three components of schizophrenia: cognitive-
perceptual problems (positive symptoms), interpersonal problems (negative symptoms) 
and disorganisation (Raine et al., 1994). However, other underlying dimensional 
structures of the SPQ have also been demonstrated in the literature, which will be 
discussed in detail in later sections.  
Being a popular measure of schizotypy among researchers, the SPQ has received 
a number of revisions. Such as an adaption of a Likert version, in which the original 
dichotomous (yes/no) response format became a 5-point score scale from ‘Strongly 
disagree’ to ‘Strongly agree’ (Wuthrich & Bates, 2005); a brief version, the SPQ-B 
(Raine & Benishay, 1995), in which the SPQ was shortened into 22-items; a 5-point 
Likert version for the SPQ-B, in which participants’ response ranges from ‘Strongly 
Disagree’ to ‘Neutral’ to ‘Strongly Agree’ (Cohen, Matthews, Najolia, & Brown, 2010); 
a brief-revised version of SPQ, the SPQ-BR, which employs a 5-point Likert scale and 
contains 34 items extracted from the original SPQ (Cohen et al., 2010) and a brief-revised 
updated version (Davidson, Hoffman, & Spaulding, 2016). Among them, the SPQ-B has 
received much more attention and been considered as more preferable than the original 
74-items SPQ, as its brevity makes it a more attractive option as a screening measure 
(SPQ-B; Raine & Benishay, 1995). It retains 22 items from the original SPQ scale, also 
inherits the 3-factor dimensions structure (Raine & Benishay, 1995).  
Both the SPQ and SPQ-B have demonstrated construct validity across cultures 
and invariance across psychopathology, gender and religion (Axelrod, Grilo, Sanislow, & 
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McGlashan, 2001; Aycicegi, Dinn, & Harris, 2005; Badoud, Chanal, Van der Linden, 
Eliez, & Debbane, 2011; Chen, Hsiao, & Lin, 1997; Compton, Chien, & Bollini, 2007; 
Compton, Goulding, Bakeman, & McClure-Tone, 2009a, 2009b; Fossati, Raine, Carretta, 
Leonardi, & Maffei, 2003; Hu & Bentler, 1999; Ma et al., 2015; Mata, Mataix-Cols, & 
Peralta, 2005; Preti et al., 2015; Ciero, 2015; Compton, Chien & Bollini, 2007; Chen, 
Hsiao & Lin, 1997; Fossati et al., 2003; Fonseca-Pedrero et al., 2014a; Fonseca-Pedrero 
et al., 2014b; Ortuno-Sierra et al., 2013; Reynold et al., 2000). They have been both 
applied with the non-clinical community and psychiatric populations (Axelrod et al., 
2001; Badoud et al., 2011; Compton et al., 2007; Compton et al., 2009; Gross et al., 2014; 
Mata et al., 2005). In addition, they have undergone translation and validation in different 
languages and cultures (e.g. Chinese SPQ and SPQ-B, Spanish SPQ-B, Japanese SPQ-B, 
Italian SPQ, French SPQ, Greek SPQ, and etc) (Aycicegi et al., 2005; Badoud et al., 2011; 
Compton et al., 2007; Fonseca-Pedrero et al., 2011; Fonssati et al., 2003; Ito et al., 2010; 
Ma et al., 2015; Mata et al., 2005; Preti et al., 2015; Stefanis et al., 2004). Refer to Table 
2 for more details of the previous studies in regards to statistical analytic method, latent 




Table 1. Summary of psychometric measures of schizotypy: authors and years, name of the test, purpose of development, content, 
subscales, number of items, internal consistency and other findings (in chronological order). 
Authors 
(years) 
Test  Purpose of 
development  
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Table 2. Psychometric studies of SPQ and its brief versions, outlining sample description, statistical analytic methods, materials, 
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Although the SPQ and SPQ-B have been widely applied and replicated around the 
world, they are not without limitations. Firstly, there are inconsistencies in the findings 
regarding the underlying factor structure proposed for the SPQ.  For example, there has 
been significant debate about which model - Raine’s 3-factor model or Stefanis et al.’s 4-
factor model provides the best structural fit? Such controversy can raise intrinsic 
questions like, whether the SPQ is even capable of assessing schizotypal traits. Secondly, 
the majority of cross-cultural studies presents incongruous results in regards to 
replicating Raine’s original 3-factor structure.  This implies the cross-cultural validity of 
these instruments, after a myriad of replication studies, is in fact still unestablished. 
Thirdly, the SPQ and SPQ-B subscales have been criticized for low levels of reliability 
(Cohen et al., 2010), which occurs especially when a translated version is involved. It, in 
turn, implicates potential bias in instrument construction. The following section of the 
report will discuss these issues of dimensional structure, the cross-cultural construct 
validity, and the implications of mixed findings of psychometric property.  
Schizotypy as a dimensional structure 
 
There is no doubt that schizotypy by nature possesses a multiple dimensional 
structures, but the dispute among the researchers at the moment is how many and what 
kind of dimensional factors can truly elucidate schizotypal traits. For the SPQ’s factorial 
structure, Stefanis and colleagues created the 4-factor model by pointing out the 
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insufficient factor inclusion of original 3-factor. They argued that the 'positive' 
schizotypy factor in Raine et al.’s (1994) 3-factor model, which includes items of 
cognitive-perceptual and paranoid dimensions, should, in fact, be two independent factors. 
This model was reported to provide the best fit among all factor models (e.g. Kendler 2-
factor, Crow 2-factor, Fogelson et al 5-factor, etc) including Raine’s 3-factor model 
(Stefanis et al., 2004). However, past results actually indicated that both Raine’s original 
3-factor and Stefanis et al.’s 4-factor have been well replicated (for 3-factor: Axelrod et 
al., 2001; Badoud et al., 2011; Chen et al., 1997; Compton et al., 2007; Compton et al., 
2009a; Fonseca-Pedroero et al., 2009; Fossati et al., 2003; Mata et al., 2005; Reynold et 
al., 2009; for 4-factor: Compton et al., 2009b; Cicero, 2015; Gross et al., 2014).  
Moreover, recent studies have taken up great interest in investigating a complex 
construct of the SPQ, which is testing its bifactor model that includes finding both nine-
subscale as the first-order and two-factor as the second-order (Preti et al., 2015b), and 
first-order remains the same but with a four-factor as the second-order (Fonseca-Pedrero 
et al., 2014b). Nonetheless, the findings from a measurement invariance study by Cicero 
(2015), who used 1158 multi-ethnic sample found that Stefanis et al’s 4-factor model fits 
better than 3-factor and displayed configural and metric invariance across groups. The 
lack of scalar invariance was due to intercepts of ideas of reference and suspiciousness on 
the White sample (samples include Asian, White, Pacific Islander, and others), which 
suggest the cause for divergent finding may lie in ethnic difference.  
Similarly, factor analytic studies exploring the dimensional structure of the SPQ-
B have yielded mixed results with 2, 3 and 4 factor models all receiving some support 
(Axelrod et al., 2001; Ayciegi et al., 2005; Boyda et al., 2013; Cohen et al., 2010; 
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Compton et al., 2007; Compton et al., 2009a; Fonseca-Pedrero et al., 2009; Ma et al., 
2015; Mata et al., 2005). To my knowledge, only a few preceding studies have offered 
evidence of the measurement invariance across cultures for SPQ-B. One of the studies 
suggested that Raine’s 3-factor model provided the best fit and measurement equivalence 
across Spanish and Swiss samples (Ortuno-Sierra et al., 2013). Another found that both 
3- and 4-factor are invariant across gender and age in Spanish students (Fonseca-Pedrero 
et al., 2011). One possible explanation can be, that since the paranoid factor from 4-factor 
model is intrinsically related to the cognitive-perceptual construct, how schizotypal traits 
of these constructs are manifested in a group of people may be less distinctive. Rather, 
they may be located in a grey area (on the borderline in-between cognitive-perceptual and 
paranoid problems). Subtle individual differences in the sample such as ethnic and 
cultural variations could sometimes enlarge such differences, which created the outcome 
of both factor solutions being valid at the same time. This assumption, in addition, gives 
an explanation for why more than one past studies have attempted to modify the existing 
3-factor/4-factor models after they failed to provide an ideal fit to their sample data 
(Barron et al., 2015; Cohen et al., 2010; Wuthrich & Bates, 2006). 
Modifying existing models 
 
Modifying the existing factorial models to fit the sample populations exist in both 
the SPQ and SPQ-B studies (Barron et al., 2015; Cohen et al., 2010; Wuthrich & Bates, 
2006). For example, for SPQ, Wuthrich and Bates (2006) modified Raine et al.’s 3-factor 
model in hope to produce a better fit in the Australian university students sample as their 
initial finding showed that both the 4-factor model and 3-factor model fit data sample 
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inadequately among all the competing models (i.e. 2-, 3- and 4-factor solutions). 
Similarly, the SPQ-B was criticized for its validity, as the result, Cohen and colleagues’ 
modified and revised the original SPQ-B for the same reason in their study (Cohen et al., 
2010). By adding more items to the SPQ-B as well as constructing the scale with a Likert 
response format, the dimensional structure of SPQ-BR (i.e. 7-factor second order with 3- 
/4-factor as first order) has demonstrated goodness of fit through a replication study 
(Callaway, et al., 2014) as well as measurement invariance across American and Spanish 
samples (Fonseca-Pedrero et al., 2016). In general, past study results have displayed 
inconsistent factorial solutions for the both SPQ and SPQ-B, the implication was that 
perhaps subtle individual differences may be the underlying cause as some researchers 




Establishing the cross-culture construct validity for an assessment tool usually 
entails the replication of the factor structure. If the factor dimensions of the instrument 
demonstrate invariance/equivalence across cultures, then the cross-cultural validity may 
be inferred (Dana, 2005). This is usually achieved by testing multiple-group CFA, as well 
as measurement invariance (Dana, 2005). In the case of the SPQ and the SPQ-B, cross-
cultural validity appears to be problematic. Firstly, there is incongruence in the factorial 
structure of these instruments across cultural contexts. For example, in a Chinese context, 
Raine’s 3-factor model was found to be the constant best fitting model through 
confirmatory factor analysis (CFA) while a 2-factor model was detected with a Turkish 
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SPQ-B by principal-components factor analysis (Aycicegi et al., 2005; Chen et al., 1997; 
Ma et al., 2015). These findings suggest that perhaps the subtle cultural differences 
contribute to the factorial solutions in dissimilar cultures. In particular, Chinese samples 
have been found to report significantly lower SPQ scores than their Caucasian 
counterparts. It may be that the less permissive Chinese culture might have inhibited the 
respondents from reporting some abnormal experiences (Chen, Hsiao & Lin, 1997). For 
interpersonal schizotypal aspects, Caucasian participants tend to have lower scores than 
other ethnic groups (Cicero, 2015). Previous research suggests that people in Western 
cultures express emotions more strongly than people in Asian cultures, especially in 
social situations (Matsumoto, 1989). Furthermore, as a representation of cultural 
behaviour, the extent and purpose of eye contact vary across cultures. Maintaining eye 
contact is considered respectful in European cultures, whereas too much eye contact 
could appear disrespectful in East-Asian cultures (McCarthy, Lee, Itakura & Muir, 2006). 
In general, the concept of culture denotes to people’s way of living, their values, beliefs, 
knowledge and practices which strongly shape the way people think, feel and behave 
(Jack, Caldara & Schyns, 2012). Having significant differences in cultural practices (e.g. 
expression of emotion, eye contact) would possibly reflect and influence how people in a 
particular culture would interpret and respond to psychological assessments, 
consequently, it is essential to consider the cultural implications when applying the SPQ 
and SPQ-B cross-culturally.  
 
Second, only a few studies have performed measurement invariance on the SPQ 
and SPQ-B to establish cross-cultural validity (Cicero, 2015; Fonseca-Pedreoro et al., 
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2014a; Ortuno-Sierra et al., 2013). And only one preceding study has provided evidence 
of the measurement invariance of the SPQ-B across cultural groups (i.e. with Spanish and 
Swiss sample; Ortuno-Sierra et al., 2013). Ortuno-Sierra and colleagues found that 
Raine’s 3-factor model provided the best fit and measurement equivalence across Spanish 
and Swiss samples. Nonetheless, there is a possibility that since both Spain and 
Switzerland are located in Europe and to a certain extent share a similar Western culture 
the generalizability of the study may be limited. In light of the cultural differences above, 
it is possible that measurement invariance is difficult to establish due to the divergent 
factorial finding, consequently, further investigations are required to ascertain this.   
Mixed psychometric property in the cultural context 
 
Many translated SPQ and SPQ-B subscales are associated with low levels of 
reliability (Axelrod et al., 2001; Aycicegi et al., 2005; Fonseca-Pedrero et al., 2011; Ma 
et al., 2015; Preti et al., 2015), which signifies a potential bias in instrument construction 
in relation to translation accuracy. For example, low reliability was reported with the 
Chinese version SPQ-B (i.e. evaluated using Kuder-Richardson formula 20, reliability 
coefficients for the three subscales are between 0.67-0.73; Ma et al., 2015). Similarly, 
poor reliability coefficients, ranging from 0.60 to 0.67 have also been reported for the 
Japanese version SPQ-B (Ito et al., 2010). To further illustrate the issue of reliability in 
the translated SPQ-B, in the aforementioned study where the researchers attempted to 
validate the Turkish version SPQ-B with English SPQ-B, observed that the original 
English SPQ-B (i.e. alpha coefficients: 0.52, 0.74, 0.68) showed relatively better 
reliability than the Turkish version SPQ-B across subscales (i.e. alpha coefficients: 0.58, 
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0.66, and 0.60) (Aycicegi et al., 2005). Furthermore, cultural bias is probably present in 
the process of constructing the translated scale. Taking the example of Chinese SPQ-B 
again, the authors acknowledged that some items on this instrument were made to be 
semantically ambiguous in order to limit the effects of social stigmatisation associated 
with psychotic individuals. In the translation process, three experts in medical fields were 
involved to ensure the accuracy of the words chosen, however neutral words were often 
selected to avoid illness-related connotations (Ma et al., 2010). It, in turn, creates a 
predicament, upon the conspicuous cultural difference presented above that may affect 
how participants respond to the items on SPQ-B, how can we ascertain the findings 
resulted from this scale is genuine, and not due to translation accuracies concerning the 
content of the item? It is, therefore, crucial to contemplate, whether the current translated 
SPQ and SPQ-B are valid cross-culturally for assessing schizotypal traits.  
Future directions 
 
In summary, this report has reviewed the theoretical models that gave birth to the 
idea of ‘schizotypy’ (i.e. quasi-dimensional, dimensional and full-dimensional 
approaches), outlined the association between schizotypy and mental health issues, 
examined the assessment tools of schizotypy (the SPQ and the SPQ-B), followed by 
discussing the limitations of preceding studies with references to the SPQ and SPQ-B (i.e. 
controversial factorial structure, issues in cross-cultural application, mixed psychometric 
property) and provided possible explanations for those shortcomings. The following 
section of this report will offer suggestions on how to improve the sensitivity and cross-
cultural validity of the instrument in order to assess schizotypal traits more veraciously in 
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the community. To achieve the intended objectives, corresponding studies are proposed 
below.   
Measurement invariance studies 
 
There are well-established differences in perceptions, reporting of psychosis-
related traits and behaviours based on ethnic minority and immigration status within- 
countries and cultures (e.g. Linscott, Marie, Arnott & Clarke, 2006; Morgan, 
Charalambides, Hutchinson & Murray, 2010). However, before within-culture can be 
established, general reliability and validity for cross-culture difference on which the SPQ 
was designed for must be established. In other words, invariance testing needs to be 
conducted to determine if the scale appears to be measuring the same construct in 
different culture, then we can move to establish within-culture reliability and validity. 
Therefore, firstly, to establish the cross-culture construct validity for an assessment tool is 
done through replicating the same factor structure across cultures, through performing 
multiple-group CFAs, as well as measurement invariance (Dana, 2005). Measurement 
Invariance indicates whether the construct measured has the same structure and meaning 
across the groups compared, that entails testing a hierarchical set of steps with additional 
constraints applied each time (Byrne, 2012). To be precise, the first step (configural 
model) begins by determining a well-fitting multi-group baseline model and continuing 
with the establishment of successive equivalence constraints in the model parameters 
across groups (Byrne, 2012). Following the configural model, strong invariance (metric) 
model and a strict invariance (scalar) model models are to be established. Measurement 




To my knowledge, only a few preceding studies have provided evidence of the 
measurement invariance of the SPQ and SPQ-B across cultural groups (Cicero, 2015; 
Ortuno-Sierra et al., 2013; Fonseca-Pedrero et al., 2017; 2018). However, the 
generalizability of their results may be limited as their sample data were mainly collected 
from Western cultures except for Fonseca-Pedrero and colleagues’ works in 2017 and 
2018. It is therefore encouraged to include samples from other cultural groups to examine 
the schizotypal traits for establishing the cross-cultural validity.  
The Likert scale response format 
 
In past literature, the majority of the studies used the instrument with a 
dichotomous format and only a few studies adopted Likert version for the SPQ or SPQ-B 
(Cohen et al., 2010; Wuthrich & Bates, 2005; Wuthrich & Bates, 2006). Compared to 
binary choices (Yes / No), studies using a 5-point Likert scale (ranging from ‘0’ (strongly 
disagree) to ‘4’ (strongly agree) reported increased reliability of the instrument and 
schizotypal symptom reporting. It implies that a Likert scale response format may 
potentially be more sensitive than the traditional dichotomous format in predicating 
schizotypal traits (Wuthrich & Bates, 2005). It is because, having a traditional binary 
format can induce issues like ‘leading questions’ as it creates acquiescence bias (Johns, 
2010). In other words, due to limited response options, the design of the questionnaire 
can potentially lead respondents towards a particular answer or opinion easily. For 
instance, when participants are given only two choices (“agree” or “disagree”) for a 
question such as “Individuals are more to blame than social conditions for crime in this 
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country”, they had to select an option which may not truly reflect their opinion because 
they could not “remaining neutral” (Johns, 2010).  
Such sensitivity of an instrument is extremely important as an evolution of 
schizotypal traits is not merely limited to formal diagnosis of schizophrenia but also 
relate to other mental health issues (e.g. creativity, low subjective wellbeing, 
neurocognitive abnormalities, and social deficits) (Abbott & Byrne, 2012; Nettle, 2006). 
It is therefore recommended in future research that, investigators shall adopt a Likert 
format SPQ/SPQ-B for higher reliability.   
Review and revise the schizotypy assessment tools  
 
In light of the divergent cultural findings, it is necessary to contemplate two 
aspects. First, whether one instrument that is reliable and valid in one particular culture 
can be applied “as it is” in another after translation. Culture in general greatly impacts on 
people’s way of living, their values, beliefs, knowledge and practices that strongly shape 
how they think, feel and behave (Jack, Caldara & Schyns, 2012). In regards to creating 
cross-cultural instruments, rewriting the targeted instrument into another language has 
been widely accepted in psychological research. However a translation that is simply 
linguistically correct may not suffice, not to mention the procedure itself is often 
associated with various kinds of error (van de Vijver & Tanzer, 2004). The adaptation 
should be implemented in such a way that the underlying constructs were measured 
adequately in each language with consideration of differential appropriateness of the item 
content in light of cultural difference (van de Vijver & Tanzer, 2004). Thus, reassembly 




Second, for revising the schizotypy assessment tools, the future researchers may 
consider investigating how the schizotypal traits are manifested in clinical samples and 
how such traits in a clinical population, if possible, are influenced by cultural context. 
The conception of the original SPQ could be traced back to 1991, which is based on the 
diagnostic criteria of schizotypal personality disorder in DSM-III-R that is well regarded 
and frequently referred to as a diagnostic guideline for psychological disorders in a 
clinical setting. It thereby suggests that the SPQ was initially designed to potentially 
serve as an assessment in clinical diagnosis. However, given that currently the majority 
of the studies on schizotypy were confined to community and student samples (Axelrod, 
Grilo, Sanislow & McGlashan, 2001; Compton, Goulding, Bakeman & McClure-Tone, 
2009a; Compton, Goulding, Bakeman & McClure-Tone, 2009b; Gross et al., 2014; Ma et 
al., 2005), evidence of the SPQ’s validity for assessing clinical samples is rather limited. 
Furthermore, the psychometric properties of the SPQ may vary when examined in 
clinical settings, as the factors and items underlying SPD may possess different 
sensitivity and specificity for identifying schizotypal traits in persons across clinical and 
community samples (Axelrod et al., 2001). It is thus advised that, the future researchers 
should examine how the manifestation of schizotypal traits occur in clinical samples in 
order to determine an appropriate cut-off point to delineate to what extent is the scores 
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Study One: The Schizotypal Personality Questionnaire-Brief lacks measurement 
invariance across three countries 
Abstract 
 
The Schizotypal Personality Questionnaire-Brief (SPQ-B) is a commonly-used 
tool for measuring schizotypal personality traits and due to its wide application, its cross-
cultural validity is of interest. Previous studies suggest that the SPQ-B either has a three- 
or four-factor structure, but the majority of studies have been conducted in Western 
contexts and little is known about the psychometric properties of the scale in other 
populations. In this study factorial invariance testing across three cultural contexts – 
Australia, China and Chile was conducted.  In total, 729 young adults (Mean age = 23.99 
years, SD = 9.87 years) participated.  Invariance testing did not support the four-factor 
model across three countries. Confirmatory Factor Analyses revealed that neither the 
four- nor three-factor model had strong fit in any of the settings. However, in comparison 
with other competing models, the four-factor model showed the best for the Australian 
sample, while the three-factor model was the most reasonable for both Chinese and 
Chilean samples. The reliability of the SPQ-B scores, estimated with Omega, ranged 
from 0.86 to 0.91.These findings suggest that the SPQ-B factors are not consistent across 
different cultural groups. We suggest that these differences could be attributed to 
potential confounding cultural and translation issues. 
 
Note: This chapter has been published in the journal of Psychiatry research, see citation: 
96 
 
Liu, S., Mellor, D., Ling, M., Saiz, J. L., Vinet, E. V., Xu, X., Renati, S & Byrne, L. K. 
(2017). The Schizotypal Personality Questionnaire-Brief lacks measurement invariance 






Schizotypy is a heterogeneous construct that has been used by researchers and 
clinicians to describe schizotypal traits, psychosis-proneness, and psychotic-like 
experiences.  Coined by Meehl (1962), it refers to a personality organisation that 
represents the vulnerability for developing psychotic-spectrum disorders. Expression of 
schizotypal traits (e.g. hallucinatory and delusional experiences), despite having a 
transient nature and possibly vanishing over time, can occur in the general population, 
without necessarily being associated with a mental health condition (Fonseca-Pedrero & 
Debbané, 2017; Linscott & Van Os, 2013; Van Os et al., 2009). For example, an 
international study conducted by McGrath and colleagues (2015) sampling 31261 adults 
in the community from 18 countries, found that the average life-time prevalence of 
psychotic experience was 5.8%. Further, evidence from a meta-analysis showed that the 
risk of conversion to a clinical psychotic outcome among people who report subthreshold 
psychotic experiences (0.56%) is 3.5 times higher than those without exposure to such 
experiences (0.16%), particularly the experiences were severe or persistent (Kaymaz et 
al., 2012). Other longitudinal studies (e.g., Poulton et al., 2000; Zammit et al., 2013) also 
suggest that adolescents and young adults who report such schizotypal experiences are at 
greater risk of developing psychosis and related disorders than those who do not. These 
studies suggest that the presence of schizotypal features may represent a liability to 
developing symptoms of schizophrenia or transitioning from subclinical impairments to a 
full-blown psychosis, and this is especially the case if genetic and environmental risk 
factors are present (e.g. degree of relatedness to family member with schizophrenia, 
cannabis use) (Linscott and Van Os, 2013; Debbané et al., 2015; Van Os et al., 2009). It 
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is therefore important to identify and address schizotypal traits as early as possible as 
early detection and intervention may enable prevention of, or reduce the probability of 
progression in psychosis (Fonseca-Pedrero et al., 2016; Ortuno-Sierra et al., 2013).  
The Schizotypal Personality Questionnaire-Brief version (SPQ-B; Raine and 
Benishay, 1995) is one of the most popular scales used to assess schizotypal traits 
(Reynolds et al., 2000). Derived from the original 74-item scale developed by Raine 
(1991), it consists of 22 items, responded to using a Yes/No format, that reflect the 
diagnostic criteria of schizotypal personality disorder first described in the DSM-III-R 
(American Psychiatric Association, 1987). These items cover nine distinct domains (i.e. 
ideas of reference, excessive social anxiety, odd beliefs or magical thinking, unusual 
perceptual experiences, odd or eccentric behaviour, no close friends, odd speech, 
constricted affect, and suspiciousness) that are grouped into three factors which relate in 
part to the three components of schizophrenia: cognitive-perceptual problems (positive 
symptoms), interpersonal problems (negative symptoms) and disorganization (Raine and 
Benishay, 1995). 
The brevity of the SPQ-B while still capturing the three factors reflected by the 
larger scale, makes it an attractive screening measure and it has been used both in non-
clinical and psychiatric populations (Axelrod et al., 2001; Compton et al., 2007; Compton 
et al., 2009; Mata et al, 2005). In addition, the SPQ-B has been translated into different 
languages and validated in a variety of culture contexts, including China (Ma et al., 2010; 
Ma et al., 2015), Spain (Fonseca-Pedrero et al., 2009; Fonseca-Pedrero et al., 2011a; 
Fonseca-Pedrero et al., 2011b; Fonseca-Pedrero et al., 2014; Mata et al., 2005), Japan (Ito 
et al., 2008; Ito et al., 2010), and Turkey (Aycicegi et al., 2005).  
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Despite these advantages and its widespread use, Stefanis and colleagues (2004) 
argued that the 'positive' schizotypy factor in Raine’s (1991) three-factor model for the 
SPQ, which includes items of cognitive-perceptual and paranoid dimensions, should in 
fact be two independent factors. They suggested a four-factor model that consists of 
interpersonal, cognitive-perceptual, disorganized, and paranoid factors. While this four-
factor structure has been well replicated in both the SPQ and SPQ-B (Cicero, 2015; 
Cohen et al., 2010; Fonseca-Pedrero et al., 2009; Fonseca-Pedrero et al., 2014; Lahmar et 
al., 2014; Smallman et al., 2010), there is little evidence to suggest that it is valid across 
cultures. For example, the four-factor model in the SPQ-B has been replicated in Spanish 
community samples (Fonseca-Pedrero et al., 2009; Fonseca-Pedrero et al., 2011a), but the 
original three-factor model (cognitive-perceptual, interpersonal and disorganised) was 
supported in China (Ma et al., 2015), and a two-factor model was identified by Principal 
Component Analysis in Turkey and Italy (Aycicegi et al., 2005; Preti et al., 2015).  
Only two previous studies have provided evidence of the four-factor model 
solution of the SPQ across different cultural groups in the same study (Cicero, 2015; 
Fonseca-Pedrero et al., 2014). Cicero (2015) replicated the four-factor structure within 
cultural subgroup samples in the United States (i.e. Asian, Caucasian, Pacific Islander, 
etc.) while Fonseca-Pedrero and colleagues (2014) established measurement invariance 
for the four-factor model across samples of Spanish and US college students. Although 
the four-factor structure of SPQ-B has not been replicated in Eastern contexts, past 
evidence of measurement invariance across diverse ethnic groups demonstrated in 
Cicero’s study infers that  a four-factor model may apply in both Western and Eastern 
cultures.   
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In relation to culture, Cohen et al. (2015) suggested that it is important to assess 
schizotypy in different cultures as social and affective functioning has the potential to 
vary considerably across cultures. In fact, previous studies have demonstrated variation in 
schizotypal traits and psychotic-like experiences across countries (Cicero, 2015; Linscott 
and Van Os, 2013). For example, Caucasian respondents have been reported to have 
lower scores on the SPQ than other ethnic groups on the ‘interpersonal’ schizotypal 
factor while Chinese respondents tend to report significantly lower SPQ scores than their 
Caucasian counterparts (Chen et al., 1997; Cicero, 2015). These findings suggest that 
potential ethnic or cultural factors were at play, which is worth investigation.  
The current study aims to examine the measurement invariance of the four-factor 
structure of the SPQ-B across samples from both Western (i.e., Australia and Chile) and 
Eastern cultures (i.e., China). In light of Cicero’s (2015) findings in the United States 
across multiple ethnic groups, we hypothesized that the four-factor structure in the SPQ-
B would be invariant across countries. In addition, in line with reported cultural 
variations in SPQ scores, we further hypothesized that scores would differ between 




Data for the current study were drawn from a larger series of studies examining 
schizotypal traits and social cognition (e.g., see Prado et al., 2014). The participants were 
729 (M = 23.99 years, SD = 9.87 years) non-clinical community sample and university 
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students recruited in Australia, mainland China, and Chile. A total of 304 males (M = 
23.58 years, SD = 7.50 years) and 421 females (M = 24.07 years, SD = 11.05 years) took 
part in the study. Refer to Table 1 for detailed gender and age composition in the sample 
populations. The Australian sample included 139 participants, of whom 64 were male 
(46.7%) and 72 female (51.8%) with a mean age of 32.23 (SD = 12.66). The average 
years of education was 15.6 (SD = 3.77).  All of the sample were born in Australia, with 
the majority reporting that both parents were also born in Australia.  Of those whose 
parents were born elsewhere, 17 participants indicated that one or both of their parents 
were born in the UK.  Seven indicated that one or both of their parents were born in New 
Zealand or South Africa.  Four indicated that one of their parents was born in Europe and 
one in Scandinavia.  The Mainland Chinese sample included 269 participants, of whom 
92 were male (34.2%) and 177 female (65.8%) with a mean age of 23.13 (SD = 11.42 
years). The average years of education for this group was 15.63 years (SD = 2.25).  All 
participants indicated that they and their parents were born in China.  The Chilean sample 
included 321 participants, of whom 149 were male (46.4%) and 172 female (53.6%) with 
a means age of 21.15 (SD = 2.20 years).  The Chilean group reported an average years of 
education of 15.96 (SD = 2.02).  All of the Chilean sample were born in Chile and only 
four participants indicated that one of their parents was not born in Chile.  For those four, 
three reported one parent had been born in another South American country (Argentina, 
Peru and Venezuela) and the other had one parent from Palestine.  The three groups 
differed significantly with regard to age (F(2, 726) = 75.691, p < 0.001), with the 
Australian sample being significantly older than the other two groups (32.23), and the 
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Chinese sample (23.13) being older than the Chilean sample (21.15). There was no 
difference between the groups with regard to years of education. 
 
Table 1. Gender composition, mean and standard deviation of age across sample 
populations   
Country  n Male Female Mean age 
(SD) 
Age range 
Australia 139 64 (46.7%) 72 (51.8%) 32.23 (12.66) 18-69 
China 269 92 (34.2%) 177 
(65.8%) 
23.13 (11.42) 18-92 
Chile  321 149 (46.4%) 172 
(53.6%) 
21.15 (2.20) 18-34 
Note: SD = standard deviation 
Materials  
The Schizotypal Personality Questionnaire – Brief (SPQ-B) is a 22-item 
dichotomous (yes/no) format self-report questionnaire for the assessment of schizotypal 
personality traits developed by Raine and Benishay (1995).  Based on the 74-item SPQ, it 
consists of three subscales: Cognitive-Perceptual dimension (ideas of reference, paranoid 
ideation magical thinking and unusual perception, e.g. “When shopping, do you get the 
feeling that other people are taking notice of you?”); Interpersonal dimension (social 
anxiety, no close friends, blunted affect and paranoid ideation, e.g. “I feel very 
uncomfortable in social situations involving unfamiliar people”); and Disorganised 
dimension (odd speech and behavior, e.g. “I am an odd, unusual person”). It produces a 
total score and an individual score for each subscale, calculated by summing up each 
question with an affirmative answer (“Yes”). Higher scores on the SPQ-B indicate higher 
levels of schizotypal traits.  
The psychometric properties of the SPQ-B have been reported to be acceptable 
across non-clinical populations and psychiatric patients (Axelrod et al., 2001; Compton et 
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al., 2007; Compton et al., 2009; Mata et al., 2005) with reliability co-efficients ranging 
from 0.75 to 0.83 for the total score (0.58 to 0.87 for the subscales), and test-retest 
reliability ranging from 0.70 to 0.95 (Compton et al., 2007). The criterion validity is also 
acceptable given that the correlation between the SPQ-B and the Structured Clinical 
Interview for DSM-III-R Personality Disorders (SCID-III) averaged 0.62 (Raine and 
Benishay, 1995; Fonseca-Pedrero et al., 2009).  
Translation  
Australian participants completed the original English SPQ-B version (Raine and 
Benishay, 1995). The Chinese participants completed the version translated with a back-
translation technique and verified by three bilingual experts in the fields of psychology, 
nursing and psychiatry (Ma et al., 2010). The Spanish version of the SPQ-B used in Chile 
was translated by a bilingual English-Spanish translator and verified by an expert in 
schizotypy research (Mata et al., 2005).  This version has been used in numerous studies 
(Fonseca-Pedrero et al., 2009; Fonseca-Pedrero et al., 2010; Fonseca-Pedrero et al., 
2011b). 
Procedure 
Approval to conduct the study was obtained from the relevant institutional human 
research ethics committees. The Australian participants were recruited from the 
community and Deakin University, online via email, social network sites and 
promotional posters across Deakin University in Melbourne, Australia. The mainland 
Chinese population was recruited through the distributions of flyers and class 
announcements at universities in Chengdu, Sichuan province, and the Chilean sample 
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was recruited using the same methods (ie. flyers, class announcements and social 
networking sites) at three universities located in the Araucana region of Chile. 
All participants who agreed to take part were directed to a web page. Initially they 
were requested to read a Plain Language Statement in their language of choice (i.e. 
English, Spanish or simplified Chinese) that described the nature of the study and the 
requirements of participants. Upon agreeing to participate, they were directed to the 
version of the SPQ-B survey in their preferred language. 
Analytic procedure 
Preliminary analyses were conducted to identify missing data (less than 0.01%), 
deleting unnecessary sample cases (i.e. ‘unknown’ cultural group, 28 cases) and 
transferring the data file into Mplus (Version 7.31). Descriptive statistics, confirmatory 
factor analysis (CFA), measurement invariance (MI), reliability analysis (i.e. McDonald’s 
Omega) were then performed.  
Firstly, CFA were performed across all cultural groups to test different theoretical 
models proposed in past literature. Due to the categorical nature of the data, we used the 
robust Mean-adjusted Weighted Least Square method (WLSMV) in Mplus for the 
estimation of parameters. The model fit was determined by the following fit indices: chi-
square (2), comparative fit index (CFI), Tucker-Lewis Index (TLI), root mean square 
error of approximation (RMSEA) and weighted root mean square residual (WRMR) 
against established criteria (Hu and Bentler, 1999; Yu, 2002). To achieve the goodness of 
fit of the data to the model, it was suggested that the values of CFI and TLI should be 
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over 0.95 and the RMSEA and WRMR values should be under 0.08 to be considered as a 
reasonable fit (Hu and Bentler, 1991).  
 
Second, invariance testing was conducted using Multiple Group CFA, using 
increasingly stringent criteria for equivalence beginning with evaluation of the degree to 
which the same factors are measured by the same items and proceeding to a test of 
equivalence of all coefficients, variances, intercepts and covariances (Milfont and Fischer, 
2010). It reflected that the construct measured had the same structure and meaning across 
the groups compared, that entailed testing a hierarchical set of steps (Byrne, 2004; Byrne, 
2012). The first step was known as the configural model that was the least restrictive 
model specified, it began with the determination of a well-fitting multi-group baseline 
model which represents a benchmark for comparing against subsequent specified 
invariance models. It is established by specifying and testing the CFA model for each 
group and assessed by the goodness-of-fit criteria. The following steps involved were 
imposing equality constraints on the factor loadings and item intercepts across the groups 
to establish strong invariance (metric) model and a strict invariance model (scalar). In the 
current study, MI testing was terminated at configural model level due to poor 
identification of goodness of fit indices, which prevented the testing to continue as 
stricter factor and item constraints would be applied in subsequent strong and strict 
invariance models. 
Third, the reliability of the SPQ-B was assessed. Due to the limitations of 
Cronbach’s alpha (Dunn et al., 2014), coefficient Omega for SPQ-B total scores and 
subscales for each group was estimated (Geldhof et al., 2014). For an alpha to produce a 
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correct estimation of reliability, items must meet the assumption of being tau-equivalent 
which allows the items to have different means and variances. When this does not hold, 
use of Omega instead of Alpha for scale reliability assessment is recommended (Dunn et 
al., 2014).  
Results 
 
The means, standard deviations and the range of scores on the SPQ-B total scale 
as well as each of the specified subscales across three countries are presented in Table 2. 
Table 2. The SPQ-B total and subscales mean scores, standard deviations and range 
across three different countries for the four factor structure 
                                         Australia China   Chile   
 Mean SD Range Mean SD Range Mean SD Range 
SPQ-B total 7.66 4.59 0-20 7.04 3.77 0-17 10.27 4.15 0-20 
Cognitive-
Perceptual 
1.33 1.18 0-4 1.29 0.97 0-4 1.58 1.14 0-4 
Interpersonal  3.85 2.71 0-10 3.37 2.15 0-9 5.29 2.49 0-10 
Disorganized 1.99 1.75 0-6 1.44 1.42 0-6 2.58 1.72 0-6 
Paranoid 1.98 1.55 0-6 1.92 1.33 0-6 2.85 1.47 0-6 
Note: SD = standard deviation 
 
Confirmatory factor analysis 
 
Table 3 shows the goodness-of-fit indices for the CFA models tested for each of 
the countries. As can be seen, the hypothetical models that displayed goodness-of-fit 
indices across three samples were less than ideal, and the best-fitting model appeared to 
be inconsistent across the samples. In comparison with other competing models, the four-
factor model showed the best for the Australian sample, while the three-factor model was 
the most reasonable for both Chinese and Chilean samples. Measurement invariance of 
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the four-factor structure was conducted subsequently to assess the appropriateness of 




Table 3. Goodness-of-fit indices for the theoretical model proposed across three countries 
Australia 
Factor models 2 df CFI TLI RMSEA WRMR 
One factor 546.830 209 0.633 0.594 0.108 1.633 
Two factor  (Siever & Gunderson, 1983) 467.626 210 0.720 0.692 0.094 1.504 
Three-factor (Raine et al., 1994) 336.708 205 0.857 0.839 0.068 1.184 
Three-factor (Raine & Benishay 1995) 349.708 209 0.847 0.831 0.070 1.231 
Four-factor (Stefanis et al., 2004) 333.251 203 0.858 0.839 0.068 1.177 
China 
Factor model 2 df CFI TLI RMSEA WRMR 
One factor 336.758 209 0.839 0.822 0.048 1.144 
Two factor (Siever & Gunderson, 1983) 346.096 210 0.828 0.811 0.049 1.177 
Three-factor (Raine et al., 1994) 326.026 205 0.847 0.828 0.047 1.135 
Three-factor (Raine & Benishay, 1995) 340.982 209 0.834 0.816 0.048 0.172 
Four-factor (Stefanis et al., 2004) 376.006 203 0.782 0.752 0.056 1.257 
Chile 
Factor model  2 df CFI TLI RMSEA WRMR 
One factor 728.474 209 0.735 0.707 0.088 1.732 
Two factor (Siever & Gunderson, 1983) 782.254 210 0.708 0.679 0.092 1.869 
Three-factor (Raine et al., 1994) 572.313 205 0.813 0.789 0.075 1.564 
Three-factor (Raine & Benishay, 1995) 665.795 209 0.767 0.743 0.083 1.743 
Four-factor (Stefanis et al., 2004) 599.149 203 0.798 0.770 0.078 1.595 
Note: 2 = chi-square; df = degrees of freedom; CFI = comparative index fit; TLI = Tucker-Lewis Index; RMSEA = root 






The Stefanis’ four-factor model is a well-replicated and supported model of 
schizotypal traits in the schizotypy literature, however, the four-factor model did not fit the 
SPQ-B data adequately in the current study across all samples when constrained to configural 
invariance (CFI = 0.841, TLI = 0.822, WRMR = 2.165). Evaluation of these models 
produced non-positive definite psi matrices and a number of indicators did not have 
significant relationships to their respective latent variables within each group. MI was 
terminated at this step as failing to establish the baseline model (configure invariance) 
implicitly excludes the possibility of MI; that is, where groups are not consistent with respect 
to which items indicate particular factors, it would be inappropriate to continue to models 
where more strict constraints would be imposed (Byrne, 2004; Byrne, 2012).  
 
Reliability estimation for the SPQ-B scores 
 
Table 4 shows the Omega values for the SPQ-B scales and subscales for all countries. 
As can be seen, the values ranged between 0.66 to 0.94 for the subscales, and from 0.86 to 
0.91 for the total score across all cultural samples. 
 
Table 4. Reliability (McDonald’s ω) of the SPQ-B total and subscale scores in the current 
study grouped by countries for four-factor structure 
 Australia China Chile 
Scale/subscale Omega [95% CI] Omega [95% CI] Omega [95% CI] 
SPQ-B total score 0.91 [0.88, 0.94] 0.86 [0.84, 0.89] 0.86 [0.83, 0.89] 
Cognitive-
perceptual 
0.73 [0.60, 1.00] 0.94 [0.29, 1.01] 0.84 [0.23, 1.34] 
Interpersonal  0.90 [0.86, 0.93] 0.82 [0.77, 0.86] 0.88 [0.85, 0.90] 
Disorganized  0.87 [0.82, 0.91] 0.76 [0.69, 0.83] 0.81 [0.77, 0.85] 
Paranoid 0.74 [0.63, 0.84] 0.66 [0.58, 0.76] 0.66 [0.58, 0.86] 







The aim of the present study was to examine measurement invariance of the four-
factor structure of the SPQ-B across Australian, Chinese, and Chilean young adult samples. 
Unexpectedly, the results of multiple CFA models revealed diverse underlying structures the 
samples (e.g. 4-factor for Australian and 3-factor for both Chinese and Chilean sample). 
Further, measurement invariance could not be established. These findings help to improve 
our understanding of expression of schizotypy with regard to its structure and content across 
cultures, and raise questions about the cross-culture validity of the SPQ-B. 
First, CFA models tested all the theoretical factorial structure across the samples. 
Despite the inadequate model fit indices, these findings are somewhat consistent with the past 
studies favouring a four-factor structure in Western countries and a three-factor model in the 
Chinese context (Chen et al., 1997; Cicero, 2015; Fonseca-Pedrero et al., 2014; Ma et al., 
2015). Consistent with previous findings (Wuthrich and Bates, 2006), a 4-factor structure 
provided a better fit than other competing models in the Australian sample. One possible 
explanation for this may be that the items of ‘Paranoia’ and ‘Ideas of reference’ have both 
theoretical and clinical similarities, as suggested by Wuthrich and Bates (2006), who reported 
that some items of ‘Ideas of references’ loaded more strongly on  the ‘Paranoid’ subscale in 
the Australian sample. Although the three-factor model has been frequently supported in 
studies using the Spanish version of the SPQ-B (Fonseca-Pedrero et al., 2009; Fonseca-
Pedrero et al., 2011), as our findings indicated poor model fit for this structure it is uncertain 
whether this generalises to the Chilean context.  
Second, measurement invariance could not be established across the Australian, 
Chinese and Chilean samples as anticipated. This contrasts with the outcomes of many past 




a variety of cultures (e.g. Oxford-Liverpool Inventory of Feelings and Experiences, SPQ-BR, 
SPQ; Cicero, 2015; Fonseca-Pedrero et al., 2015; Fonseca-Pedrero et al., 2016). Notably 
however, the majority of these previous studies have focused on Western populations (e.g. 
North America, Spain, Europe), which are likely to be more homogenous than our diverse 
samples. Our lack of invariance could suggest a confounding cultural or language influence 
in the SPQ-B structure, which could be manifested through different factors and item 
composition as reported in current divergent findings. Such an implication is plausible as 
previous research has indeed found cultural differences in terms of how participants respond 
to the SPQ-B items.   
This is not surprising as Cohen et al. (2015) stressed that social and affective variables 
vary considerably across cultures. In this regard, while the factor structures of the total 
schizotypy scales such as the SPQ have has been found invariant across cultures, individual 
subscales, particularly those related to negative schizotypy (‘interpersonal’ factor) vary as a 
function of culture as they reflect the environmental and cultural determinants of social and 
affective functions (Cohen et al., 2015). For example, Caucasian respondents tend to have 
lower scores than other ethnic groups on the ‘interpersonal’ schizotypal factor (Cicero, 2015), 
and Spanish adolescents report higher level of negative schizotypal traits than Swiss 
adolescents (Ortuno-Sierra et al., 2013). Likewise, the current Chilean sample was found to 
have significantly higher scores on the ‘interpersonal’ dimension as well as across other 
subscales than the Australian and Chinese samples.  
A theoretical framework that might assist in accounting for the lack of invariance 
across studies is Hofstede's (1980; 2001) approach to describing cultural differentiation.  This 
theory proposes five dimensions upon which cultures vary: (1) Power distance, which reflects 
the extent to which groups of people in a culture accept injustice and inequality in the 




extent to which individuals give primacy to themselves or the interests of their immediate 
family and other social groups; (3) Uncertainty avoidance, which is the extent to which 
people in a culture feel threatened by situations where outcomes cannot be predicted or are 
not clear, (4) Masculinity-femininity, which is the degree to which the society emphasizes 
achievement, heroism, assertiveness and material rewards for success, as opposed to 
cooperation, modesty, caring for the weak and quality of life (5) Long-term orientation, 
which refers to the extent to which a culture has a pragmatic perspective of long or short-term 
historical orientation.  One further dimension was added to the theory later: Indulgence, 
which reflects the extent to which people try to control their desires and impulses, based on 
the way they were raised. Relatively weak control is called “Indulgence” and relatively strong 
control is called “Restraint”.  
When the three counties in this study are compared on the national level on these 
dimensions it is clear that they are considerably different in cultural orientation (see Figure 1).  
On the dimension that is perhaps the most likely to determine social interactions and social 
perceptions, individualism/collectivism, China and Chile are similar, and both very different 
to Australia. Chileans are much more tolerant of uncertainty than Chinese and Australians, 
Chile is a less masculine society than both Australia and China, yet Chinese are more focused 
on the longer term than Chileans and Australians. China is a restrained society, whereas Chile 
and Australia are not.  The overall pattern of cultural dimension in each country could have 
an impact on the way individuals experience the world and themselves, and hence how they 
respond to scales such as the SPQ-B.  As a result, tests such as the SPQ-B, developed in one 
culture may depend too much on social and cultural factors of that culture and may not 
demonstrate factorial invariance across cultures. These factors may also account for elevated 
scores among one group in comparison to another as we found using the original factor 




Australian and Chinese samples).  On the other hand, studies that assess the invariance of 
tests that do not assess variables prone to subtle cultural differences may report more positive 
findings than we were able to do.  Future studies might include measures of adherence to 
cultural dimensions such as those outlined above. Yoo, Donthu, and Lenartowicz’s (2011) 
Individual Cultural Values Scale (CVSCALE) may be an appropriate tool for this purpose. 
 
 
Figure 1 Scores on cultural dimensions for China, Chile and Australia generated at 
https://geert-hofstede.com/china.html 
 
An alternative explanation for the differences in scores could be a response bias in 
self-reported data. In other words, how participants respond to a self-administered scale could 
be affected by cultural differences in the tendency to give socially desirable answers (e.g. 
Japanese respondents tend to suppress expression of positive affect than their American 
counterpart) (Iwata et al., 1995). Further, when self-report data are compared between 
equivalent demographic groups from Asian (East /South-East) and North 




















































1984), such response bias is observed. Despite this, it is difficult to infer what exactly lead to 
the lack of measurement invariance in present study as opposed to previous literature: it may 
be the influence of measurement error manifested through the lack of cross-cultural construct 
validity, or the bias in participants’ response style, or a combination of these factors. 
Consequently, more investigation is required to provide insights into how culture influences 
social and affective functions within the context of schizotypy.  
The results of the present study should be interpreted in light of the following 
limitations. Any response bias in the Chinese sample may have been due to translation issues. 
A bilingual researcher (with interpreting qualification) on the current research team (SL) 
found that although the Chinese version of the SPQ-B had been verified using back-
translation techniques, several items on the scale appeared to be semantically ambiguous due 
to the connotations associated with item wording. For example, the item “I tend to keep in the 
background on social occasions” was translated to “”, which has the 
connotations of ‘behind the scene’ or ‘hide in the backstage’ and this misses the essence of 
lack of social involvement. Considering the SPQ-B is only a 22-item scale, this may have 
affected how participants responded to these items and reduced the validity and reliability of 
the instrument. Therefore, we strongly encourage researchers in the future to exercise caution 
when developing or revising a translated scale, other than using the back-translation 
technique, assistance from linguists and psychologists would be prove helpful in terms of 
maximizing the accuracy of the instrument (Van de Vijver and Tanzer, 2004). In addition, 
conducting a pre-test pilot study with participants from the targeted population may also be 
useful to ensure the accuracy of translation.  
Second, for a sample that completed the original English language version of the 
SPQ-B, the four-factor structure was the best fitting model in the Australian sample but the 




correlations may be unstable at low sample size (Schönbrodt and Perugini, 2013). 
Alternatively, another possibility is that the SPQ-B structure is unstable from sample to 
sample, even when participants respond it in English. For example, a four-factor structure of 
SPQ-B was observed in Cohen et al.’s (2010) study while a three-factor structure was 
reported in Compton et al.’s (2009) finding in the English-speaking context. Thus, the 
factorial structure of SPQ-B has not been established across all English-speaking samples. 
Furthermore, given the nature of the multicultural population of the city of Melbourne in 
which the Australian data were collected, the cultural composition of the sample may have 
been heterogeneous which may have in turn affected the results, although examination of the 
participants responses with regard to where they and their parents were born suggests that our 
sample was reasonable homogenous with all participants and most of their parents being born 
in Australia or other Commonwealth countries. The findings are also inconsistent with those 
of Cicero’s (2015) study which found factorial invariance for the SPQ across ethnic groups. 
The SPQ scale is more nuanced than the SPQ-B due to the larger number of items and may 
therefore better capture schizotypal traits in this population. Due to these limitations, the 
Schizotypal Personality Questionnaire-Brief Revised (SPQ-BR) may be a more appropriate 
tool for assessing schizotypal traits as invariance across cultures has previously been reported 
(Fonseca-Pedrero et al., 2016). The advantages are, firstly it includes more items than the 
SPQ-B which would allow it to examine the aspects of schizotypy more comprehensively 
(Callaway et al., 2014; Cohen et al., 2010), and secondly it adopts a Likert response format, 
which offers a greater sensitivity by providing a range of response options rather than a 
binary ‘Yes/No’ format (Wuthrich and Bates, 2005). 
A further limitation was that no information was collected with regard to whether any 
of the participants had pre-existing psychological disorders and socio-economic information 




educated, caution needs to be applied when interpreting the findings with individuals outside 
of this demographic group. 
In summary, our study examined the measurement invariance, the theoretical factor 
model structure of the SPQ-B across samples from Australia, China and Chile. The results 
did not provide support for measurement invariance as unsatisfactory model fit indices were 
observed across the samples. This implies that the cross-cultural validity of SPQ-B is limited 
across the Australian, Chinese, and Chilean samples. In terms of future directions, researchers 
are encouraged to explore in greater depth whether the structure of the SPQ-B truly varies 
depending on the culture in which it is applied, and how it may affect schizotypy assessment 
cross culturally. Lastly, we recommend researchers practice caution when utilizing the 
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Linking Chapter: connecting study one with study two 
As previously identified, measurement invariance did not hold across Australian, 
Chinese and Chilean samples and the results of multiple Confirmatory Factor Analyses (CFA) 
presented different factorial structure for each country. This invariance study not only 
highlighted the lack of cross-cultural validity of the SPQ-B, but also the need to understand 
and minimize confounding cultural and language influence presented in the SPQ-B structure, 
thus leading to the investigation of study two. As such, the following study presented in 
Chapter V aimed to address these issues through focusing on one particular culture solely and 
delve into the structure of schizotypal measures in this culture, by exploring the SPQ and its 







Study Two: Using the Schizotypal Personality Questionnaire Instruments in China: A 
Validation Study 
Abstract 
Schizotypy is a multidimensional construct that is closely linked to psychosis-
spectrum disorders but how it manifests in different cultural contexts needs clarification. This 
study aimed to examine the structural validity of associated measures of schizotypal traits i.e. 
Schizotypal Personality Questionnaire (SPQ), Schizotypal Personality Questionnaire – Brief 
(SPQ-B) and Schizotypal Personality Questionnaire – Brief Revised (SPQ-BR) in a Chinese 
sample. 1410 non-clinical Chinese participants (age range from 18 to 51 years old, M = 20.03 
years, SD = 2.80 years) were recruited across multiple provinces through partnering 
universities. The reliability of the schizotypal measure scores, estimated with McDonald’s 
Omega, ranged between 0.90 to 0.96 across all schizotypal measures for total scores, and 
values for subscale scores ranged between 0.76 to 0.86 for the SPQ, 0.77 to 0.81 for the SPQ-
B and 0.64 to 0.80 for the SPQ-BR. Confirmatory factor analysis (CFA) revealed that neither 
the purported 3- nor 4-factor models (including second order factors) examined in SPQ, SPQ-
B and SPQ-BR fit the Chinese sample desirably. Such findings present important theoretical 
and clinical implications for cross-cultural research of schizotypy, cross-cultural 
psychological assessment as well as psychiatric diagnostic systems. Further investigation into 
how cross cultural applications of SPQ-B may influence its underlying structure may be 
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the Schizotypal Personality Questionnaire Instruments in China: A Validation Study. 






The Schizotypal Personality Questionnaire (SPQ) (Raine, 1991) is one of the most 
widely used self-report tools for assessing schizotypal traits in both clinical and non-clinical 
populations. It consists of 74 items, responded to using a dichotomous (Yes/No) format that 
reflects the diagnostic criteria of Schizotypal Personality Disorder (SPD) as first described in 
the DSM-III-R (APA, 1987). These items cover nine distinct domains (i.e. ideas of reference, 
excessive social anxiety, odd beliefs or magical thinking, unusual perceptual experiences, odd 
or eccentric behaviour, no close friends, odd speech, constricted affect, and suspiciousness) 
that are grouped into three factors which relate in part to the three components of 
schizophrenia: cognitive-perceptual problems (positive symptoms), interpersonal problems 
(negative symptoms) and disorganization (Raine & Benishay, 1995). These also represent the 
main features of DSM-5 SPD criteria in the chapter on Schizophrenia spectrum and other 
psychotic disorders (APA, 2013). Since its conception, due to its popularity, there has been a 
number of adaptations of the SPQ, including the development of a short form, the 22-item 
Schizotypal Personality Questionnaire-Brief (SPQ-B; with dichotomous response format) 
(Raine & Benishay, 1995), the 32-item Schizotypal Personality Questionnaire-Brief revised 
(SPQ-BR; with a 5-point Likert response format) (Cohen, Matthew, Najolia & Brown, 2010), 
and the 34-item Schizotypal Personality Questionnaire-Brief revised updated (SPQ-BR 
updated) (Davidson, Hoffman & Spaulding, 2016). The psychometric properties of the SPQ 
and its related measures have been extensively examined and replicated in numerous 
countries and a variety of settings, including Western and non-Western cultures (e.g. Cicero, 
2016; Fonseca-Pedrero et al., 2014, 2018; Liu et al., 2017). The three-factor model proposed 
by Raine (1991), which comprises the Cognitive-Perceptual (Positive), Interpersonal 
(Negative) and Disorganized dimensions, has been replicated in Australia, China, Spain, 




Ma et al., 2010, 2015; Yu, Bernardo & Zaroff, 2015; Wuthrich & Bates, 2005, 2006). The 
four-factor model proposed by Stephanis et al. (2004), which includes Cognitive-Perceptual, 
Interpersonal, Disorganised, and Paranoid factors has also been frequently supported in 
diverse contexts (Bora & Arabaci, 2009; Compton, Goulding, Bakeman & McClure-Tone, 
2009; Cicero, 2016; Cohen et al., 2010; Fonseca-Pedrero et al., 2014; Gross, Mellin, Silvia, 
Barrantes-Vidal & Kwapil, 2014). 
While the latent structure of the SPQ has been found to reflect the proposed 
underlying structure of schizotypal traits and has received support in cross-cultural research 
(Fonseca-Pedrero et al., 2018), it is not clear that this structure is replicated in the SPQ-B and 
its translations. Recent factor analytic studies exploring the dimensional structure of the SPQ-
B have yielded mixed results, suggesting its factorial structure in cross-cultural settings may 
be unstable and require further investigation (Fonseca-Pedrero et al., 2017b; Liu et al., 2017). 
For instance, Fonseca-Pedrero and colleagues’ measurement invariance study found that 
although configural invariance of the SPQ-B has been established in a large cross-national 
sample (14 countries), Confirmatory Factor Analyses (CFA) revealed that the SPQ-B items in 
a Chinese sample, in particular, could not be grouped according to any of the factor models 
tested (i.e. unidimensional, bidimensional, 3-factor and bifactor) (Fonseca-Pedrero et al., 
2017b). Similar findings with a Chinese community sample have also been reported by Liu 
and colleagues (2017).  In this study, none of the theoretical models examined had acceptable 
fit (i.e. 1-, 2-, 3- and 4-factor). The variability of latent factor structures found across these 
Chinese studies could be partially due to the type and size of the participant sample (Fonseca-
Pedrero et al., 2018), the limited number of items in the SPQ-B, and more importantly, the 
culture in which the instrument was applied (Liu et al., 2017). Overall, evidence suggests that 




sensitivity and should not be used as a screening tool for identifying susceptibility to 
psychosis until its psychometric properties are further evaluated (Ma et al., 2010). 
In contrast to the SPQ-B, the full length SPQ (74 items) and SPQ-BR (32 items) may 
be more appropriate for assessing schizotypal traits in Chinese population as they are able to 
measure the aspects of schizotypy more comprehensively than the SPQ-B due to larger 
number of items. Therefore they may better capture schizotypal traits in Chinese population 
(Liu et al., 2017). Furthermore, both of the SPQ and SPQ-BR have shown adequate cross 
cultural validity through measurement invariance studies (i.e. invariance found for the SPQ 
across 12 countries, and for the SPQ-BR across American and Spanish samples) (Fonseca-
Pedrero et al., 2018; Fonseca-Pedrero, Cohen, Ortuño-Sierra, Pérez de Albéniz & Muñiz, 
2017a). However, to date, to our knowledge that the SPQ-BR has not been validated in China. 
Further, there has been no direct comparison of the factorial structure underlying the SPQ and 
its related measures in the Chinese population.   
Identifying the appropriate structure of schizotypal traits in this population is 
important because within the Chinese context, schizotypal traits have been found to be 
closely associated with a range of psychiatric morbidity, such as autistic traits (Shi et al., 
2017), physical and social anhedonia (Chan et al., 2012a; Wang et al., 2014), and genetic 
susceptibility for progressing into schizophrenia (Ma et al., 2007). Establishing a structurally 
valid screening tool will enable early detection of schizotypy and intervention.   
Therefore, aim of the present study is to explore and identify which Chinese version 
of the schizotypal measures, i.e. SPQ, SPQ-B, SPQ-BR is most suitable for measuring 
schizotypal traits in the Chinese population. Based on prior research and observation, we 
hypothesized that three- and four-factor models of the SPQ, SPQ-B and SPQ-BR would 







In this study 1410 Chinese participants (age range from 18 to 51 years old, M = 20.03 
years, SD = 2.80 years) were recruited using a snowballing approach that commenced with 
university students in mainland China. In addition research collaborators promoted the study 
via social networks, smartphone application (e.g. Wechat), promotional posters and talks in 
classrooms across all partnering universities (i.e. Sichuan Normal University, Sichuan 
University of Science and Engineering, Jining Normal University and Shaoxing University). 
A total of 340 males (24.2%) and 1068 females (75.7%) took part in the study. The majority 
of participants (1122, 79.6%) had completed a Bachelor’s degree, 211 (15%) participants 
completed a Diploma Certificate, 62 (4.4%) participants had completed Secondary/High 
School education, 9 (0.6%) participants had completed a post graduate degree, 2 (0.1%) 
participants had completed Primary School education and 6 (0.4%) did not specify their 
education level.  In terms of location of residence in China, the majority of participants (1011, 
71.7%) lived in Sichuan province, 208 (14.8%) participants lived in Inner Mongolia province 
and the rest of participants (191, 13.5%) lived in other provinces (i.e. 1.4% in Gansu province, 
1.4% in Guizhou province, 1.2% in Zhejiang province, 1.0% in Xinjiang province, etc). 
Participants aged below 18 years or with a history of clinical diagnosis of any mental health 
condition were excluded from the study.  
Materials 
As described above, the Schizotypal Personality Questionnaire (SPQ, Raine, 1991) is 
a popular 74-item self-report scale designed for Schizotypal Personality Disorder (SPD) as 
defined in the DSM-III-R (APA, 1987) and now the DSM-5 (APA, 2013). In the present 




multiple studies (e.g. Chinese langugae, Chen et al., 1997; Fonseca-Pedrero et al., 2018). The 
Chinese SPQ utilized in the present study was initially translated and validated in Chen et 
al.’s study (1997). It was translated by means of two-stage translation, in which the process 
was guided by researchers with clinical experience (Chen et al., 1997).  
The SPQ-B and the SPQ-BR can both be derived from the longer 74 item SPQ as they 
were the brief version of the SPQ scale. In the present study, the items of the SPQ and SPQ-
BR were extracted from the SPQ.  
The Schizotypal Personality Questionnaire-Brief (SPQ-B, Raine & Benishay, 1995) 
shortened version of the SPQ (Raine, 1991) that includes 22 of the 74 items that fall within 
three domains: Cognitive-Perceptual (Ideas of Reference, Paranoid Ideation, Magical 
Thinking, Unusual Perceptual Experience), Interpersonal (Social Anxiety, No close Friends, 
Constricted Affect, Paranoid Ideation), and Disorganised (Odd Behaviour and Speech). 1997).  
The Schizotypal Personality Questionnaire-Brief Revised (SPQ-BR, Cohen et al., 
2010) contains 32 items and is scored on a five-point Likert scale (1 = “Strongly Disagree” to 
5 = “Strongly Agree”). There are seven trait subscales that include: Odd Beliefs or Magical 
Thinking, Unusual Perceptual Experiences, Excessive Social Anxiety, Odd or Eccentric 
Behaviour, Odd Speech, No Close Friends and Constricted Affect, and Ideas of References 
and Suspiciousness. It has been demonstrated sound psychometric properties through several 
sources (Callaway, Cohen, Matthew & Dinzeo, 2014; Cohen et al., 2010; Fonseca-Pedrero et 
al., 2017a), for instance, reliability estimated with Omega, value ranged from 0.67 to 0.91 in 
American and Spanish samples (Fonseca-Pedrero et al., 2017a).  
The estimation of reliability of SPQ, SPQ-B and SPQ-BR in present work were 






Approval to conduct the study was obtained from the relevant institutional human 
research ethics committees. Participants were initially directed to a webpage to read a Plain 
Language Statement in simplified Chinese that described the nature of the study and the 
requirements of participants. In any unlikely events of feeling psychological discomfort or 
distress after completing the questionnaires, they were encouraged to access free counselling 
service as detailed on the webpage. Upon agreeing to participate, they were then required to 
answer questions in relation to demographics such as age, gender, and education level, 
geographical location of residence in China, living arrangement, and followed by all the 
questionnaire items that were displayed in a randomised fashion. Most participants did not 
receive incentives for taking part in the study except for the participants recruited from 
Sichuan Normal University, where participation was not mandatory but students received 
course credit for filling out the questionnaires. 
 
Analytic procedure 
Preliminary analyses were conducted to identify missing data (less than 0.01%) before 
the data file was imported into Mplus (Version 7.31). Descriptive statistics and reliability 
(McDonald’s Omega) were calculated as the first step. Next, in order to determine the best 
fitting model each of the three Schizotypy measures (i.e. SPQ, SPQ-B, SPQ-BR), several 
confirmatory factor analyses (CFA) were conducted based on prior research findings. Due to 
the continuous nature of the data, we used the robust Maximum Likelihood method (ML) in 
Mplus for the estimation of parameters. The model fit was determined by the following fit 
indices: chi-square (χ2), comparative fit index (CFI), Tucker-Lewis Index (TLI), Root Mean 
Square Error of Approximation (RMSEA) and Standardized Root Mean square Residual 




the RMSEA and SRMR < 0.08. The Akaike information criteria (AIC) and Bayesian 
information criterion (BIC) do not have cut-off values, instead, they provide indications for 




Descriptive statistics and reliability  
Refer to Table 1 (Appendix) for detailed SPQ, SPQ-B and SPQ-BR mean scores, 
standard deviation and range in the sample populations. The psychometric properties of the 
SPQ, SPQ-BR, and SPQ-B total score as well as each of specific subscales are displayed in 
Table 2. As can be seen, McDonald’s Omega coefficient were excellent for all scales and 
subscales. Values for the total scales ranged between 0.90 to 0.96 across all schizotypal 
measures, and values for subscale scores ranged between 0.76 to 0.86 for the SPQ, 0.77 to 
0.81 for the SPQ-B and 0.64 to 0.80 for the SPQ-BR.  
 
Structure of schizotypal traits: CFA for SPQ, SPQ-BR and SPQ-B 
Confirmatory factor analyses (CFA) were performed for testing theoretical models 
proposed. Model fit indices for SPQ, SPQ-B and SPQ-BR are presented in Table 3. As can be 
seen, though the model fit indices presented for all proposed models across the schizotypal 
measures were not ideal, the 3-factor second order with 7 factors as the first order in the SPQ-
BR appeared to be close to a reasonable fit. Also, unexpectedly, the 4-factor structure in the 
SPQ as well as the 4-factor second order with 7 factors as the first order in the SPQ-BR were 




Table 1. The total, mean score, standard deviation and range across SPQ, SPQ-B, and SPQ-BR 
 Mean SD Range  Mean  SD Range  Mean SD Range 
SPQ 
Total 
120.06 36.57 0-292  SPQ-B 
Total 
35.64 12.29 0-88 SPQ-BR 
Total 
52.83 16.74 0-128 
IREF 17.06 5.29 0-36 INT 14.41 5.27 0-32 IREF 10.17 3.88 0-24 
ESA  14.82 5.75 0-32 COG 12.53 4.94 0-32 MGT 6.09 2.91 0-16 
MGT 10.85 4.29 0-28 DIS 8.72 3.95 0-24 UPE 5.82 2.75 0-16 
UPE  13.13 5.57 0-36     ESA 7.48 3.19 0-16 
OB 10.63 4.92 0-28     CA/NCF 9.35 4.06 0-24 
NCF 13.78 5.47 0-36     EB 6.16 2.96 0-16 
OS 16.06 5.40 0-36     OS 7.79 2.65 0-16 
CA 12.96 4.89 0-32         
PI 12.68 5.11 0-32         
Note: For SPQ: IREF = Ideas of References; ESA = Excessive Social Anxiety; MGT = Magical Thinking; UPE = Unusual Perceptual 
Experience; OB = Odd Behaviour; NCF = No Close Friends; OS = Odd Speech; CA = Constricted Affect; PI= Paranoid Ideation.  
For SPQ-B: INT = Interpersonal; COG = Cognitive-Perceptual; DIS = Disorganised. 
For SPQ-BR: IREF = Ideas of References; ESA = Excessive Social Anxiety; MGT = Magical Thinking; UPE = Unusual Perceptual Experience; 















Table 2. Reliability (McDonald’s ω) of the SPQ, SPQ-B and SPQ-BR total and subscale scores in the current study. 
  Omega [95% CI]  Omega [95% 
CI] 
  Omega [95% 
CI] 
SPQ Total  0.96 [0.96, 0.97] SPQ-B Total    0.90 [0.89, 0.91]  SPQ-BR Total 
 
0.92[0.91,0.93] 
IREF 0.80 [0.78, 0.82] INT 0.81 [0.79, 0.82] IREF 0.78 [0.76 , 0.80] 
ESA  0.86 [0.85, 0.87] COG 0.79 [0.76, 0.81] MGT 0.71 [0.68 , 0.74] 
MGT 0.76 [0.74, 0.78] DIS 0.77 [0.74, 0.79] UPE 0.69 [0.66 , 0.72] 
UPE  0.82 [0.80, 0.84]   ESA 0.80 [0.78 ,0.82 ] 
OB 0.85 [0.84, 0.87]   CA/NCF 0.76 [0.74 ,0.78 ] 
NCF 0.80 [0.78, 0.82]   EB 0.75 [0.72, 0.77] 
OS 0.81 [0.79, 0.82]   OS 0.64 [0.60, 0.67] 
CA 0.77 [0.75, 0.79]     
PI 0.83 [0.81, 0.84]     
Note: 95% CI refers to 95% confidence interval.   
For SPQ: IREF = Ideas of References; ESA = Excessive Social Anxiety; MGT = Magical Thinking; UPE = Unusual Perceptual Experience; OB 
= Odd Behaviour; NCF = No Close Friends; OS = Odd Speech; CA = Constricted Affect; PI= Paranoid Ideation.  
For SPQ-B: INT = Interpersonal; COG = Cognitive-Perceptual; DIS = Disorganised. 
For SPQ-BR: IREF = Ideas of References; ESA = Excessive Social Anxiety; MGT = Magical Thinking; UPE = Unusual Perceptual Experience; 














Table 3. Goodness-fit-indices for the theoretical model proposed for SPQ, SPQ-B and SPQ-BR. 
 
Note: χ2 = chi-square; df = degrees of freedom; CFI = comparative index fit; TLI = Tucker-Lewis Index; RMSEA = root mean square error of 
approximation; SRMR = Standardized root mean square residual; AIC = Akaike information criterion; BIC = Bayesian information criterion.  
 
SPQ   
Factor models χ2 Df CFI TLI RMSEA SRMR AIC BIC 
3-factor (Raine et al., 1994) 10786.855 2616 0.794 0.787 0.047 0.053 257584.892 258808.456 
2-factor second order (9-factors 
as 1st order)  
(Preti et al., 2015) 
9340.406 2617 0.830 0.825 0.043 0.055 256136.443 257354.755 
3-factor second order (9-factors 
as 1st order)  
(Fonseca-Pedrero et a., 2014) 
9035.307 2614 0.838 0.833 0.042 0.053 255837.344 257071.410 
SPQ-B         
Factor models χ2 Df CFI TLI RMSEA SRMR AIC BIC 
One factor 1771.836 209 0.831 0.814 0.073 0.054 78610.997 78957.585 
Two factor (Siever & 
Gunderson, 1983) 
1551.195 208 0.855 0.839 0.068 0.052 78392.356 78744.196 
Three-factor (Raine et al., 1994) 1328.229 202 0.878 0.861 0.063 0.047 78181.390 78564.738 
Three-factor (Raine & Benishay, 
1995) 
1395.485 206 0.872 0.856 0.064 0.048 78240.646 78602.989 
Four-factor (Stefanis et al., 
2004) 
1315.886 199 0.879 0.860 0.063 0.047 78175.047 78574.149 
SPQ-BR         
Factor models χ2 Df CFI TLI RMSEA SRMR AIC BIC 
3-factor second order (7-factor 
as 1st order) (Cohen et al., 2010) 





Few studies have examined schizotypal traits in the Chinese context, let alone directly 
comparing which particular schizotypal measure would be most ideal for capturing such 
personality traits. Considering its potential to predict psychosis and schizophrenia-spectrum 
disorder as an extended psychosis phenotype and the issues of ethnic differences presented in 
the majority of existing findings (Mason, 2015), we sought to address this gap in literature by 
examining the latent factor structure of the SPQ, SPQ-B and SPQ-BR in a Chinese sample. 
To this end, we estimated the descriptive statistics and reliability scores of all scales and 
analysed the internal structure of the SPQ, SPQ-B and SPQ-BR scores, through CFA. 
Notably, this is the first study to examine the SPQ and its brief measures with participants 
recruited from multiple provinces in China. Such investigation has potential to reveal the 
manifestation of schizotypal traits in the broader Chinese population and advance our 
understanding of schizotypy cross-nationally. 
The hypothesis that either a 3-factor or 4-factor solution would provide the best fit for 
data across the schizotypal measures, was not supported. The examination of the factorial 
structure underlying the SPQ, SPQ-B and SPQ-BR indicated that that neither the 3-factor nor 
4-factor model fit the data satisfactorily. Further, the 4-factor model including 4-factor 
second order model for the SPQ and SPQ-BR was not identified in the sample. Such result is 
incongruent with many past studies that have successfully detected a 3- or 4-factor model in 
either the SPQ or SPQ-BR (Fonseca-Pedrero et al., 2017a; Fonseca-Pedrero et al., 2018; Yu 
et al., 2016). An explanation offered by Fonseca-Pedrero and colleagues could possibly shed 
on some light on this, that in Stefanis et al.’s 4-factor model, the Interpersonal and Paranoid 
factors have two subscales in common (i.e. Excessive Social Anxiety and Paranoid Ideation), 
which could render the interpretation of subscales cross-loading problematic (Fonseca-




Chinese sample. In the case of SPQ-B, although configural invariance of the SPQ-B has been 
found in a large cross-national sample (14 countries), CFA revealed that the SPQ-B items in 
the Chinese sample could not be grouped into any of the factor models tested (i.e. 
unidimensional, bidimensional, 3-factor and bifactor) (Fonseca-Pedrero et al., 2017b). 
Similar findings have also been reported in Liu et al.’s study (2017), which indicated there 
might be a confounding cultural or language influence in the SPQ-B structure (Liu et al., 
2017). Although it appears there is no acceptable fit in all the models tested, three-factor 
models, particularly in the SPQ-BR, were the only models with the most promising 
goodness-of-fit indices. Further investigation into how cross-cultural applications of SPQ-BR 
may influence its underlying structure may be fruitful.   
The results of current study should be interpreted in the light of the following 
limitations. First, the attempt on identifying 3-/4-factor solutions in the schizotypal measures 
were unsuccessful, it may be due to the possibility that there are potential cultural or ethnic 
confounds in the structure of measures examined in this study. Recent evidence from 
affective sciences has raised questions about whether emotional expression and experience is 
structurally similar across cultures. Individual subscales, particularly those related to negative 
schizotypy (interpersonal dimension) that reflect environmental and cultural components vary 
as a function of culture (Cohen, Mohr, Ettinger, Chan & Park, 2015). For example, a recent 
study on an instrument for assessing anticipatory anhedonia discovered different factor 
solutions for individuals from the United States and China, the authors argued that hedonic 
experience is defined by cultural and contextual environment (Chan et al., 2012b).  This 
highlights how affective and emotional construct can vary across cultures. Future research 
may consider investigating in depth how cultural influences social and affective functions 
within the context of schizotypy to further our understanding of how schizotypy manifests 




the development of psychosis for an at-risk population. Second, we did not explore any 
potential impact that could be due to ethnicity. While the Chinese population is mainly Han, 
there are more than thirty minor racial groups living in Mainland China. Given that minority 
ethnic and migrant groups can be over-represented among those individuals with schizotypal 
traits or schizophrenia (Linscott, Marie, Arnott & Clarke, 2006), it is important that future 
researchers not only take the cultural but also ethnic difference into account. Lastly, despite 
recruiting across multiple provinces in China, the majority of participants were university 
students residing in Sichuan province. This may have resulted in a more homogeneous data 
set, and may affect generalizability of the results to other populations of interest. Future study 
may consider controlling the area of residence in the analyses and/or counter balancing such 
limitation by including more a broader community sample.  
In conclusion, schizotypy is a multidimensional construct that is closely linked to 
psychosis-spectrum disorders. However, how it manifests in different cultural contexts needs 
clarification. This study aimed to examine the structural validity of three different but 
associated measures of schizotypal traits in a Chinese sample. It was found that neither the 
purported 3- or 4-factor models were supported by any schizotypal measures fit the Chinese 
sample desirably. Such findings may suggest cross-cultural differences in the responses of 
schizotypal measures, psychometric problems caused by potential inadequacy of these scales 
should not be ignored. It will be difficult to assess cross-cultural differences with a measure 
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Linking chapter: connecting study two with study three 
The aim of the study two was to explore and identify which Chinese version of the 
schizotypal measures is most suitable for measuring schizotypal traits in the Chinese 
population. However, results of this study identified none of the schizotypal measures 
(including the SPQ, SPQ-B and SPQ-BR) presented a good model fit, therefore did not 
appear to be adequate measures for assessing schizotypal measures in the Chinese population. 
It is due to potential cultural or ethnic issues associated with these translated scales, in line 
with limitations identified in the first study. It thereby gives rise to the conception of study 
three. Presented in Chapter VI, the following study was designed to resolve the issues 
associated with culture and language influences by developing and validating a culturally 
appropriate instrument for schizotypy in the Chinese population with improved translation, 




Study Three: Toward a more culturally appropriate brief measure of schizotypal 
traits: Chinese SPQ-BR Updated 
Abstract 
 
Previous evidence suggests the SPQ and its shortened versions may not be 
adequate for measuring schizotypy in the Chinese population. This study aimed to 
develop and validate a more culturally appropriate instrument for measuring schizotypal 
traits in the Chinese population with considerations of cultural specifics and improved 
translation. 1410 non-clinical Chinese participants (age range from 18 to 51 years old, M 
= 20.03 years, SD = 2.80 years) were recruited across multiple provinces through 
partnering universities. Confirmatory factor analysis (CFA) revealed the attempt to 
improving the structure of SPQ-B was not successful despite a clear improvement of 
model fit. In contrast, when comparing the goodness-of-fit between the models tested in 
the SPQ-BR and CSPQ-BRU (new version of SPQ-BR with updated translation), a much 
more significant improvement was observed, making the CSPQ-BRU a preferable scale 
in assessing schizotypy in Chinese sample. Limitations and implications of this study 







Schizotypy is a complex multidimensional personality construct that is closely 
associated with many of the cognitive and behavioural characteristics of psychotic 
disorder (Meehl, 1962). Schizotypal traits, even those insufficient in severity to meet a 
clinical diagnosis, are associated with increased risk of psychiatric morbidity (e.g. 
adolescent suicidal ideation and behaviour, mental health issues, autistic traits) (Kelleher 
et al., 2014; Shi et al., 2017; Schimanski et al., 2017). Recent literature has shown that 
they can be intrinsically similar but less severe than symptoms presented by patients with 
the schizophrenia-spectrum disorder. They have been found to be associated with similar 
deficits in brain function, eye movement, neurocognition, language, etc, to those seen in 
patients with psychosis (Cohen et al., 2015a; Ettinger et al., 2015). These above findings 
reveal an important overlap in schizotypal traits and psychosis-spectrum disorders, 
supporting the idea that the schizotypy framework indicates a unifying construct that 
links a broad continuum of clinical and subclinical psychosis manifestations together 
with normal personality variation (Kwapil & Barrantes-Vidal, 2015). Therefore, 
understanding schizotypal traits in non-clinical samples may not only assist to clarify 
aetiological mechanism, but also provide an opportunity to examine putative risk and 
protective factors (without concerns of confounding factors such as medication), and 
provide empirical support for developing early detection and preventive intervention 
strategies for those individuals at risk for psychosis-spectrum disorders (Barrantes-Vidal 
et al., 2015; Fonseca-Pedrero et a., 2017b).  
The Schizotypal Personality Questionnaire-Brief (SPQ-B, Raine & Benishay, 
1995) has become one of the most widely used self-report tools to assess schizotypal 




Questionnaire (SPQ), which consists of 22 items, responded to using a dichotomous 
(Yes/No) format, that reflect the diagnostic criteria of Schizotypal Personality Disorder 
(SPD) first described in the DSM-III-R (American Psychiatric Association, 1987). These 
items cover three distinct domains: Cognitive-Perceptual (Ideas of Reference, Paranoid 
Ideation, Magical Thinking, Unusual Perceptual Experience), Interpersonal (Social 
Anxiety, No close Friends, Constricted Affect, Paranoid Ideation), and Disorganised 
(Odd Behaviour and Speech) that can be grouped into three factors (Raine and Benishay, 
1995). In contrast, the other brief version of SPQ, the Schizotypal Personality 
Questionnaire-Brief revised (SPQ-BR, Cohen et al., 2010) is a relatively new instrument 
that contains 32 items and is scored on a five-point Likert scale (1 = “Strongly Disagree” 
to 5 = “Strongly Agree” ). Its items can be grouped into seven trait subscales: Odd 
Beliefs or Magical Thinking, Unusual Perceptual Experiences, Excessive Social Anxiety, 
Odd or Eccentric Behaviour, Odd Speech, No Close Friends and Constricted Affect, and 
Ideas of References and Suspiciousness. The psychometric properties of SPQ-B and 
SPQ-BR have been extensively examined and replicated in numerous countries (e.g. 
Western and non-Western cultures) (e.g. Fonseca-Pedrero et al., 2014, 2017a; Liu et al., 
2017, 2018).  
Although both of these brief measures have been widely replicated in different 
cultural context (e.g. measurement invariance studies on SPQ-B and SPQ-BR, Fonseca-
Pedrero et al., 2016; 2017a), there is no universal agreement on the underlying structure 
of the SPQ-B and SPQ-BR especially in the Chinese sample (Fonseca-Pedrero et al., 
2017a; Liu et al., 2018), suggesting the cross-cultural validity of these instruments are 




configural invariance of the SPQ-B was established across 14 countries, factor analyses 
results indicated that the SPQ-B items could not be grouped into any purported factor 
models in its Chinese sample (i.e. unidimensional, bidimensional, 3-factor, etc) (Fonseca-
Pedrero et al., 2017a). Similarly, a recent study investigating the validity of schizotypal 
measures among Chinese university students showed none of the factor model (i.e. 3-/4-
factor, second-order factor) tested for the SPQ-B and SPQ-BR displayed desirably fit 
(Liu et al., 2018). The variability of latent factor structure found may be due to the type 
and size of participant samples (Fonseca-Pedrero et al., 2018), but more importantly, 
there is limited research on how culture impacts the structure and application of these 
measures. Especially, given that the schizotypy factors related to ‘Interpersonal’ 
dimension can vary considerably as a function of culture (Cohen et al., 2015), it further 
accentuates the role culture plays in determining a universal structure for schizotypy.  
In particular, a recent study found that the SPQ-B lacks measurement invariance 
across Australian, Chinese and Chilean population due to potential confounding cultural 
and translation issue. Liu and colleagues found that the 4-factor model fits Australian 
sample the best, while the 3-factor model provides a better alternative fit for the Chinese 
and Chilean sample. The lack of measurement invariance could be possibly due to a 
confounding cultural or language influence in the SPQ-B structure, which was identified 
in the scale’s Chinese translation (Liu et al., 2017). Moreover, as a brief measure of 
schizotypy, SPQ-BR shares a number of common items with the SPQ-B, if there are 
issues concerning cultural or language influence in the SPQ-B, perhaps these may extend 




they found that none of the schizotypal measured examined (i.e. SPQ, SPQ-B, SPQ-BR) 
fit Chinese sample satisfactorily, implicating underlying cultural influence.   
In this case, the first step toward revising the brief measures of schizotypy is to 
update the Chinese translation of both SPQ-B and SPQ-BR, in order to establish an 
instrument that is linguistically and culturally most appreciate for the particular cultural 
context. 
Therefore, the aim of the present study is to develop and validate a more 
culturally appropriate instrument for measuring schizotypal traits in the Chinese 
population with considerations of cultural specifics and improved translation. In line with 
past evidence, we hypothesized that three- and four-factor models of the SPQ-B and 
SPQ-BR would provide the best fit to the data in the Chinese non-clinical sample. 
Moreover, we further predicted that, based on past research, the SPQ-BR with updated 
translation would be the best out of all competing measures for Chinese non-clinical 
sample.    
Method 
Participants 
The participants were 1410 non-clinical university students, their family and 
friends (age range from 18 to 51 years old, M = 20.03 years, SD = 2.80 years,) recruited 
in mainland China online by research collaborators via social networks, smartphone 
application (e.g. Wechat), promotional posters and talks in classrooms across all 
partnering universities (i.e. Sichuan Normal University, Sichuan University of Science 




males (24.2%) and 1068 females (75.7%) took part in the study. Regarding the level of 
education, the majority of participants (1122, 79.6%) completed a Bachelor’s degree, 211 
(15%) participants completed a Diploma Certificate, 62 (4.4%) participants completed 
Secondary/High School education, 9 (0.6%) participants completed a Master’s degree or 
above, 2 (0.1%) participants completed Primary School education and while the rest (6, 
0.4%) did not specify their education level.  In terms of location of residence in China, 
the majority of participants (1011, 71.7%) live in Sichuan province, 208 (14.8%) 
participants live in Inner Mongolia province and the rest of participants (191, 13.5%) live 
in other provinces (i.e. 1.4% in Gansu province, 1.4% in Guizhou province, 1.2% in 
Zhejiang province, 1.0% in Xinjiang province, etc). In terms of the living arrangement, 
1153 participants are living in a dormitory provided by their university or workplace, 209 
participants are living with family, 20 participants are living in a shared house, 14 
participants are living alone by themselves, and 14 participants are living in an 
unspecified condition. Participants with age below 18 years and history of clinical 
diagnosis of any mental health conditions were excluded from the study.  
Materials 
The data used in this study was from a much larger project, certain dataset 
included in the analyses had been used in another study (e.g. Liu et al., 2018) and 
submitted for publication.  
The items of SPQ-B and SPQ-BR were both extracted from the 74-item SPQ as 
they were the brief version of this scale. The participants completed the full-length SPQ 




completed by means of two-stage translated, which was guided by researchers with 
clinical experience (Chen et al., 1997).  
As described above, the Schizotypal Personality Questionnaire-Brief (SPQ-B, 
Raine & Benishay, 1995) is a 22-item self-report scale, shorted based on the full-length 
SPQ (74-item) (Raine, 1991). Due to the limitations identified with dichotomous 
response option (Wuthrich & Bates, 2005), the SPQ-B was administered to participants 
as a five-point Likert scale in the present study.  Two versions of the SPQ-B were utilized 
in the present study. The first version was the original SPQ-B (extracted from SPQ), 
translated into Chinese by Chen et al. in 1997. The second version of the SPQ-B was 
independently translated by Liu (first author), it would be referred to Chinese SPQ-B 
updated.  
The Schizotypal Personality Questionnaire-Brief Revised (SPQ-BR) (Cohen et al., 
2010) contains 32 items and is scored on a five-point Likert scale (1 = “Strongly Disagree” 
to 5 = “Strongly Agree”). There are seven trait subscales that include: Odd Beliefs or 
Magical Thinking, Unusual Perceptual Experiences, Excessive Social Anxiety, Odd or 
Eccentric Behaviour, Odd Speech, No Close Friends and Constricted Affect, and Ideas of 
References and Suspiciousness. It has been demonstrated sound psychometric properties 
through several sources (Callaway et al., 2014; Cohen et al., 2010; Fonseca-Pedrero et al., 
2016). 
Estimation of psychometric properties of all versions of SPQ-B and SPQ-BR in 






    The Chinese SPQ-B updated was translation by Liu (the first author, a bilingual 
researcher with interpreting credential) with a back-translation technique and verified by 
a NAATI accredited English-Chinese translator (National Accreditation Authority for 
Translators and Interpreters (NAATI), is the only organisation authorised by every state 
of Australia to issue accreditation for translator and interpreters for providing 
professional language service) and a bilingual postgraduate student from Faculty of 
Education at Deakin University.  
Procedures 
Approval to conduct this study was obtained from human research ethics 
committees in relevant institutions. Participants were initially directed to a webpage to 
read a Plain Language Statement in simplified Chinese that described the nature of the 
study. In the unlikely events of feeling psychological discomfort or distress after 
completing the questionnaires online, they were advised to access free counselling 
service listed on the webpage. Upon agreeing to participate, they were then required to 
answer questions in relation to demographics (e.g. age, gender, education level, 
geographical location of residence in China, and living arrangement), and followed by all 
the questionnaires that were displayed in a randomised fashion. Most participants did not 
receive incentives for taking part in the study except for people recruited in Sichuan 
Normal University, where despite participation was not mandatory, they received an 





Preliminary analyses were conducted to identify missing data (less than 0.01%) 
and transferring the data file into Mplus (Version 7.31). Descriptive statistics and 
reliability were estimated as the first step. Next, several confirmatory factor analyses 
(CFA) were conducted to compare the model fit indices of both versions of SPQ-B. Due 
to the continuous nature of the data, we used the robust Maximum Likelihood method 
(ML) in Mplus for the estimation of parameters. The model fit was determined by the 
following fit indices: chi-square (χ2), comparative fit index (CFI), Tucker-Lewis Index 
(TLI), root mean square error of approximation (RMSEA) and Standardized Root Mean 
Square Residual (SRMR) against established criteria (Hu & Bentler, 1999; Yu, 2002). 
These criteria indicate that the values of CFI and TLI should be over 0.95 and the 
RMSEA and SRMR values should be under 0.08 to for the fit of the model to be 
considered reasonable (Hu & Bentler, 1991). The values of Akaike Information Criterion 
(AIC) and Bayesian Information Criterion (BIC) were provided as indications for better 
goodness of fit that models, smaller AIC and BIC values have a better fit.  
Results 
 
Descriptive statistics and reliability  
Refer to Table 1 (Appendix) for detailed SPQ-B and SPQ-BR mean scores, 
standard deviation and range in the sample populations. The psychometric properties of 
the SPQ-B and SPQ-BR total score, as well as each of specified subscales, are displayed 
in Table 2. As can be seen, Cronbach’s alpha coefficients were excellent for the data 




schizotypal measures, and values for subscale scores ranged between 0.77 to 0.81 for the 
SPQ-B, 0.79 to 0.81 for the Chinese SPQ-B Updated and 0.63 to 0.80 for the SPQ-BR.  
 
The schizotypal measure with revised translation: the Chinese SPQ-B Updated 
Confirmatory factor analyses (CFA) were performed for testing theoretical models 
proposed in the Likert version of Schizotypal measures. Model fit indices for SPQ-B and 
Chinese SPQ-B Updated are presented from Table 3. Despite the unsatisfactory model of 
fit, it can be seen that compared to the SPQ-B, model fit indices of the proposed models 
have been improved in the Chinese SPQ-B Updated slightly. The change of CFI between 
any models of the SPQ-B and the Chinese SPQ-B Updated was over 0.02, indicating an 
interpretable improvement.  
 
Revising the SPQ-BR: introducing Chinese SPQ-BR Updated 
As one of the objectives of the present study is to develop and validate a 
culturally appropriate brief measure for schizotypy by improving the translation, multiple 
CFAs for different theoretical measurement models were performed for the SPQ-BR (see 
Table 4), it showed that though the model fit indices presented was not ideal, the 3-factor 
second order with 7 factors as the first order in the SPQ-BR appeared to be close to a 
reasonable fit. However, unexpectedly, the 4-factor second order with 7 factors as the 
first order in the SPQ-BR was not identified.  
Consequently, due to the significant improvement observed in the Chinese SPQ-B 
Updated, we revised the translation of the SPQ-BR by extracting eight items (i.e. SPQB3, 




SPQ-B Updated that was commonly shared between the Chinese SPQ-B Updated and the 
SPQ-BR in aim of updating and enhancing psychometric property of the SPQ-BR. The 
version of SPQ-BR with revised translation was referred to the Chinese SPQ-BR Updated. 
As can be seen, in comparison with the original SPQ-BR indices, the goodness of fit of 
the Chinese SPQ-BR Updated presented a good fit of the same model, suggesting this is 




Table 1. The total, mean score, standard deviation and range across SPQ-B, Chinese SPQ-B updated and SPQ-BR 
 Mean SD Range  Mean  SD Range  Mean SD Range 
SPQ-B 
Total 




35.64 12.29 0-88 SPQ-BR 
Total 
52.83 16.74 0-128 
INT 14.78 5.26 0-32 INT 14.41 5.27 0-32 IREF 10.17 3.88 0-24 
COG 12.78 4.86 0-32 COG 12.53 4.94 0-32 MGT 6.09 2.91 0-16 
DIS 8.89 3.89 0-24 DIS 8.72 3.95 0-24 UPE 5.82 2.75 0-16 
          ESA 7.48 3.19 0-16 
        CA/NCF 9.35 4.06 0-24 
        EB 6.16 2.96 0-16 
        OS 7.79 2.65 0-16 
Note:  
For SPQ-B: INT = Interpersonal; COG = Cognitive-Perceptual; DIS = Disorganised. 
For SPQ-BR: IREF = Ideas of References; ESA = Excessive Social Anxiety; MGT = Magical Thinking; UPE = Unusual Perceptual 






Table 2. Reliability (Cronbach’s α) for SPQ, SPQ-B, SPQ-BR total score, and across subscale levels are presented.    
  Cronbach’s α   Cronbach’s α   Cronbach’s α  Cronbach’s α 








INT .81 INT .81 IREF .78 IREF .77 
COG .79 COG .79 MGT .71 MGT .69 
DIS .77 DIS .80 UPE .69 UPE .69 
    ESA .80 ESA .80 
    CA/NCF .76 CA/NCF .76 
    EB .74 EB .79 
    OS .63 OS .63 
Note:  
For SPQ-B: INT = Interpersonal; COG = Cognitive-Perceptual; DIS = Disorganised. 
For SPQ-BR: IREF = Ideas of References; ESA = Excessive Social Anxiety; MGT = Magical Thinking; UPE = Unusual Perceptual 




Table 3. Goodness-fit-indices for the theoretical model proposed for both versions of SPQ-B: SPQ-B and Chinese SPQ-B Updated 
Note: χ2 = chi-square; df = degrees of freedom; CFI = comparative index fit; TLI = Tucker-Lewis Index; RMSEA = root mean square 
error of approximation; SRMR = Standardized root mean square residual; AIC = Akaike information criterion; BIC = Bayesian 











Factor model χ2 df CFI TLI RMSEA SRMR 
One factor 1771.836 209 0.831 0.814 0.073 0.054 
Two factor (Siever & Gunderson, 
1983) 
1551.195 208 0.855 0.839 0.068 0.052 
Three-factor (Raine et al., 1994) 1328.229 202 0.878 0.861 0.063 0.047 
Three-factor (Raine & Benishay, 
1995) 
1395.485 206 0.872 0.856 0.064 0.048 
Four-factor (Stefanis et al., 2004) 1315.886 199 0.879 0.860 0.063 0.047 
Chinese SPQ-B Updated       
One factor 1838.070 209 0.835 0.817 0.105 2.174 
Two factor (Siever & Gunderson, 
1983) 
1477.982 210 0.871 0.859 0.093 2.034 
Three-factor (Raine et al., 1994) 1205.271 205 0.899 0.886 0.083 1.797 
Three-factor (Raine & Benishay, 
1995) 
1347.592 209 0.885 0.872 0.088 1.931 




Table 4. Goodness-fit-indices for the theoretical model proposed for both versions of SPQ-BR: SPQ-BR and Chinese SPQ-BR 
Updated  
Note: χ2 = chi-square; df = degrees of freedom; CFI = comparative index fit; TLI = Tucker-Lewis Index; RMSEA = root mean square 
error of approximation; SRMR = Standardized root mean square residual
SPQ-BR         
Factor model χ2 df CFI TLI RMSEA SRMR AIC BIC 
3-factor second order (7-factor as 1st order) (Cohen et al., 
2010) 
1888.138 454 0.898 0.888 0.047 0.047 112986.256 113542.899 
Chinese SPQ-BR Updated         
Factor model         
3-factor second order (7-factor as 1st order) (Cohen et al., 
2010) 





To date, there has been limited information on the latent structure of schizotypal 
traits in the Chinese population. Few studies have examined the schizotypal traits in a 
Chinese context, let alone revising schizotypal measures to improve their translation and 
capacity to capture personality traits in the Chinese population. Considering the 
limitations identified in the brief measures, the main goal of this work was to revise and 
develop updated brief measures of schizotypy by providing a new translation. To this end, 
we analysed the internal structure of the SPQ-B and Chinese SPQ-B Updated and SPQ-
BR scores through CFA. In addition, the factorial structure of SPQ-BR with new items 
replaced (i.e. the Chinese SPQ-BR Updated) was examined as subsequent analysis. 
Lastly, the descriptive statistics and reliability scores of all scales were estimated. 
Notably, this is the first novel study to update the brief measures of SPQ with participants 
recruited from multiple provinces in China. Such investigation presents significant 
theoretical and clinical implications for cross-cultural research of schizotypy, cross-
cultural psychological assessment research especially in areas of developing and 
validating translated instruments.  
The hypothesis that either a 3-factor or 4-factor solution would provide the best fit 
for data across the schizotypal measures, is not supported. The examination of the 
factorial structure underlying the SPQ-B and SPQ-BR scores indicated that neither 3-
factor nor 4-factor model fits the Chinese sample satisfactorily. While the current result is 
incongruent to many past studies that found otherwise (Fonseca-Pedrero et al., 2016; 




from past studies demonstrated poor identifications of theoretical models of SPQ-B in the 
Chinese population. For example, Fonseca-Pedrero and colleagues found configural 
invariance of SPQ-B in a large cross-national sample (14 countries), but CFA revealed 
that the SPQ-B items in Chinese sample could not be grouped in any of the factor models 
tested (i.e. unidimensional, bidimensional, 3-factor and bifactor) (Fonseca-Pedrero et al., 
2017b). Similar findings were also reported by Liu et al.’s invariance study cross cultures, 
which implied a confounding cultural or language influence in the SPQ-B structure (Liu 
et al., 2017). In addition, Liu and colleagues’ recent investigation suggested that perhaps 
it was difficult to ascertain the latent structure of brief measures not only because of 
cultural or language issues but also cross-loading between factors (Liu et al., 2018). 
Especially, in Stefanis et al.’s 4-factor model, the Interpersonal and Paranoid factors have 
two subscales in common (i.e. Excessive Social Anxiety and Paranoid Ideation), which 
possibly makes the interpretation of subscales cross-loading problematic (Fonseca-
Pedrero et al., 2017a), thereby caused problems with identifying the factor in the Chinese 
sample. (This section of the Discussion overlaps with certain content from the previous 
chapter, Chapter V as it shares the same dataset) 
Despite the effort of addressing the aforementioned translation issue, the attempt 
on updating the SPQ-B (i.e. creating Chinese SPQ-B Updated) was not successful. CFAs 
were conducted in the Chinese SPQ-B Updated to test its model of fit in the sample, 
results displayed were less than ideal. However, comparing with the original Chinese 
SPQ-B, the goodness-of-fit of models examined in the new version has been significantly 




participants’ understanding and comprehension of the items and lead to better 
identification of the underlying factorial structure of SPQ-B. 
The second hypothesis, that SPQ-BR with updated translation (i.e. Chinese SPQ-
BR Updated) would be the best out of all competing measures for Chinese non-clinical 
sample is supported. Since both the 3- (second order) and 4-factor models were poorly 
identified for the SPQ-BR in the sample, we attempted to modify the SPQ-BR by update 
the translation of certain items. 8 items that were shared between Chinese SPQ-B 
Updated and SPQ-BR were used to replace original SPQ-BR items for examination. 
After the modification process, the goodness-of-fit for the model in SPQ-BR has been 
improved from the extent of being unsatisfactory to reasonable. It thereby suggests that 
the key component that leads to the strengthened identification of latent structure is 
revised translation. Such outcome provides evidence to the notion that in the majority of 
past cross-cultural studies, differential findings due to ethnic or cultural differences could 
be attributed to the translation of the scale to some extent. It further accentuates the 
importance of having a linguistically accurate instrument, so that potential problematic 
interpretations associated with item wording can be minimized.  
The results of the current study should be interpreted in light of the following 
limitations. Firstly, although the attempt on amending the schizotypal measures through 
revising translation was successful, we did not explore the possible cultural or ethnic 
confounds in the structure of measures examined in this study, which could have 
impacted on the result. Recent evidence from affective sciences has raised questions 
about whether emotional expression and experiences is structurally similar across 




(interpersonal dimension) that reflect environmental and cultural components vary as a 
function of culture (Cohen et al., 2015). This can be exemplified by a recent investigation 
on an instrument for anticipatory anhedonia.  It discovered different factor solutions for 
individuals from the United States and China, as hedonic experience are defined based on 
cultural and contextual environment (Chan et al., 2012b), this highlighted how affective 
and emotional construct can vary across cultures. Future research may consider 
investigating how cultural influences social and affective functions within the context of 
schizotypy in depth to further understanding of how schizotypy manifests itself in Eastern 
culture in order to prevent psychosis. Second, we did not explore any potential impact 
that could be brought upon by ethnicity. While the Chinese population has mainly 
consisted of the Han race, there are more than thirty minor racial groups living in 
Mainland China. Given that minority ethnic and migrant groups can be over-represented 
among those individuals with schizotypal traits or schizophrenia (Linscott, Marie, Arnott 
& Clarke, 2006), it is important that future researchers to not solely take the cultural but 
also ethnic difference into account. (This section of the Discussion overlaps with certain 
content from the previous chapter, Chapter V as it shares the same dataset) 
In conclusion, schizotypal traits are a multidimensional construct that is closely 
linked to psychosis-spectrum disorders, but how it manifests itself in different cultural 
contexts is still questionable. This study aimed to examine schizotypal traits in Chinese 
sample and revise existing brief measures of schizotypy with a revised translation. It was 
found that neither 3- or 4-factor models demonstrated acceptable fit in existing brief 
schizotypal measures in the Chinese sample until revised translations of items were 
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Linking Chapter: Linking Study three to Study four  
As previously identified in study three, the successful validation of CSPQ-BRU in 
Chinese sample has made it a preferable scale in assessing schizotypy in this population 
in comparison to the SPQ-B and the SPQ-B with updated translation. Given there is 
paucity in the literature on the screening ability of schizotypal measures in clinical groups, 
especially in Asian countries, it inspired the development of study four. The main goal of 
the last study, presented in Chapter VII, is to investigate schizotypal traits in a Chinese 
clinical sample with the updated Schizotypal Personality Questionnaire-Brief Revised, 








Study Four: Schizotypal traits predict clinical disorders: a clinical study using 
Chinese Schizotypal Personality Questionnaire Brief Revise Updated (CSPQ-BRU)  
 Abstract  
To date, there is limited literature on the screening ability of schizotypy measures 
in clinical groups, and especially in Asian populations. The main goal of this work was to 
investigate schizotypal traits in a Chinese clinical sample with an updated Schizotypal 
Personality Questionnaire-Brief Revised, known as the CSPQ-BRU. 90 patients (30 
schizophrenia, 30 anxiety and 30 depression; mean age = 37.71 years, SD = 14.81 years, 
range = 18-66 years) were recruited from the Shanghai Mental Health Center, Shanghai, 
they completed questionnaires of 32-item CSPQ-BRU and 21-item Depression Anxiety 
Stress Scales (DASS). As predicted, patients with schizophrenia displayed the highest 
level of positive schizotypy (i.e. Magical Thinking and Unusual Perceptual Experiences) 
compared to anxiety and depression groups. However, unexpectedly, they did not have 
the highest scores on the CSPQ-BRU total score. Patients with depression and anxiety 
actually scored significantly higher than schizophrenia patients on Excessive Social 
Anxiety element. Results also show that positive schizotypy (i.e. Ideas of Reference) on 
the CSPQ-BRU was positively correlated with anxiety subscale on DASS-21, while 
negative schizotypy (i.e. Excessive Social Anxiety and Constricted Affect) on the CSPQ-
BRU were positively correlated with depressive symptoms on the DASS-21. Overall, the 




of the test, such as Magical Thinking, Unusual Perceptual Experience and Eccentric 
Behaviour might be useful in predicting diagnoses of schizophrenia. In conclusion, the 
CSPQ-BRU does not exclusively tap into schizotypal traits and therefore may not be 
useful for that purpose in clinical groups. 
 
Note: This chapter has been submitted to Schizophrenia Research, see citation: 
Liu, S., Jin, F., Mellor, D., Ling, M., Peng, D. H., & Byrne, L. K. (2018). Schizotypal 
traits predict clinical disorders: a clinical study using Chinese Schizotypal Personality 





Recent research suggests that there is a significant overlap between schizotypy 
and schizophrenia, anxiety and depression. Schizotypal traits can be intrinsically similar 
but less severe than symptoms presented by individuals with the schizophrenia-spectrum 
disorder. Research has found that positive schizotypy (e.g. unusual experiences, magic 
ideation) is associated with positive psychotic symptoms (i.e. psychopathology, assessed 
by the Brief Psychiatric Rating Scale); while negative schizotypy (e.g. introvertive 
anhedonia) is associated with negative psychotic symptoms (measured by the Scale for 
the Assessment of Negative Symptoms) (Lin et al., 2013). Furthermore, findings indicate 
that schizotypy shares other common characteristics with schizophrenia, such as genetic 
proximity (e.g. similar chromosomal region; Walter, Fernandez, Snelling, & Barkus, 
2016), brain structure and functional deficits (Ettinger, Meyhofer, Steffens, Wagner & 
Koutsouleris, 2014; Ettinger et al., 2015), cognition and eye movements (Ettinger et al., 
2015), and environmental risk factors (e.g. winter birth, urbanity, migrant status, 
childhood trauma, cannabis use; Ettinger et al., 2014; Mimarakis, Roumeliotaki, Roussos, 
Giakoumaki, & Bitsios, 2018), supporting the notion that schizotypal traits represent a 
unifying construct that links a broad continuum of clinical and subclinical psychosis 
manifestations together with normal personality variation (Kwapil & Barrantes-Vidal, 
2015).  
Symptoms of anxiety and depression are frequently present in patients with 
schizophrenia and individuals with high levels of schizotypy (Hanssen et al., 2003; 
Lewandowski et al., 2006; Seghers, McCleery, & Docherty, 2011; Rossler et al., 2011). 
In a longitudinal study investigating co-occurrence of personality disorders, McGlashan 




with an Axis-I disorders in DSM-IV is as high as 66.3% for major depression, 20.9% for 
dysthymia, 40.7% for panic disorder, and 31.4% for social phobia. Indeed, many of the 
symptom expressions of schizophrenia overlap with symptom features of anxiety (e.g. 
worry, concentration difficulties) and depression (e.g. social withdrawal, anhedonia), 
suggesting there may be a common underlying mechanism (Lewandowski et al., 2006). 
For example, Hanssen and colleagues reported that three patient groups, schizophrenia 
and other psychotic disorders, mood, and anxiety disorders, scored significantly higher on 
the positive, negative and depressive dimensions on the Community Assessment of 
Psychic Experiences (CAPE) scale that measures psychotic experiences than non-patients. 
Patients with psychotic disorders had the greatest difference in positive psychosis items 
compared to non-patients, whereas patients with mood and anxiety disorders had the 
highest depressive symptom scores and positive symptoms scores comparing to non-
patients and patients with psychotic disorders (Hassen et al., 2003). Similarly, strong 
correlations between anxiety and the positive factor of schizophrenia and schizotypy have 
been reported as well (e.g., Lewandowski et al., 2006; Lin et al., 2013). In contrast, 
findings on depression are rather inconsistent. Depression has often been found to be 
either related to positive schizotypy (Lin et al., 2013), or the disorganized and negative 
schizotypy (i.e. interpersonal factors) (Fonseca-Pedrero, Paino, Lemos-Giraldez, & 
Muniz, 2011; Najolia, Buckner, & Cohen, 2012). In aother case, it is related to all aspects 
of schizotypy (i.e. cognitive disorganisation, unusual experience, introvertive anhedonia) 





Such variability in findings could be partially explained by issues inherent in 
measures of schizotypy. For example, the design of the scale assessing schizotypy could 
unintentionally inflate scores in anxiety-related domains. In particular, one item on the 
Oxford-Liverpool Inventory of Feelings and Experiences (O-LIFE) asks “do you ever 
have a sense of vague danger or sudden dread for reasons that you do not understand”. 
This is likely to be endorsed by individuals experiencing high levels of anxiety 
(Hodgekins, 2015), especially considering that the O-LIFE only gives respondents a 
dichotomous answering format “true” or “false”. In other cases, some items on another 
commonly-used measure, the Schizotypal Personality Questionnaire (SPQ) appear to be 
outdated or problematic (Gross, Kwapil, Raulin, Silvia, Barrantes-Vidal, 2018), while 
certain items relevant to depressive symptoms (e.g., “I tend to keep in the background on 
social occasions”) on the short form of the SPQ, the SPQ-B, are associated with 
ambiguous wording in the Chinese translated version (Liu et al., 2017).  
In the Chinese context specifically, problems in relation to the SPQ and its brief 
versions have been recently identified. Liu and colleagues found the SPQ-B lacked 
invariance across countries due to potential language and culture issues (Liu et al., 2017), 
and their follow-up study showed that in fact, none of the SPQ or its brief versions (i.e. 
SPQ-B and SPQ-BR) produced desirable fit for a Chinese university student sample (Liu 
et al., 2018a) due to the same reasons. Considering the significance of validating 
schizotypy assessment in clinical populations, it is important to have a linguistically- and 
culturally-appropriate tool for several reasons. First, as the factors and items underlying 
schizotypy may possess different sensitivity and specificity for identifying schizotypal 




properties of the measuring instrument in clinical settings is important (Axelrod, Grilo, 
Sanishlow, McGlashan, 2001). Second, applying the assessment tool in clinical samples 
will allow us to augment psychological evaluations such as personality assessment, 
problem clarification and treatment planning (Axelrod et al., 2001), as well as elucidate 
its potential to be used as a screening tool for mental health disorders. Lastly, examining 
the manifestation of schizotypal traits in clinical samples will assist us to determine an 
appropriate cut-off point to delineate the extent to which scores derived from the SPQ are 
clinically significant and the extent to which they only denote mild trait properties. 
Therefore, the purpose of the present study is to investigate schizotypal traits in a 
Chinese clinical sample. There are three aims, the first of which is to validate a recently 
developed instrument, the Chinese SPQ-BR Update (CSPQ-BRU) in a clinical sample. 
This revised version of the SPQ-BR with adjusted translations has shown an improved 
model fit compared to other translation and factor structures and has adequate 
psychometric properties in a Chinese student sample (Liu et al., 2018b). The second aim 
is to examine the discriminant validity of the CSPQ-BRU. Specifically, we wish to 
determine if those with clinically diagnosed schizophrenia, anxiety, and depression differ 
in this version of the SPQ. The third aim is to explore whether this instrument can 
successfully predict membership of clinical diagnoses, i.e. explore which group of 
diagnoses participants belongs to based on scores derived from CSPQ-BRU. Based on 
past research, i) it is hypothesized that schizophrenia patients will score higher on 
positive schizotypy compared to patients from the other two diagnosis groups. ii) It is 
further predicted that positive schizotypy dimensions will be positively correlated with 




depression dimension. Lastly, iii) it is expected that scores obtained on CSPQ-BRU will 
successfully predict the diagnoses of schizophrenia rather than diagnoses of anxiety and 
depression.   
Method 
Participants 
The participants were 90 patients recruited from the Shanghai Mental Health 
Centre, Shanghai, Mainland China (Mean age = 37.71 years, SD = 14.81 years, range = 
18-66 years). A total of 31 males (M = 42.90 years, SD = 15.89 years) and 59 females (M 
= 34.98 years, SD = 13.56 years) took part in the study. There are 30 participants in each 
psychiatric diagnose group respectively, i.e. 30 schizophrenia patients, 30 anxiety 
patients and 30 depression patients. The demographic characteristics (i.e. gender, age, 
education, employment status, the location of residence, length of diagnoses) of the 
sample is presented in Table 1.     
Patients diagnosed with either Schizophrenia, Generalised Anxiety Disorder or 
Major Depression by a psychiatrist and/or psychologist was eligible for this study. 
However, patients aged below 18 years, and/or with a diagnosis of other mental health 
disorders (e.g. bipolar, substance dependence) or patients who are diagnosed with dual-
diagnoses were excluded from the study. Refer to Table 2 for specific demographics 
breakdown (i.e. gender, age, hospitalization, medication and medication dosage) across 







Table 1. Demographic characteristics of the sample. 
N = 90  
Gender  31 Male, 59 Female 
Age (Mean (SD)) 42.9 (15.89) Male, 34.98 (13.56) Female 
Education (%)  
  Postgraduate  6 (6.7%) 
  Bachelor’s degree 38 (42.2%) 
  Diploma certificate 17 (18.9%) 
  High school or below 29 (32.2%) 
Employment Status (%)  
  Full-time or Part-time  39 (43.3%) 
  Unemployed  16 (17.8%) 
  Students  12 (13.3%) 
  Retired  18 (20%) 
  Other  5 (5.6%) 
Location of residence (%)  
  Shanghai 65 (72.2%) 
  Zhejiang province  6 (6.7%) 
  Jiangsu province 4 (4.4%) 
  Anhui province 3 (3.3%) 
  Other  12 (13.4%) 
Length of Diagnoses (%)  
  One year 41 (45.6%) 
  Two years 7 (7.8%) 
  Three – Nine years 19 (20.3%) 
  Ten years or more 20 (23%) 







Table 2. Gender composition, mean and standard deviation of age, inpatients, outpatients 
and medication (number of participants who are on medication), mean medication 
dosage across all diagnostic groups. 




Anxiety  (n= 30) 
Gender (%)    
  Male  16 (53.3%) 7 (23.3%) 8 (26.7%) 
  Female  14 (46.7%) 23 (76.7%) 22 (73.3%) 
Age    
  Mean age (SD) 42.50 (14.71) 34.77 (13.76) 35.87(15.20) 
  Age range (years) 18-66 18-64 19-63 
Hospitalization (%)    
  Inpatients (n= 34) 30 (100%) 4 (13.3%) 0 (0%) 
  Outpatients (n= 56)  0 (0%) 26 (86.7%) 30 (100%) 
Medication (%)    
  Yes (n= 63) 28 (93.3%) 16 (53.3%) 19 (63.3%) 
  No (n= 27) 2 (6.7%) 14 (46.7%) 11 (37.7%) 
Mean Medication 
Dosage (mg) 
254.46 107.94 79.11 
Note: For schizophrenia patients, antipsychotic medications were converted to 
Chlorpromazine. For both depression and anxiety patients, antidepressant medications 






A stratified sampling method was used for recruitment, such that the sample 
included equal numbers of patients in each diagnostic group of interest. Patients were 
recruited from outpatient clinics, and recruitment concluded once it reached 30 
participants in each diagnostic group.   
Materials 
Schizotypal traits were assessed by the Chinese Schizotypal Personality 
Questionnaire-Brief Revised Updated (CSPQ-BRU, Liu et al., 2018b), which contains 32 
items and is scored on a five-point Likert scale (1 = “Strongly Disagree” to 5 = “Strongly 
Agree”). Participants were required to select a response that was most applicable to them. 
Scores were calculated by summing each item up, with higher scores indicating higher 
level of schizotypal traits. There are seven trait subscales: Ideas of References (IREF), 
Magical Thinking (MGT), Unusual Perceptual Experiences (UPE), Excessive Social 
Anxiety (ESA), Constricted Affect or No Close Friends (CA/NCF), Eccentric Behaviour 
(EB), and Odd Speech (OS). These subscales can be grouped into a second order three-
factor model, which includes a Cognitive-Perceptual dimension (i.e. IREF, MGT, UPE), 
and Interpersonal dimension (i.e. ESA, CA/NCF) and a Disorganized dimension (i.e. EB, 
OS). The nature of items and subscales remained the same as the original SPQ-BR 
developed by Cohen and colleagues (Cohen, Matthews, Najolia, & Brown, 2010), with 
improvements of the translation made on the original Chinese version (Chen, Hsiao & 
Lin, 1997). It has demonstrated sound psychometric properties through a validation study 
in China, with reliability estimated with Cronbach’s alpha, with value ranged from 0.92 




study, Cronbach's alpha for the CSPQ-BRU was .93, with subscales also demonstrating 
excellent reliability (a =.72-.85), apart from Unusual Perceptual Experiences (.62) (see 
Table 3). 
The Depression Anxiety Stress Scale-21 (DASS-21) is a popular self-report 
instrument used to measure the frequency and severity of experiencing negative emotions 
over the previous week (Lovibond & Lovibond, 1995). There are three 7-item subscales, 
which include self-reported experiences of depression (e.g. loss of self-esteem/incentives 
and depressed mood), anxiety (e.g. fear and anticipation of negative events) and stress 
(e.g. persistent state of over-arousal and low frustration tolerance). Each item is scored on 
a four-point scale (0 = “did not apply to me at all”, 3 = “applied to me very much, or 
most of the time”). Participants were required to rate the degree to which each of the 
items applied to them over the past week, with higher scores indicative of more severe 
emotional distress. To calculate comparable scores with full DASS, each 7-items 
subscale score was multiplied by two.  
DASS-21 has been translated into a number of languages, including Chinese, 
French, Japanese, Spanish and etc, and has shown good validity across different racial 
groups (i.e. African American, Caucasian, Hispanic and Asian) and Asian countries (e.g. 
Australia, China, Malaysia, Singapore, Malaysian, etc) (Gong, Xie, Xu, & Luo., 2010; 
Mellor et al., 2015; Norton, 2007; Oei, Sawang, Goh, & Mukhtar., 2013). Sound 
psychometric properties across different populations have been demonstrated in both 
clinical and community samples (Antony, Bieling, Cox, Enns, & Swinson., 1998; Nortan, 
2007; Oei et al., 2013). The DASS-21 used in the current study was translated and 




Chinese into simplified Chinese by the first author. In the current study, the reliability of 
the DASS-21 total score as well as each of its subscales was excellent for all scales and 
subscales. For the total scale, Cronbach a was 0.93 while for the subscales it ranged from 
0.83 to 0.90 (see Table 3). 
Procedure  
Approval to conduct the study was obtained from the relevant institutional human 
research ethics committees. Both inpatients and outpatients admitted to Shanghai Mental 
Health Centre who had met the diagnostic criteria for schizophrenia, anxiety or 
depression during the Structured Clinical Interview based on the DSM-IV administered 
by a psychiatrist were invited to take part in this study. After being advised of the nature 
of this study through via a Plain Language Statement in simplified Chinese, participants 
provided written informed consent, and completed hard copies of the questionnaires 
described above and a demographic questionnaire on which they recorded their gender, 
age, level of education, employment status, hospitalization, medication use, and length of 
diagnosis. Each of the participants received 50 Chinese Yuan (approximately $10 
Australian dollars) as compensation for their time in participating.  
Statistical Analysis  
To test the hypothesis i), a series of analysis of variance (ANOVA) analyses were 
used to examine between-group differences on CSPQ-BRU and DASS-21 total as well as 
subscale scores. For hypothesis ii), a series of Pearson’s correlation was performed for 
examining the relationship between CSPQ-BRU subscales and DASS-21 subscales. A 




for hypothesis iii), with subscales of CSPQ-BRU and DASS-21 as predictors and 
diagnosis groups (i.e. schizophrenia, anxiety and depression) as outcome variables on 
SPSS. Finally, ANOVA analyses were also used for examining between-group 
differences in medication use and demographic variables such as age and gender.  
Results 
Medication dosage conversion  
For schizophrenia patients, apart from prescribed antipsychotic drugs, one-third of 
the patients (n=10) were on drugs for treating side-effects associated with the 
antipsychotic drugs (e.g. Magnesium Valproate, Trihexyphenidyl). Different 
antipsychotic medication dosages were converted to Chlorpromazine using an 
Antipsychotic dosage calculator 
(http://psychopharmacopeia.com/antipsychotic_conversion.php). However, drugs such as 
Clozapine and Amisulpride that could not be converted by the calculator were not 
included in the calculation.    
For anxiety and depression patients, all antidepressants dosages were converted to 
Fluoxetine according to a standard provided by Hayasaka and colleagues (Hayasaka et al., 
2015). However, several patients were prescribed tranquillizers such as Lorazepam, 
Diazepam, Alprazolam, or Serotonin and Noradrenaline Reuptake Inhibitors (SNRI) e.g. 
duloxetine, that could not be standardized into Fluoxetine dosage. In addition, two 
patients were taking Chinese medicine instead of Western antidepressants, which could 
not be standardized into Fluoxetine either. Mean medication dosage was presented in 





ANOVA revealed that participants not on medication scored significantly higher 
than participants who were on medication in each measure. Significant differences were 
also found for the following subordinate dimensions: IREF (F (1 , 87) = 11.720, p < .001), 
CA (F (1 , 86) = 5.812, p = .018), and ESA (F (1, 88) = 6.553, p = .012) for CSPQ-BRU; 
and Depression (F (1 , 88) = 11.474, p < .001) and Stress (F (1, 88) = 7.325, p = .008) for 
DASS-21.   
 
Descriptive variables  
There was no significant difference between diagnosis groups in respects to 
gender and age. Refer to Table 2 for Gender composition, the mean and standard 
deviation of age, hospitalization (inpatient and outpatient) and medication, mean 
medication dosage across all diagnosis groups.  
 
Correlations between CSPQ-BRU and DASS-21 
A weak negative correlation between age and CSPQ-BRU total score (r = -.255, n 
= 82, p = .021.) and a moderate negative correlation between age and DASS-21 total 
scores (r = -.451, n = 89, p < .001) were found. There was no gender difference on 
CSPQ-BRU total scores but significance gender difference was observed on DASS-21 
total scores (F (1, 87) = 11.535, p <.001), with females scoring higher than males.  
Dimensions of IREF, CA, ESA, EB, and OS were significantly positively 
correlated with all DASS-21 subscales (i.e. Depression, Anxiety and Stress). No 
significant relationships were observed between the MGT or UPE and the Anxiety and 






A series of ANOVA analyses were performed to examine the between-group 
differences, schizophrenia group was used as a reference (Table 4). There was no 
significant difference between the diagnosis groups (i.e. schizophrenia, anxiety, 
depression) on CSPQ-BRU total scores but difference between subscales were displayed: 
MGT (F (2, 84) = 7.538, p < .001), with schizophrenia patients (M = 6.86, SD = 3.39) 
scoring significantly higher than anxiety patients (M = 4.21, SD = 2.96) and depression 
patients (M = 4.10, SD = 2.76); UPE (F(2, 86) = 3.684, p = .029), with schizophrenia 
patients (M = 5.59, SD = 2.76) scoring significantly higher than depression patients only 
(M = 3.63, SD = 2.99); ESA (F (2, 87) = 6.289, p = .003), with schizophrenia patients (M 
= 5.90, SD = 2.66) scoring significantly lower than anxiety patients (M = 9.13, SD = 4.26) 
and depression patients (M = 8.53, SD = 4.14).  
In contrast, there is a significant difference between the diagnosis groups on the 
DASS-21 total scores as well as its subscales: DASS-21 total (F (2, 86) = 12.194, p 
< .001), with schizophrenia patients (M= 26.67, SD= 26.29) scoring significantly lower 
than anxiety patients (M = 60.00, SD = 27.39) and depression patients (M = 49.40 , SD = 
25.96); Depression (F(2, 87) = 11.469, p < .001), with schizophrenia patients (M = 7.40, 
SD = 8.92) scoring significantly lower than anxiety patients (M = 16.93, SD = 10.90) and 
depression patients (M = 19.60, SD = 11.16); Anxiety (F (2, 86) = 12.538, p < .001), with 
schizophrenia patients (M = 9.80, SD = 9.65) scoring lower than anxiety patients only (M 




patients (M = 9.47, SD = 9.08) scoring lower than anxiety patients (M = 21.60, SD = 9.40) 
and depression patients (M = 17.60, SD = 9.59). Refer to Table 4 for details.    
 
Predicting differential diagnoses 
Multinomial logistic regression analysis was conducted to ascertain whether 
CSPQ-BRU subscale scores would be predictive of diagnoses, DASS-21 subscales were 
inserted into the model as controls. The schizophrenia group was used as the reference 
group. The model had a Nagelkerke’s pseudo-r2 of .685, suggesting approximately 69% 
of the variance was explained. Unexpectedly, only MGT was a significant predictor of 
anxiety diagnosis, odds ratio (Exp (B)) indicates that one unit increase of MGT increases 
the likelihood of the diagnosis of anxiety by 0.55 times, meaning there is little chance for 
the schizophrenia patients to be classified in the anxiety group based on the MGT.  In 
contrast, significant predictors for diagnoses of depression were UPE, EB on CSPQ-BRU, 
and Depression and Anxiety on DASS-21. Odds ratios show the likelihood of 
successfully predicting the diagnosis of depression was 0.62 (UPE), 0.56 (EB), 1.21 
(Depression), 0.83 (Anxiety) respectively. Except for Depression on DASS-21, the rest of 
the predictors suggests there is a little chance for schizophrenia participants to be 
classified in the depression group based on the scores of UPE, EB, and Anxiety. Refer to 






Table 3. Reliability (Cronbach’s α) for CSPQ-BRU and DASS-21 in Chinese clinical 
sample 
 Cronbach’s α  Cronbach’s α 
CSPQ-BRU total  .93 DASS-21 total  .94 
IREF .82 Depression .90 
MGT .78 Anxiety .84 
UPE .62 Stress .83 
ESA .83   
CA/NCF .81   
EB .85   
OS .74   
Note: IREF = Ideas of References; ESA = Excessive Social Anxiety; MGT = Magical 
Thinking; UPE = Unusual Perceptual Experience; OS = Odd Speech; CA = Constricted 




Table 4. The CSPQ-BRU and DASS-21 total, subscale mean scores across all diagnosis groups  
 Schizophrenia   Anxiety   Depression   P value 
 Mean SD Range  Mean SD Range Mean SD Range  
CSPQ-BRU 
total 
48.96 19.60 1-87 53.14 17.26 19-82 52.43 23.60 12-97 .725 
IREF 8.97 3.99 1-18 10.27 4.28 1-19 9.87 5.83 0-20 .560 
MGT 6.86a 3.39 0-16 4.21b 2.96 0-11 4.10b 2.76 0-9 .001** 
UPE 5.59a 2.76 0-11 4.77 2.57 0-10 3.63b 2.99 0-9 .029* 
ESA 5.90a 2.66 0-12 9.13b 4.26 0-16 8.53b 4.14 3-16 .003* 
CA/NCF 10.07 4.41 0-17 11.43 4.99 3-20 12.72 5.41 3-24 .131 
EB 5.73 3.15 0-16 5.67 3.74 0-12 5.72 3.93 0-14 .997 
OS 6.17 2.94 0-14 7.20 3.16 2-15 7.43 3.42 1-14 .276 
DASS-21 total 26.67a 26.29 0-80 60.00b 27.39 14-116 49.40b 25.96 0-90 .000** 
Depression 7.40a 8.92 0-28 16.93b 10.90 2-42 19.60b 11.16 0-40 .000** 
Anxiety 9.80a 9.65 0-30 21.24b 9.73 6-40 12.20 8.26 0-30 .000** 
Stress 9.47a 9.08 0-28 21.60b 9.40 2-40 17.60b 9.59 0-32 .000** 
Note: IREF = Ideas of References; MGT = Magical Thinking; UPE = Unusual Perceptual Experience; ESA = Excessive Social 
Anxiety; CA/NCF = Constricted Affect/No Close Friends; EB = Eccentric Behaviour; OS = Odd Speech. 




a Group indicates the reference group.  













Table 5. The regression coefficients (Exp (B) = Odds Ratio) of the anxiety and depression in contrast to schizophrenia group using 
CSPQ-BRU and DASS-21 subscales as predictors 
 Anxiety (n= 30)  Depression (n= 30)  
Variable Exp (B) 95% Cl Exp (B) 95% Cl 
CSPQ-BRU     
  IREF 1.05 0.77-1.42 1.05 0.76-1.44 
  MGT 0.55* 0.33-0.91 0.69 0.44-1.08 
  UPE 0.87 0.57-1.31 0.62* 0.41-0.96 
  ESA 1.52 0.97-2.36 1.27 0.81-2.00 
  CA/NCF 1.04 0.75-1.45 1.28 0.89-1.83 
  EB 0.71 0.42-1.18 0.56* 0.33-0.94 
  OS 1.26 0.84-1.89 1.47 0.98-2.18 
DASS-21      
  Depression 1.03 0.86-1.22 1.21* 1.01-1.45 
  Anxiety 0.96 0.82-1.13 0.83* 0.70-0.98 
  Stress 1.19 0.97-1.44 1.12 0.91-1.37 
Note. IREF = Ideas of References; ESA = Excessive Social Anxiety; MGT = Magical Thinking; UPE = Unusual Perceptual 
Experience; OS = Odd Speech; CA = Constricted Affect/No Close Friends; EB = Eccentric Behaviour. 
*p< .05. 
Exp (B) = Odds Ratio. 





To date, there is limited literature on the screening ability of schizotypy measures 
for use with clinical populations, especially in Asia. The advantage of assessing 
schizotypy in clinical samples include scrutinizing the potential change in psychometric 
properties of schizotypal measures in clinical populations, assisting clinical psychological 
evaluations such as personality assessment, problem clarification and treatment planning 
as well as elucidating its ability as a screening tool in predicting mental health disorders. 
The main goal of this work was to investigate schizotypal traits in a Chinese clinical 
sample with an updated SPQ-BR, known as the CSPQ-BRU.  
Our analyses highlighted several important findings. First, as predicted, patients 
with schizophrenia displayed the highest level of positive schizotypy (i.e. Magic 
Thinking and Unusual Perceptual experiences) compared to anxiety and depression 
groups. This is in consensus with past findings (Hassen et al., 2003). However, it is 
notable that although non-significant, unexpectedly, the schizophrenia group reported the 
lowest overall schizotypal traits compared to anxiety and depression groups. In fact, the 
average scores of the schizophrenia group were lower than we found in the sample of 
Chinese college students in our previous work (Liu et al., 2018a). This unexpected 
finding suggests that this measure has limited utility for accurate measurement of 
schizotypal traits. If the continuum model were to hold, then we would expect to see 
higher scores in the schizophrenia group than in the college group.  This outcome means 
that any suggested cut-off point for schizophrenia would be inaccurate and non-specific, 
and in turn, calls the validity of the CSPQ-BRU into question. Further, patients with 




Disorganization features compared to patients with schizophrenia. This is somewhat 
consistent with past findings as there is a report on patients with mood and anxiety 
disorders having the highest depressive symptom scores on CAPE (Hassen et al., 2003), 
indicating a potential overlap between negative schizotypy and features of anxiety and 
depression. Alternatively, another possibility for the current findings may relate to the 
inpatient and medication status of the clinical participants.  All of the participants 
diagnosed with schizophrenia were inpatients with the majority of them being on 
medications.  In contrast, relatively few anxiety and depression group combined were 
inpatients, with approximately half of them on medication (Table 2). Considering clinical 
evidence suggests that patients receiving active antipsychotic medication tended to have 
lower scores on schizotypal measures (Koenigsberg et al., 2003), it is possible that the 
effect of antipsychotic medication might have affected how patients responded to self-
reported schizotypal features in the current study.  
Second, schizophrenia patients only obtained high scores on positive schizotypy 
but low scores on anxiety and depressive symptoms. Such results support the hypothesis 
and suggest a promising discriminatory potential for the CSPQ-BRU as it was able to 
differentiate patients who suffer from anxiety, depression and schizophrenia. Furthermore, 
as expected, positive schizotypy (i.e. Ideas of Reference) on the CSPQ-BRU was 
positively correlated with anxiety dimension on DASS-21 and all negative schizotypy 
dimensions (i.e. ESA and CA) on the CSPQ-BURE were positively correlated with 
depressive symptoms on the DASS-21. Patients diagnosed with anxiety presented a 
significantly high level of schizotypal traits on the ESA dimension as well as the highest 




This suggests the level of negative schizotypy possibly matches the level of anxiety and 
stress symptoms reported. Similarly, patients diagnosed with depression scored the 
highest on the CA (i.e. negative schizotypy) dimension of the CSPQ-BRU. This subscale 
corresponds with depressive symptomatology. This is in accordance with past evidence, 
that affective disorder may be etiologically related to the psychotic disorder, with shared 
characteristics of symptom features of anxiety (e.g. worry, concentration difficulties) and 
depression (e.g. social withdrawal, anhedonia) (Lewandowski et al., 2006).  
Third, MGT was the sole significant predictor for anxiety by using schizophrenia 
patients as the reference group, the small odds ratio indicated it is less likely for the 
schizophrenia patients to be classified in the anxiety group based on MGT. Therefore, 
individuals that score high on MGT is more likely to be diagnosed as schizophrenia than 
anxiety. In contrast, UPE and EB on the CSPQ-BRU emerged as significant predictors 
for depression, the small odds ratios indicated it is less likely for schizophrenia patients to 
be classified in the depression group based on these variables. Hence, patients who score 
high on UPE and EB are more likely to be diagnosed as schizophrenia than depression. 
However, other positive schizotypy and disorganized dimensions such as IREF, OS that 
mark the cognitive-perceptual and interpersonal traits of schizotypy that were not 
explicitly observed as significant predictors for either anxiety or depression. This 
suggests that the screening ability of CSPQ-BRU is perhaps limited as schizophrenia is 
characterized by dysfunction in aspects of cognitive-perceptual, interpersonal, 
disorganized dimensions, having three predictors alone cannot guarantee its screening 
ability. Given that the CSPQ-BRU is the most linguistically appropriate and most 




CSPQ-BRU should not be used as a screening tool in clinical populations despite 
presenting a reasonable discriminatory ability.  
This study should be interpreted in light of the following limitations. First of all, 
due to their lack of insight, many patients with schizophrenia may not have a full 
understanding of the severity of their symptoms and therefore could not provide an 
accurate account of their experiences and symptoms while filling out the self-reported 
questionnaires. Considering that lack of insight is frequently reported in many mental 
health conditions, in future, researchers are encouraged to include data on the opinions of 
patients’ consulting doctors, to obtain a more objective point of view. Second, due to the 
limited number of participants as well as the complexity of medications prescribed and 
the difficulties in standardizing all medications dosages, medications were not controlled 
as a covariate in the analysis of the current study. Because the patients with schizophrenia 
were predominantly on antipsychotics, they may have responded differently to 
questionnaires than if they were not medicated (Koenigsberg et al., 2003). We 
recommend that future researchers employ a larger sample size and control the potential 
impact of medication. Lastly, as the results indicated that the CSPQ-BRU has limited 
validity in our clinical sample, future researchers may consider assessing schizotypal 
traits with other available schizotypy measures such as the Multidimensional Schizotypy 
Scale (MSS) which is recently developed and has been reported to have good validity 
across sex and ethnicity (Kwapil, Gross, Silvia, Raulin, & Barrantes-Vidal, 2018).     
In conclusion, this is the first study to investigate schizotypal traits in a Chinese 
psychiatric sample with a recently validated schizotypal measure. The results 




clinical sample with limited validity for differential diagnosis. Notwithstanding the 
limitations identified, this work has significant implications for cross-cultural research on 
schizotypy. It offers insights in psychological assessment and treatment suggestions for 
clinical practice in relation to schizophrenia, anxiety and depression. Additional research 
to determine whether schizotypy measures can predict progression toward schizophrenia 
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Summary and General Discussion  
General Discussion  
 
Schizotypal traits, when considered as an attenuated form of schizophrenia, hold 
promise in research as they grant a unique opportunity to investigate neurodevelopmental 
and psychological factors underlying schizophrenia (Lensenweger, 2018). Theories 
deriving from both quasi-dimensional and dimensional approaches have been employed 
to conceptualize and understand schizotypy as early as the 1950s (e.g. Rado, 1953; 
Claridge, 1997). While there are many self-report instruments measuring schizotypal 
traits, the Schizotypal Personality Questionnaire (SPQ) and its shortened versions such as 
the Schizotypal Personality Questionnaire-Brief (SPQ-B) and Schizotypal Personality 
Questionnaire-Brief Revised (SPQ-BR) have been particularly popular as they have been 
applied widely in clinical and non-clinical settings, and validated across different cultures 
(Axelrod et al., 2001; Aycicegi et al., 2005; Badoud et al., 2011; Compton et al., 2007; 
Fonseca-Pedrero et al., 2011; Fonseca-Pedrero et al., 2016;  Fonssati et al., 2003; Ito et al., 
2010; Ma et al., 2015; Mata et al., 2005; Preti et al., 2015; Stefanis et al., 2004). However, 
at the same time, the questions on the scales’ cross-cultural validity have also been 
brought to light. Such as, can test scores obtained in different cultural populations be 
interpreted in the same way across these populations? Can one instrument that is reliable 
and valid in one particular culture be applied in another after translation? Different 
factorial structure of both SPQ and SPQ-B have been found in cultural contexts (Cicero, 




translation issues, implicating a need for evaluating the cross-cultural validity of SPQ and 
its related measure thus highlighted an important area for further research.  
To address some of these gaps that have emerged from the literature, the purpose 
of this thesis was to evaluate whether the current popular schizotypy assessment tool – 
SPQ and its related brief measures can be used cross-culturally with a special focus on 
Chinese context. Therefore, the aim of the first chapter was to outline and encapsulate the 
theoretical framework of schizotypy, it depicted how schizotypy was conceptualized in 
terms of Quasi-dimensional Model, Dimensional Model, and Fully Dimensional Model 
as well as consequences and outcomes associated with schizotypy. The second chapter 
critically reviewed the relationship between schizotypy and clinical disorders, by 
introducing the key characteristics of schizotypy, identifying central theoretical and 
empirical researches that discuss the overlap between schizotypy and schizophrenia, 
anxiety and depression. The third chapter selectively explored the different assessment 
tools of schizotypy with a particular focus on the self-reported psychometric instrument, 
the SPQ and its related versions. Findings revealed there is a lack of cross-cultural 
validity in the SPQ and its related versions, this could possibly be attributed to limitations 
such as bias in the construction and cultural differences. Such gaps in research provided 
rationale for the following empirical research in this thesis.   
A series of cross-cultural investigations were conducted in order to (i) better 
understand the underlying factorial structure of the SPQ-B across countries from both 
Western and Eastern cultures; (ii) examine the structure of the SPQ and its shortened 
versions in Chinese context; (iii) modify and develop a culturally and linguistically 




validate the CSPQ-BRU in Chinese clinical sample – whether it can be used to predict 
clinical diagnoses. This chapter will summarize and review major findings revealed from 
this series of investigations with reference to important limitations and implications, and 
conclude with recommendations for future research.        
Summary of major findings  
 
Over the course of this PhD candidature, four empirical studies have been 
conducted. The first study (Chapter IV) was published in Psychiatry Research (Liu et al., 
2017), the second (Chapter V) and the last study (Chapter VII) were submitted for 
publication in Assessment and Schizophrenia Research respectively (Liu et al., 2018a; 
2018b).  
As an assessment tool for measuring schizotypal traits, the SPQ-B was widely 
used due to its brevity (e.g. Axelrod, Grilo, Sanislow & McGlashan, 2001; Aycicegi, 
Dinn  & Harris, 2005; Fonseca-Pedrero, Paino, Lemos-Giraldez, Sierra-Baigrie & Muniz, 
2011; Liu et al., 2017). However, inconsistent reports of its latent factorial structures 
(either 3- or 4-factor model) suggest its cross-cultural validity may be limited. Thus, the 
aim of the first study of this thesis was to examine the measurement invariance of the 
SPQ-B across samples from both Western (i.e., Australia and Chile) and Eastern cultures 
(i.e., China). The findings from this study, presented in Chapter IV, revealed that the 
measurement invariance was not established. Further, the results of multiple 
Confirmatory Factor Analyses (CFA) presented the diverse factorial structure of the 
sample, i.e. 4-factor for Australian and 3-factor for both Chinese and Chilean sample. 




Cicero, 2015; Fonseca-Pedrero et al., 2015; Fonseca-Pedrero et al., 2016). However 
notably, this can be explained by differences in sample population (previous studies 
focused on Western population) as well as confounding cultural or language influence in 
the SPQ-B structure, which could be manifested through different factors and item 
composition as reported in divergent findings (Liu et al., 2017).  
This invariance study not only highlighted the lack of cross-cultural validity of the 
SPQ-B, but also the need to understand and minimize confounding cultural and language 
influence presented in the SPQ-B structure, thus leading to the second (Chapter V) and 
third paper (Chapter VI) in the thesis. The second study investigated the structure of SPQ 
and its related versions in one particular culture, the Chinese context; following by the 
third study, which examined the brief versions of SPQ closely, modified the SPQ-BR and 
created a culturally and linguistically appropriate tool for the Chinese sample, the CSPQ-
BRU.  
While previous studies show that the latent structure of the SPQ has been found to 
reflect the proposed underlying structure of schizotypal traits and received support in 
cross-cultural research (Fonseca-Pedrero et al., 2018), it is not clear that this structure is 
replicated in the SPQ-B and SPQ-BR (Liu et al., 2018a). This is especially of concern as 
schizotypal traits are found to be closely associated with a range of psychiatric morbidity 
(e.g. autistic traits, genetic susceptibility for progressing into schizophrenia) in China (Ma 
et al., 2007; Shi et al., 2017), establishing a structurally valid tool is essential for early 
detection of schizotypy and intervention. However, despite recent study reporting 
invariance in Chapman psychosis-proneness scales across culture and time (Chan et al., 




(Kwapil, Gross, Silvia, Raulin & Barrantes-Vidal., 2018) providing new insights of 
schizotypy measures, these scales are not specifically designed for Chinese settings. They 
could be too lengthy to administer in large scale studies too. So what kind of schizotypy 
scales can effectively capture the schizotypal traits in Chinese samples remain a pending 
question. Hence, the aim of the second paper was to explore and identify which Chinese 
version of the schizotypal measures is most suitable for measuring schizotypal traits in 
the Chinese population. Unexpectedly, results of this study indicated that, all of the 
schizotypal measures examined, including SPQ, SPQ-B and SPQ-BR, presented poor 
model fit and did not appear to be adequate measures for assessing schizotypal measures 
in the Chinese population. It is due to potential cultural or ethnic issues associated with 
these translated scales, in line with the limitation identified in the first study. It thereby 
gives rise to the conception of the third study. Presented in Chapter VI, the third study 
was designed to resolve the issues associated with culture and language influences by 
developing and validating a more culturally appropriate instrument for schizotypy in the 
Chinese population with an improved translation based on the original SPQ-B and SPQ-
BR. Findings of this paper suggest the attempt to improving the structure of SPQ-B was 
not successful despite a clear improvement of model fit. In contrast, when comparing the 
goodness-of-fit between the models tested in the SPQ-BR and CSPQ-BRU (new version 
of SPQ-BR with updated translation), a much more significant improvement was 
observed, making the CSPQ-BRU a preferable scale in assessing schizotypy in the 
Chinese sample.  
The outcome of the third paper provides important evidence to having improved 




wordings, thus reducing specific cultural influence to some extent. Given that schizotypal 
traits present a genetic susceptibility for progressing into schizophrenia in China (Ma et 
al., 2007), it is important to have culturally and linguistically appropriate tool for 
screening schizotypal traits in the Chinese population to enable early detection and 
prevention. 
To date, there is limited literature on the screening ability of schizotypy measures 
in clinical groups, and especially in Asian populations. The main goal of this last study, 
presented in Chapter VII, was to investigate schizotypal traits in a Chinese clinical 
sample with an updated Schizotypal Personality Questionnaire-Brief Revised, known as 
the CSPQ-BRU. The outcome of this paper shows that patients with schizophrenia 
displayed the highest level of positive schizotypy (i.e. Magical Thinking and Unusual 
Perceptual Experiences) compared to anxiety and depression groups. However, 
unexpectedly, they did not have the highest scores on the CSPQ-BRU total score. 
Patients with depression and anxiety actually scored significantly higher than 
schizophrenia patients on Excessive Social Anxiety element. Overall, the CSPQ-BRU 
was suboptimal at discriminating between clinical groups, but there are subscales of the 
test, such as Magical Thinking, Unusual Perceptual Experience and Eccentric Behaviour 
that might be useful in predicting diagnoses of schizophrenia.  
To summarize, the key findings of this series of studies are: (i) the schizotypal 
measures examined in this thesis, including SPQ, SPQ-B, SPQ-BR, and Chinese SPQ-BR 
Updated did not appear to be adequate measures for assessing schizotypal measures in 
Chinese population regardless of whether the sample was drawn from the 




and its related brief measures cannot tap into ‘schizophrenia-like’ features (especially 
positive symptomatology), but certain personality traits only; (iii) the Chinese SPQ-BR 
Updated does not exclusively tap into schizotypal traits and is not recommended as a 
screening measure for schizophrenia in Chinese clinical population, as it was effective in 
capturing more depression and anxiety related traits rather than the crucial component of 
schizotypy, the positive dimensions. Implications of these findings, as well as limitations 
and future directions for research, are discussed below.  
Theoretical and practical implications  
 
To my knowledge, the first study is the only research that investigated the cross-
cultural measurement invariance of the SPQ-B in both Western and Eastern cultures at 
the time it was accepted for publication. Results of this study not only help to improve 
our understanding of the expression of schizotypy with regard to its structure and content 
across cultures, but also indirectly question a common practice in the field of 
psychological assessment. That is, taking a scale from one culture and use it as it is in a 
different cultural group after translation while ignoring potential cultural influences the 
scale may have carried with it, which may be embedded in its structure and item wording. 
This paper offers important suggestions that, when developing or revising a translated 
scale, other than using the back-translation technique, assistance from linguists and 
psychologists would be proven helpful in terms of maximizing the accuracy of the 
instrument (Van de Vijver and Tanzer, 2004). In addition, conducting a pre-test pilot 
study with participants from the targeted population may also be useful to ensure the 




Although the second study that found none of the schizotypal measures tested 
appears to be valid in Chinese sample, such findings present significant theoretical and 
clinical implications for cross-cultural research of schizotypy, cross-cultural 
psychological assessment as well as psychiatric diagnostic systems (Liu et al., 2018a). In 
particular, it raised further questions to be tackled in cross-cultural research, for instance, 
if the SPQ was found to be valid in other cultures whereas it is not in the Chinese context, 
is it due to the intrinsic validity of the instrument itself or the culture it is applied in? 
A follow-up study (the third study) was designed to resolve some of the issues 
presented in the second study. It succeeded in validating the CSPQ-BRU in university 
student sample, which provides both theoretical and practical implications. Firstly, the 
revised translation was the key for a better functioning scale, it potentially reduces the 
ethnic or cultural influence that may have existed earlier. Secondly, this scale could be 
useful in capturing schizotypal traits in the Chinese population with more accuracy and 
precision.     
Finally, the last study utilized a clinical sample and was the first to test CSPQ-
BRU’s efficacy in determining group membership based upon clinical diagnoses. 
Findings of this paper present several implications: theoretically, it contributes to the 
growing evidence of using the schizotypal measure as a screening tool; practically, it 
offers clinicians insights in choosing a suitable screening tool for schizophrenia. 






There are a number of limitations in this thesis. First of all, Chapter I selectively 
reviewed the literature pertinent to creativity and spiritual experiences as part of the 
consequences and outcomes of schizotypy. Exploring how and why they are linked to 
schizotypy can provide valuable insights in treatment options (experiencing spiritual 
experience holds promise for healing, Jackson, 1997) as well as an application of positive 
psychology (i.e. creativity). However, this area was largely untouched in this thesis as the 
scope of investigations focused more on the cross-cultural assessment and schizotypal 
measures’ application in the clinical setting. Future research may consider investigating 
how to encourage innovation, creative productions in individuals with schizotypal traits 
as well as exploring the therapeutic value of schizotypal traits instead of paying attention 
to its pathologizing detriments only.   
Second, it may be noted that the second and third paper share the same dataset, so 
unavoidably they share certain weaknesses together, such as the gender imbalance 
(approximate 76% female and 24% male). The past studies reported gender differences in 
schizotypal scores (Mata et al., 2005; Wuthrich & Bates, 2005) and gender has yielded 
invariance across samples (Fonseca-Pedrero et al., 2011; Yu et al., 2015), whereas this 
was not tapped into in those studies. It is hence uncertain whether gender has impacted on 
the results. Future study may consider exploring factors related to demographic or other 
characteristics such as age, gender, education, ethnicity or country in which samples are 
recruited from, to control for moderating or mediating effects.     
Third, in the last study, there is a possibility that due to lack of insight, many 
patients with schizophrenia may not have a full understanding of the severity of their 




symptoms while filling out the self-reported questionnaires (Liu et al., 2018b). 
Considering that lack of insight is frequently reported in many mental health conditions, 
in future, researchers can consider whether to include data on the opinions of patients’ 
consulting doctors, to obtain a more objective point of view (Liu et al., 2018b).  
Lastly, controlling the effects of medication dosage in the last study presented to 
be a difficult challenge. Although I have attempted to standardize the dosage in different 
diagnoses groups across the board according to an online dosage calculator and a 
published article, many prescribed medications were not listed in those resources. 
Therefore, there were a few medications that could not be standardized and included in 
the calculation, which fundamentally nullify the idea of controlling the impact of 
medication. Given the evidence that patients with schizophrenia on antipsychotics may 
respond differently to questionnaires than if they were not medicated (Koenigsberg et al., 
2003), it is likely that effects of the medication have impacted on the reported results. 
Future researchers may consider employing a larger sample size when working with a 
clinical sample so that it gives freedom in carrying out various analyses.  
Recommendations for future research  
 
Several recommendations can be drawn from this PhD thesis regarding the future 
direction of research in the field of cross-cultural assessment of schizotypy. Based on the 
study findings, it is recommended that:  
(i) Understanding schizotypy requires more comprehensive studies examining 
multiple measures so that we will obtain a “full picture” of what schizotypy entails. As 




valid in China, future researchers may consider using other instruments that were 
mentioned in the early chapter of this thesis, such as Wisconsin Schizotypy Scales, 
Oxford-Liverpool Inventory of Feelings and Experiences (O-LIFE), the latest validated, 
The Multidimensional Schizotypy Scale and its brief version to assess schizotypy.  
(ii) It is intriguing and certainly a delight to see recent studies working on 
updating old schizotypal measures or developing new measures because of existing ones 
present problems. However, going back to the fundamental questions introduced at the 
beginning of this thesis, when it comes to cross-cultural research, can one instrument that 
is reliable and valid in one particular culture be applied in another after translation? Can 
the scores obtained by these scales be standardized across cultures? If indeed they can be, 
what are we measuring then? I think these are some basic but essential questions that are 
still yet answered in this field, which offers a promising opportunity for future cross-
cultural research.     
Conclusion  
 
Findings of this thesis conclude that the cross-cultural validity and the clinical 
application of the SPQ and its related measures are limited not only in the Chinese 
sample but also cross-culturally. Nonetheless, while the predictability of recently 
developed schizotypal measure, i.e. CSPQ-BRU needs further exploration or 
modification in order to be applied in a clinical setting, the thesis findings provide 
promising evidence supporting the importance of cross-cultural assessment of schizotypal 
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TO:  Participant,  
 
Plain Language Statement  
Date: May, 2017 
Full Project Title: Validation of a measure of schizotypy in a Chinese clinical sample 
Principal Researchers: Dr Linda Byrne, Professor David Mellor, and Dr Mathew Ling 
Student Researchers:  Ms Shujuan Liu 
 
Purpose 
You are invited to participate in this study. Your participation will be valued by us and 
we appreciate the time you have taken in considering our invitation.  
The study aims to assess a culturally appropriate instrument for measuring different 
aspects of thinking, feeling and behaving among Chinese people who are seeking help 
from a mental health service. The project will include patients who has been formally 
diagnosed with either schizophrenia, anxiety or depression.  
 
Procedures 
If you agree to participate in this study you will be asked to fill out a series of 




The questionnaire will ask you about your experiences (e.g. “have you had experiences 
with the supernatural?”), behaviours (e.g. “people sometimes comment on my unusual 
mannerisms or habits”), and how comfortable you feel around other people (e.g. “I prefer 
to keep to myself”).  
In addition, we will record (i) your age (ii) your gender (iii) the condition with which you 
have been diagnosed (iv) how long have you been diagnosed (v) which part of Mainland 
China you live in.  
The questionnaires will take approximately 10 minutes to complete.  
Your participation will help us to establish the usefulness of the measure. 
 
Risks and potential benefits to participants 
Your involvement in this project will not expose you to any risk of emotional or physical 
harm which is greater than that encountered in your normal daily life.  There are no 
anticipated risks, side effects, and discomforts as you are simply required to complete 
some questionnaires. However, in the unlikely event that participation in this 
experiment causes you some distress, you can contact your doctor and access 
counselling service that is available to you at Shanghai Mental Health Centre.  
 
How privacy and confidentiality will be protected 
As this study is completely voluntary, you are under no obligation to consent to 
participate. By completing the consent form you will be indicating your willingness to 
participate in the study.  All aspects of this study, including results, will be strictly 
confidential, and only the researchers will have access to information on participants. To 
maintain confidentiality, you will not be asked any information that would allow us to 
identify you in this questionnaire. 
 
Dissemination of the research results 
At the completion of this project, a report which summarizes the findings will be 
produced and the findings may also be reported in a scientific journal.  If you would like 
a copy of the findings, you may contact the researchers by means of the information 
supplied below. 
Storage of the data collected will adhere to Deakin University regulations.  All data will 
be kept in secure storage indefinitely for potential review. The research results will be 
written up in the form of a research report, and may be submitted for publication. In the 
case of publication, individual participants will not be identifiable as only anonymous 
data will be reported. 
 
Payments to participants 





Right to withdraw from the project  
If you decide after commencing the questionnaires that you do not wish to continue, then 
you do not need to do so.  Please note that as the questionnaire is anonymous, you are not 
individually identifiable, and therefore once the questionnaire has been processed, it will 
not be possible for you to withdraw from the research. 
 
Contact details of the researchers  
If you have any queries, or would like to be informed of the aggregate research finding, 
please contact Dr Linda Byrne via email at linda.byrne@deakin.edu.au.  You may do this 
in Chinese language. 
Complaints 
If you have any complaints about any aspect of the project, the way it is being 
conducted or any questions about your rights as a research participant, then you may 
contact:  
The Manager, Deakin Research Integrity, Deakin University, 221 Burwood Highway, 
Burwood Victoria, 3125, Telephone: 9251 7129, Facsimilie: 9244 6581; research-
ethics@deakin.edu.au 
Please quote project number: 2017-204 Validation of a measure of schizotypy in a 








                                              
 
 








I have read, or have had read to me in my first language and I understand the attached 
Plain Language Statement. 
I freely agree to participate in this project according to the conditions in the Plain 
Language Statement.  
I have been given a copy of the Plain Language Statement and Consent Form to keep.  
The researcher has agreed not to reveal my identity and personal details, including 
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Study One used pre-existing data (i.e. SPQ-B questionnaire) and was exempted 
from ethics review, it will not be attached. 
 
Study Two and Three administered online questionnaires in Chinese (i.e. SPQ, 
Chinese SPQ-B Updated, DASS-14 and STA), both English and Chinese versions of 
these questionnaire are attached.  
 
Study Four utilized physical copies of questionnaires in Chinese (i.e. Chinese 
SPQ-BR Updated and DASS-21), both English and Chinese versions of these 





Questionnaires used in Study Two and Three 
SPQ (Schizotypal Personality Questionnaire) 
1. Do you sometimes feel that things you see on the TV or read in the newspaper 
have a special meaning for you? 
2. I sometimes avoid going to places where there will be many people because I will 
get anxious. 
3. Have you had experiences with the supernatural? 
4. Have you often mistaken objects or shadows for people, or noises for voices? 
5. Other people see me as slightly eccentric (odd). 
6. I have little interest in getting to know other people. 
7. People sometimes find it hard to understand what I am saying. 
8. People sometimes find me aloof and distant. 
9. I am sure I am being talked about behind my back. 
10. I am aware that people notice me when I go out for a meal or to see a film. 
11. I get very nervous when I have to make polite conversation. 
12. Do you believe in telepathy (mind-reading)? 
13. Have you ever had the sense that some person or force is around you, even 
though you cannot see anyone? 
14. People sometimes comment on my unusual mannerisms and habits. 
15. I prefer to keep myself to myself. 
16. I sometimes jump quickly from one topic to another when speaking. 
17. I am not good at expressing my true feelings by the way I talk and look. 
18. Do you often feel that other people have it in for you?  
19. Do some people drop hints about you or say things with a double meaning? 
20. Do you ever get nervous when someone is walking behind you? 
21. Are you sometimes sure that other people can tell what you are thinking?  
22. When you look at a person, or yourself in a mirror, have you ever seen the face 
change right before your eyes? 
23. Sometimes other people think that I am a little strange. 
24. I am mostly quiet when with other people. 
25. I sometimes forget what I am trying to say. 
26. I rarely laugh and smile. 
27. Do you sometimes get concerned that friends or coworkers are not really loyal or 
trustworthy? 
28. Have you ever noticed a common event or object that seemed to be a special sign 
for you? 
29. I get anxious when meeting people for the first time. 
30. Do you believe in clairvoyance (psychic forces, fortune telling)? 
31. I often hear a voice speaking my thoughts aloud. 
32. Some people think that I am a very bizarre person. 
33. I find it hard to be emotionally close to other people. 
34. I often ramble on too much when speaking. 
35. My "nonverbal" communication (smiling and nodding during a conversation) is 




36. I feel I have to be on my guard even with friends. 
37. Do you sometimes see special meanings in advertisements, shop windows, or in 
the way things are arranged around you? 
38. Do you often feel nervous when you are in a group of unfamiliar people? 
39. Can other people feel your feelings when they are not there? 
40. Have you ever seen things invisible to other people? 
41. Do you feel that there is no one you are really close to outside of your immediate 
family, or people you can confide in or talk to about personal problems? 
42. Some people find me a bit vague and elusive during a conversation. 
43. I am poor at returning social courtesies and gestures. 
44. Do you often pick up hidden threats or put-downs from what people say or do? 
45. When shopping do you get the feeling that other people are taking notice of you? 
46. I feel very uncomfortable in social situations involving unfamiliar people. 
47. Have you had experiences with astrology, seeing the future, UFOs, ESP, or a sixth 
sense? 
48. Do everyday things seem unusually large or small? 
49. Writing letters to friends is more trouble than it is worth. 
50. I sometimes use words in unusual ways. 
51. I tend to avoid eye contact when conversing with others. 
52. Have you found that it is best not to let other people know too much about you? 
53. When you see people talking to each other, do you often wonder if they are 
talking about you? 
54. I would feel very anxious if I had to give a speech in front of a large group of 
people. 
55. Have you ever felt that you are communicating with another person telepathically 
(by mind-reading)? 
56. Does your sense of smell sometimes become unusually strong? 
57. I tend to keep in the background on social occasions. 
58. Do you tend to wander off the topic when having a conversation? 
59. I often feel that others have it in for me. 
60. Do you sometimes feel that other people are watching you? 
61. Do you ever suddenly feel distracted by distant sounds that you are not normally 
aware of? 
62. I attach little Importance to having close friends.  
63. Do you sometimes feel that people are talking about you? 
64. Are your thoughts sometimes so strong that you can almost hear them? 
65. Do you often have to keep an eye out to stop people from taking advantage of 
you? 
66. Do you feel that you cannot get "close" to people? 
67. I am an odd, unusual person. 
68. I do not have an expressive and lively way of speaking. 
69. I find it hard to communicate clearly what I want to say to people. 
70. I have some eccentric (odd) habits. 




72. People occasionally comment that my conversation is confusing. 
73. I tend to keep my feelings to myself. 






STA (Schizotypal personality A scale) 
1. Do you believe in telepathy? 
2. Do you often feel that other people have it in for you? 
3. When in the dark do you often see shapes and forms even though there’s nothing 
there? 
4. Does your own voice ever seem distant, faraway? 
5. Does if often happen that almost every thought immediately and automatically 
suggests an enormous number of ideas? 
6. Do you ever become oversensitive to light or noise? 
7. Do you often have vivid dreams that disturb your sleep? 
8. When you are worried or anxious do you have trouble with your bowels? 
9. Have you every felt when you looked in a mirror that your face seemed different? 
10. Do you feel it is safer to trust nobody? 
11. Do things sometimes feel as if they were not real? 
12. Do you feel lonely most of the time even when you’re with people? 
13. Do everyday things sometimes seem unusually large or small? 
14. Are you often bothered by the feeling that people are watching you? 
15. Do you feel that you cannot get ‘close’ to other people? 
16. Do you dread going into a room by yourself where other people have already 
gathered and are talking? 
17. Does your sense of smell sometimes become unusually strong? 
18. Are you sometimes sure that other people can tell what you are thinking? 
19. Have you ever had the sensation of your body or part of it changing shape? 
20. Do you ever feel sure that sometime is about to happen even though there doesn’t 
seem to be any reason for your thinking that? 
21. Do you ever suddenly feel distracted by distant sounds that you are not normally 
aware of? 
22. Do you ever have a sense of vague danger or sudden dread for reasons that you do 
not understand? 
23. Have you ever thought you heard people talking only to discover that it was in fact 
some nondescript noise? 
24. Do your thoughts ever stop suddenly causing you to interrupt what you’re saying? 
25. Do you feel that you have to be on your guard even with your friends? 
26. Do you ever feel that your thoughts don’t belong to you? 
27. When in a crowded room do you often have difficulty in following a conversation? 
28. Do you sometimes feel that your accidents are caused by mysterious forces? 
29. Do you feel at times that people are talking about you? 
30. Do you believe that dreams can come true? 
31. Do you ever feel that your speech is difficult to understand because the words are 
all mixed up and don't make sense? 
32. Are your thoughts sometimes so strong that you can almost hear them? 
33. When coming into a new situation, have you ever felt strongly that it was a repeat of 




34. Have you ever felt that you were communicating with another person 
telepathically? 
35. Are you easily distracted from work by daydreams? 
36. Are you very hurt by criticism? 





DASS21  Name:     Date: 
Please read each statement and circle a number 0, 1, 2 or 3 which indicates how much the 
statement applied to you over the past week.  There are no right or wrong answers.  Do 
not spend too much time on any statement. 
The rating scale is as follows: 
0 Did not apply to me at all 
1 Applied to me to some degree, or some of the time 
2 Applied to me to a considerable degree, or a good part of time 
3 Applied to me very much, or most of the time 
 
1 I found it hard to wind down  0 1 2 3 
 
2 I was aware of dryness of my mouth  0 1 2 3 
 
3 I couldn’t seem to experience any positive feeling at all  0 1 2 3 
 
4 I experienced breathing difficulty (eg excessively rapid 
breathing, breathlessness in the absence of physical exertion) 
 0 1 2 3 
 
 
5 I found it difficult to work up the initiative to do things  0 1 2 3 
 
6 I tended to over-react to situations  0 1 2 3 
 
7 I experienced trembling (eg in the hands)  0 1 2 3 
 
8 I felt that I was using a lot of nervous energy  0 1 2 3 
 
9 I was worried about situations in which I might panic and make 
a fool of myself 
 0 1 2 3 
 
10 I felt that I had nothing to look forward to  0 1 2 3 
 
11 I found myself getting agitated  0 1 2 3 
 
12 I found it difficult to relax  0 1 2 3 
 
13 I felt down-hearted and blue  0 1 2 3 
 
14 I was intolerant of anything that kept me from getting on with 
what I was doing 
 0 1 2 3 
 
15 I felt I was close to panic  0 1 2 3 
 
16 I was unable to become enthusiastic about anything  0 1 2 3 
 
17 I felt I wasn’t worth much as a person  0 1 2 3 
 





19 I was aware of the action of my heart in the absence of physical 
exertion (eg sense of heart rate increase, heart missing a beat) 
 0 1 2 3 
 
20 I felt scared without any good reason  0 1 2 3 
 







Questionnaires used in Study Two and Study Three in Chinese 






















































































Chinese SPQ-B Updated  


























STA (Schizotypal personality A scale) Chinese translation  
Translated by Shujuan Liu (the thesis author), NAATI accredited interpreter  
1.  
2.  

















20. 。  
21.  
22.  





























1 我觉得很难让自己安静下来 0      1      2      3 
2 我感到口干 0      1      2      3 
3 我好像不能再有任何愉快、舒畅的感觉 0      1      2      3 
4 我感到呼吸困难（例如不是做运动时也感到气促或透不过气来） 0      1      2      3 
5 我感到很难自动去开始工作 0      1      2      3 
6 我对事情往往做出过敏反应 0      1      2      3 
7 我感到颤抖（例如手震） 0      1      2      3 
8 我觉得自己消耗很多精神 0      1      2      3 
9 我忧虑一些令自己恐慌或出丑的场合 0      1      2      3 
10 我觉得自己对将来没有什么可盼望 0      1      2      3 
11 我感到忐忑不安 0      1      2      3 
12 我感到很难放松自己 0      1      2      3 
13 我感到忧郁沮丧  0      1      2      3 
14 我无法容忍任何阻碍我继续工作的事情 0      1      2      3 
15 我感到快要恐慌了 0      1      2      3 
16 我对任何事也不能热衷 0      1      2      3 







18 我发觉自己很容易被触怒 0      1      2      3 
19 我察觉自己在没有明显的体力劳动时，也感到心率不正常 0      1      2      3 
20 我无缘无故的感到害怕 0      1      2      3 




 Questionnaires used in Study Four 
SPQ-BR  
1 I sometimes avoid going to places where there will be many people because I will get 
anxious. 
2 Other people see me as slightly eccentric (odd). 
3 Do you believe in telepathy (mind-reading)? 
4 People sometimes comment on my unusual mannerisms and habits. 
5 I sometimes jump quickly from one topic to another when speaking. 
6 I am not good at expressing my true feelings by the way I talk and look. 
7 When you look at a person or yourself in a mirror, have you ever seen the face 
change right before your eyes? 
8 I sometimes forget what I am trying to say. 
9 I rarely laugh and smile. 
10 Do you sometimes get concerned that friends or co-workers are not really loyal or 
trustworthy? 
11 I get anxious when meeting people for the first time. 
12 Do you believe in clairvoyance ( psychic forces, fortune telling) ? 
13 I often hear a voice speaking my thoughts aloud. 
14 I find it hard to be emotionally close to other people 
15 I often ramble on too much when speaking. 
16 Do you often feel nervous when you are in a group of unfamiliar people? 
17 Do you feel that there is no one you are really close to outside of your immediate 
family, or people you can confide in or talk to about personal problems? 
18 When shopping do you get the feeling that other people are taking notice of you? 
19 I feel very uncomfortable in social situations involving unfamiliar people. 
20 Have you had experiences with astrology, seeing the future, UFO's, ESP, or a sixth 
sense? 
21 Do everyday things seem unusually large or small? 
22 Have you ever felt that you are communicating with another person telepathically (by 
mind-reading)? 
23 Do you tend to wander off the topic when having a conversation? 
24 I often feel that others have it in for me. 
25 Do you sometimes feel that other people are watching you? 
26 Do you sometimes feel that people are talking about you? 
27 Are your thoughts sometimes so strong that you can almost hear them? 
28 Do you often have to keep an eye out to stop people from taking advantage of you? 
29 Do you feel that you cannot get "close" to people. 
30 I am an odd, unusual person. 
31 I have some eccentric (odd) habits. 







DASS21  Name:     Date: 
Please read each statement and circle a number 0, 1, 2 or 3 which indicates how much the 
statement applied to you over the past week.  There are no right or wrong answers.  Do 
not spend too much time on any statement. 
The rating scale is as follows: 
4 Did not apply to me at all 
5 Applied to me to some degree, or some of the time 
6 Applied to me to a considerable degree, or a good part of time 
7 Applied to me very much, or most of the time 
 
1 I found it hard to wind down  0 1 2 3 
 
2 I was aware of dryness of my mouth  0 1 2 3 
 
3 I couldn’t seem to experience any positive feeling at all  0 1 2 3 
 
4 I experienced breathing difficulty (eg excessively rapid 
breathing, breathlessness in the absence of physical exertion) 
 0 1 2 3 
 
 
5 I found it difficult to work up the initiative to do things  0 1 2 3 
 
6 I tended to over-react to situations  0 1 2 3 
 
7 I experienced trembling (eg in the hands)  0 1 2 3 
 
8 I felt that I was using a lot of nervous energy  0 1 2 3 
 
9 I was worried about situations in which I might panic and make 
a fool of myself 
 0 1 2 3 
 
10 I felt that I had nothing to look forward to  0 1 2 3 
 
11 I found myself getting agitated  0 1 2 3 
 
12 I found it difficult to relax  0 1 2 3 
 
13 I felt down-hearted and blue  0 1 2 3 
 
14 I was intolerant of anything that kept me from getting on with 
what I was doing 
 0 1 2 3 
 
15 I felt I was close to panic  0 1 2 3 
 
16 I was unable to become enthusiastic about anything  0 1 2 3 
 
17 I felt I wasn’t worth much as a person  0 1 2 3 
 





19 I was aware of the action of my heart in the absence of physical 
exertion (eg sense of heart rate increase, heart missing a beat) 
 0 1 2 3 
 
20 I felt scared without any good reason  0 1 2 3 
 












ÂÃ&b;¤%/5 Personal Information 
 
1.  Age : ________   
 
 Date of Birth ________  ________  ________  
 
2.  Gender : 
 
  Male ☐ 
              G Female ☐ 
       ! Other ________ 
 
3.  Education Level : 
 
 High school or below ☐ 
 
 Diploma ☐ 
 
 Undergraduate ☐ 
 
 Postgraduate or above ☐ 
 
4.  Employment status 
 
 Full-time or Part-time work ☐  
 If ticked, what kind of work do you do : 
________  
 
 Unemployed ☐ 
  
 Student ☐ 
 
 Retired ☐ 
 





5.  Which part of Mainland China do you live in : 
________ 
 
 *o Mental Health related information 
 
1.  Hospitalization :  
 
 Inpatient ☐ 
 
 Outpatient ☐ 
 
 Other ________ 
 
 
2.  Mental Health Diagnosis : 
¥'­ Schizophrenia ☐ 
 Anxiety ☐ 
l¹ Depression ☐ 
! Other ________ 
 
3.  How long have you been diagnosed : ________ 
 
4.  Do you take any medication : 
 
 Yes ☐ 
 
 No ☐ 
 
5. “ ”  If “yes”, what kind of medication do you 
take : ________  What is the dosage : ________ 
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Appendix E  
Publication arising from this thesis  
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